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Summary
The aim of this work was to evaluate the hypothesis that the carcinogenic 
potential of a chemical may be related to its propensity to induce the enzyme 
system(s) responsible for its metabolic activation to reactive intermediates. 
This was carried out using isomers or structurally related chemicals from the 
following major classes of carcinogens: the chrysenes, azobenzenes, 
diaminonaphthalenes and related aromatic amines, and th e  
diaminotoluenes. Furthermore, correlation between the induction of rat 
hepatic CYP1A and binding to the rat cytosolic Ah receptor was determined 
for all these compounds.
Chrysene, all its methyl isomers and two benzo derivatives were potent 
inducers of CYP1A activity which was directly related to their avidity for 
binding to the Ah receptor. The 5-methyl isomer, the most potent carcinogen, 
did not differ from the other isomers in its ability to induce CYP1A1 activity. 
Treatment of rats with the various chrysenes did not stimulate their ability to 
convert them to mutagenic intermediates in the Ames test.
Azobenzene and all its substituted isomers varied in their ability to induce 
CYP1A activity which was directly related to their avidity for binding to the Ah 
receptor. 3-Methoxy-4-aminoazobenzene and o-aminoazotoluene, the most 
potent carcinogens were also the most potent inducers of CYP1A activity 
and displacers of pH]-TCDD from the Ah receptor. Treatment of rats with the 
various azobenzenes did not stimulate their ability to convert them to 
mutagenic intermediates in the Ames test.
The diaminonaphthalenes and related aromatic amines differed in their 
ability to induce CYP1A activity which was directly related to their avidity for 
binding to the Ah receptor. Only rats treated with the diaminonaphthalenes 
enhanced their own activation to mutagenic intermediates in the Ames test.
Of the diaminotoluenes, the best inducers of CYP1A activity were also the 
most effective displacers of pHj-TODD from the Ah receptor, namely, 2,3- 
and 2,4-diaminotoluene. 2,4-Diaminotoluene was the only isomer which 
enhanced its own activation to mutagenic intermediates in the Ames test.
Investigation into the binding of a series of structurally diverse aromatic 
amines to the Ah receptor revealed that a strong positive correlation 
between binding affinity and propensity to induce both CYP1A1 and 
CYP1A2 activities. Furthermore, binding to the Ah receptor was achieved by 
N-hydroxy-2 -naphthylamine, a major metabolite of 2-naphthylamine.
It can be concluded from this work that the hypothesis that the carcinogenic 
potential of a chemical may be related to its ability to induce the enzyme 
systems(s) responsible for its metabolic activation to reactive intermediates
has limitations, which need to be taken in to account in order for it to be used 
as a predictor of chemical toxicity and carcinogenesis.
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CHAPTER 1
General Introduction
1.0 General Introduction
1.1 Cancer
Cancer was once considered to be a modern day disease. However 
palaeopathologists have shown this not to be the case; they have detected 
neoplastic lesions in the bones of dinosaurs which inhabited this planet long 
before Homo sapiens. The earliest record of human cancer dates back to 
ancient Egypt; papyrus dating back to 1600BC has been discovered which 
depicts hieroglyphics referring to the word "tumour", and later in the 4 ^^  
century BC the term carcinoma was coined by Hippocrates (Pitot, 1986).
1.2 History of chemical carcinogenesis
Chemical carcinogenesis was first recognised in the 18*  ^ century by Sir 
Percival Pott who suggested that a causal relationship may have existed 
between scrotal cancer and exposure to soot amongst chimney sweeps (Pott, 
1775). The next development in this area was not until the early 2 Qth century, 
when in 1915, Yamagiwa and Ichikawa succeeded in inducing skin tumours 
on rabbit ears by the repeated painting of coal tar. Three years later Tsutsui 
produced the same result, again using coal tar, but this time on mouse skin. 
Later on, in 1921, the chemical properties of the carcinogenic component in 
the coal tar were elucidated by Bloch and Dreifuss. Bloch and Dreifuss 
discovered that the carcinogenic component possessed a high boiling point 
and was devoid of nitrogen and sulphur. Furthermore, it could form a stable 
picrate. A decade or so later, in 1933, Cook, Hewett and Hieger isolated the 
carcinogenic component from two tons of coal tar and proceeded to show that 
it possessed fluorescent properties. The carcinogenic component was 
subsequently identified as benzo[a]pyrene. To date, benzo[a]pyrene is
probably one of the most extensively studied polycyclic aromatic 
hydrocarbons (Harvey, 1991).
Another general class of chemical carcinogens are exocyclic nitrogen 
compounds known as the aromatic amines, which include the azo dye family. 
The first observation that led to the discovery of aromatic amine-induced 
carcinogenesis was by Rehn in 1895 who noticed that bladder cancer was 
more prevalent in workers at an "aniline" dye factory than in the general 
population. The cause of these cancers was later attributed to the dye 
component, 2-naphthylamine. Subsequent studies showed that 2 -naphthyl- 
amine-induced carcinogenicity was species specific; 2 -naphthylamine was 
found to be capable of inducing tumours in dogs but not in rats.
The carcinogenic properties of another group of aromatic amines, the azo 
dyes were elucidated using the compounds 2,3-dimethyl-4-aminoazo- 
benzene and N,N-dimethyl-4-aminoazobenzene. The aromatic amide, 
2 -acetylaminofluorene, which was initially developed as an insecticide but 
was never used as such due to its carcinogenic properties on chronic 
exposure to rats, has been used as the model compound to elucidate the 
mechanism of activation of these exocyclic nitrogen compounds to 
carcinogens (Miller et al., 1961).
1.3 The multistage process of chemical carcinogenesis
The onset of carcinogenesis is thought to proceed by a multistage process 
comprising at least three steps: initiation, promotion and progression 
(Figure 1.1).
(1) Initiation
Studies in the 1940s showed that application of low doses of initiating agents 
to mouse skin failed or produced very few tumours during the animals' lifetime 
(Rous and Kidd, 1941; Berenblum and Shubik, 1949). On a molecular level, 
initiation is associated with the interaction of the ultimate carcinogen with DNA 
(Miller and Miller, 1981) and is thought to be associated with a mutational 
event (Barrett and Wiseman, 1987; Barrett, 1993). Furthermore, initiation is 
regarded as an irreversible event.
(2) Promotion
Although initiating agents alone fail to produce tumours, on repeated 
application of promoting agents such as 1 2 -0 -tetradecanoylphorbol 13- 
acetate (TRA) derived from croton seeds, tumours were seen to be induced 
on mouse skin (Miller and Miller, 1981). TPA has been observed to increase 
phospholipid, RNA and DNA synthesis in mouse skin (Boutwell, 1974). 
Hyperplasia, an increase in cell number has also been associated with 
promotion. Hyperplasia has been observed in organs susceptible to tumour 
formation on application of promoting agents in conjunction with an initiator 
(Boutwell, 1974; Schulte-Hermann, 1974)Although hyperplasiais associated 
with promotion, not all hyperplastic agents manifest tumour-promoting 
activities. It is thought the most important property of promoting agents may 
be their ability to interfere with growth and differentiation (Miller and Miller, 
1981). On a higher level, promotion is observed as a foci of preneoplastic 
cells or a benign tumour, often a papilloma, arising from clonal expansion of 
an initiated cell (Barrett and Wiseman, 1987; Barrett, 1993).
(3) Progression
The last stage in cancer formation is characterised by the neoplastic cells, 
formed by intiator and promotor activity, becoming malignant. This normally 
involves increased growth rate, invasion of healthy tissue and finally 
metastasis into other tissue.
   ' . ^  ^  '« « % ®
Initiation Promotion Progression ®
Figure 1.1 The multistage process of carcinogenesis.
1.4 Xenobiotic metabolism
The metabolism of xenobiotics may be divided into three phases, namely, 
phase 1,2 and 3. However, the majority of xenobiotics are metabolised by 
phase 1 and 2  reactions.
Phase 1
Phase 1 reactions essentially comprise oxidation, reduction, hydrolysis, 
hydration and dehalogenation reactions. The main function of these reactions 
is to introduce a functional group into the molecule so that it can proceed onto 
phase 2 .
Phase 2
Phase 2 reactions are essentially conjugation reactions leading to the 
formation of water soluble products which may be excreted in the bile or 
urine. Examples of these reactions are glucuronidation, glycosidation, 
sulphation, méthylation, acétylation, amino acid conjugation, glutathione 
conjugation, fatty acid conjugation and condensation reactions of amines and 
aldehydes eg. the condensation of dopamine with 3,4-dihydroxyphenyl- 
acetaldehyde to yield tetrahydropapaveroline.
Phase 3
Phase 3 reactions normally involves further metabolism of glutathione 
conjugates to yield cysteine conjugates and mercapturic acids (Figure 1 .2 ).
Gly Gly
 ^ Transpeptidase ^
R-S-Cys ---------------^ ----------- ►  R-S-Cys
I > 1
Glu NHgGlu
Gly Peptidase
N-acetylase
R-S-Cys-NHaOO-CHs '< r~ ------------   R-S-Cys-NIt
Figure 1.2 The further metabolism of glutathione conjugates
(taken from Gibson and Skett, 1986)
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CYTOTOXICITY
Mutations
(Initiation)
Interaction with lipids
IMMUNOTOXICITY Promotion/
progression
MAUGNANCY
UPID PEROXIDES
Figure 1.3 Activation pathways of xenobiotic metabolism
Although the main objective of xenobiotic metabolism is detoxication, 
chemicals may also be activated by these supposedly "detoxication" reactions 
to yield toxic / carcinogenic species, catalysed by the same enzyme systems. 
The reactive intermediates produced on metabolic activation may interact with 
(1) DNA covalently to form adducts which, if not repaired may lead to tumour 
formation (2 ) cellular protein leading to cell death and generation of 
neoantigens (3) molecular oxygen to form superoxide anions leading to potent 
oxygen species such as hydroxyl radicals which can damage DNA (4) form 
lipid peroxides which are carcinogenic and cause cell death by destroying the 
cell structure (Figure 1 .3 ).
Phase 1 enzymes participating in the activation of chemical carcinogens 
include the FAD-monooxygenases, the prostaglandin synthase system and 
probably the most studied of the phase 1 enzyme systems, the cytochrome 
P450 monooxygenases.
1.5 Metabolic activation of chemical carcinogens
The need for chemicals such as polycyclic aromatic hydrocarbons and 
aromatic amines to be metabolically activated prior to exerting their 
carcinogenic effect was demonstrated by the Millers; rats fed N,N-dimethyl-4- 
aminoazobenzene were found to produce metabolites which were covalently 
bound to DNA (Miller and Miller, 1947). Subsequently, metabolites of
2 -acetylaminofluorene were shown to manifest greater carcinogenic effects 
than the parent compound (Miller et ai., 1964). Furthermore, the N-hydroxy 
derivatives of this aromatic amide was found to display greater carcinogenic 
properties than ring-hydroxylated products (Weisburger eta!., 1956; Morris, 
1960), thus, substantiating the requirement for metabolic activation in order 
for the carcinogenicity of these compounds to be expressed. The reactive 
species of 2 -acetylaminofluorene was shown not to be the hydroxyamide itself
Ring hydroxylated 
metabolites
N— COCH3N— COCH
Oxidation
2-AAF
Sulphate 
conjugationOxidation
N— COCH3
Sulphate ester of 
N-hydroxy-2-AAF
N-hydroxy-2-AAF NItrenlum Ion
OSO3
N— COCH3
N, O-acyi 
transfer OCOCH3 
N— H N— H
Acetyl ester of NItrenlum ion
N-hydroxy-2-AAF
Figure 1.4 The metabolic activation of acetylaminofluorene
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but a product formed on further metabolism, namely a species derived from 
the sulphate ester (Miller, 1970). Other routes of activation of
2 -acetylaminofluorene include transfer of the acetyl group from the nitrogen 
atom to the oxygen atom catalysed by acyltransferase to produce 
acetoxylamine (Figure 1.4). The ultimate carcinogen of these exonitrogen 
compounds is thought to be the nitrenium ion .
The role of metabolic activation in the carcinogenicity of polycyclic aromatic 
hydrocarbons was not established until the 1970s when microsomes were 
found to catalyse the binding of benzo[a]pyrene and its trans dihydrodiol 
metabolites to DNA (Borgen et ai, 1973). Furthermore, the binding of the
7.8-dihydrodiol was found to be ten-times greater than that of the parent 
compound (Borgen et ai, 1973). This eventually led to the suggestion that the 
diol-epoxide was the reactive species in the carcinogenicity of benzo[a]pyrene 
(Sims et ai, 1974) and the subsequent proposal of the bay-region hypothesis 
as its mechanism of activation (Jerina et ai, 1976). According to the bay 
region hypothesis, the formation of a carbocation adjacent to the bay region is 
more reactive than that formed at other sites on the molecule (Figure 1.5), 
thus accounting for the high reactivity of the 7,8-dihydrodiol-9,10-epoxide of 
benzo[a]pyrene (Jerina et ai, 1976). Genotoxicity studies have shown that the
7.8-dihydrodiol was highly mutagenic to bacteria only in the presence of a 
activation system whilst the 7,8-dihydrodiol-9,10-epoxide did not require 
activation. This observation is attributed to the highly electrophilic nature of 
the 7,8-dihydrodiol-9,10-epoxide which is not manifested by the dihydrodiol 
(Phillips, 1983). Diol-epoxide reactivity is associated to the formation of a 
carbocation at position 1 0 , adjacent to the bay region (Conney, 1982).
Epoxide hydrolase
Benzo[a]pyrene 7,8-epoxide
OH
bay region Mixed function oxidases Benzo[a]pyrene 7,8-dihydrodiol
Mixed function oxidases
Benzo[a]pyrene
Reaction with 
DNA, RNA, protein
Benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxide 
[ H -
HO
HO
OH
>
Figure 1.5 The metabolic activation of benzo[a]pyrene
1.6  THE CYTOCHROME P450 ENZYME SYSTEM
1.6.1 Introduction
Cytochrome P450 is the terminal component of the mixed function oxidase 
system. It is so called due to its characteristic peak at 450nm when the 
reduced haemoprotein is bound to CO. Cytochrome P450 is capable of 
activating molecular oxygen (O2 — > 0 ^+ -1- 0 2 -) and subsequently 
introducing an oxygen atom into the substrate which is also bound to the 
enzyme. The main role of cytochrome P450 in xenobiotic metabolism is to
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introduce a polar group into an essentially lipophillic molecule, so increasing 
its polarity and facilitating conjugation by phase 2  enzymes and excretion.
In addition to its important role in the metabolism of xenobiotics, the 
cytochrome P450 enzyme system also participates in the biosynthesis and 
metabolism of endogenous substrates such as vitamin D (Hasson et al.,
1981), testosterone (Ryan eta!., 1982), progesterone, oestradiol (Johnson at 
a!., 1983), prostaglandin (Okita eta!., 1981; Vatsis at a!., 1982), fatty acids 
(Gibson and Bains 1985; Tamburini at a!., 1984) and cholesterol (Waxman at 
a!., 1986).
Cytochrome P450 is an ubiquitous enzyme, since it has been located in both 
prokaryotes and eukaryotes. It has been detected in bacteria, yeasts, plants, 
insects, fish as well as mammals. The cytochrome P450 enzyme system is 
localised in mitochondria, on the endoplasmic reticulum and nuclear 
envelope. Furthermore, the enzyme system has been shown to exist in 
multiple forms (Nelson and Strobel, 1987; Gonzalez, 1990) and levels of these 
enzymes can be increased by treatment with chemical inducing agents.
1 .6 . 2  Multiolicitv
Induction studies have revealed that cytochrome P450 exists in multiple 
forms. These cytochrome P450 isozymes differ in their absorption spectra 
maxima when complexed to carbon monoxide, substrate specificity, 
immunological properties, peptide maps, molecular weight on SDS gels, 
kinetic properties and sensitivity towards inhibitors after pretreatment of 
animals with different chemical inducers (Welton and Aust, 1984). Amino acid 
homology has been found amongst the various cytochrome P450s, and 
sequencing of the enzymes' apoprotein and cDNA has revealed that 
cytochrome P450 exists as a multigene superfamily (Whitlock, 1986). To date.
11
221 cytochrome P450 genes and 12 putative pseudogenes have been 
characterised (Nelson et ai, 1993).
1.6.3 Characteristics of the P450 suoeraene familv
Cytochrome P450 proteins are classed as belonging to the same family if they 
possess 40% or more similarity in amino acid sequence to each other. 
However, there are a few exceptions such as CYP2 D, CYP4C1 and CYP1 1 . 
CYP4C1 from cockroach is only 30-36% identical to other members in the 
family whilst the mitochondrial proteins see and c l 1 are only 34-39% identical 
but are still considered to belong to the CYP4 and CYP1 1  families, 
respectively (Nebert at ai, 1991). Within a gene family, any protein within one 
subfamily needs to possess 40-65%homolqgyin amino acid sequence to a 
protein in any other subfamily (Nebert at ai, 1991). Finally, within a gene 
subfamily, any two proteins will possess 70% or more homology in amino acid 
sequence.
1.6.4 Nomenclature
The current cytochrome P450 nomenclature drawn up by Nelson at a i, (1993) 
recommends that for the gene and cDNA, the italicized root symbol "CYP" for 
humans ("cyp" for mouse) to represent "cytochrome P450". The family is then 
denoted by an Arabic number, a letter to designate the subfamily (where two 
or more exist). Finally, an Arabic numeral is used to represent the individual 
gene within the subfamily. For mouse genes, it is recommended that a 
hyphen preceeds the final number. The presence of a "P" ("p" in mouse) after 
the gene number denotes a pseudogene. If a gene is the sole member of a 
family, the subfamily letter and gene number need not be included. It is 
recommended that human nomenclature is used for species other than
12
mouse and that mRNA and enzyme in all species including mouse are 
denoted by capital letters, without italics and hyphens.
1.6.5 The cytochrome P450 catalytic cycle
NADH
.V NADH-cytochrome bg 
reductase
cytochrome bgL i^
NADPH cytochrome P450 
reductase
NADPH
Fe— RH
Fe — RH
ROH
0Ôl(.l
Fe— RH^ 
O2
(6)
(3)
)
0 2
Fe3+
(1)
F e ^ R H
(2) NAD PHrcytochrome
f
NADPH P450 reductase
Fe^-— RH
Step 1. The drug binds to the oxidised form (Fe3+) of the cytochrome P450. 
Step 2. First e" reduction of the substrate bound ferric (Fe3+) cytochrome 
P450 to the ferrous (Fe2+) form of the haemoprotein. Reduction occurs by 
utilising NADPH + H+ transferred by NADPH-cytochrome P450 reductase. 
Step 3. Molecular oxygen binds to the ferrous (Fe2+) cytochrome P450 
substrate adduct.
Step 4. Electron rearrangement
Step 5. Introduction of a second electron from NADPH-cytochrome P450 
reductase and / or cytochrome bs.
Step 6 . Chemical oxygen insertion into the carbon substrate resulting in 
product formation (Gibson and Skett, 1986).
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1.6.6 Cytochrome P450 and xenobiotic metabolism
Although there are many cytochrome P450 families, only four appear to be 
inyolyed in the metabolism of xenobiotics, namely, CYP1 , CYP2, CYP3 and 
CYP4. Of the four families, the CYP1 family appears to be the most important 
in the metabolic actiyation of carcinogens. CYP1 almost always catalyses the 
formation of genotoxic species from chemical carcinogens except for the 
nitrosamines which appear to be actiyated by CYP2E and CYP2B (loannides, 
1990a).
1.6.7 Cytochrome P450 Induction
The phenomenon of enzyme induction whereby low ley els of pre-existing 
enzymes are increased or the de novo synthesis of enzyme(s) which are not 
normally present in untreated animals occurs is important, since it may alter 
the way a chemical is metabolised. A change in enzyme population can 
potentially alter the balance between the actiyation and deactiyation 
pathways, depending on the nature of the enzymes induced. The 
hepatotoxicity of compounds such as carbon tetrachloride and bromobenzene 
is modified according to pretreatment; in both cases phénobarbital increased 
the hepatotoxic effect of these compounds whilst animals pretreated with
3-methylcholanthrene were protected from hepatotoxicity (Mitchell at al., 
1984). Simultaneous administration of rodents with 3-methylcholanthrene and 
aminoazo dyes also elicited a protectiye effect; 3-methylcholanthrene reduced 
the carcinogenicity of the aminoazo dye by directing its metabolism towards 
the deactiyation pathway (Conney, 1982).
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Of the cytochrome P450 supergene family there appear to be four major 
inducible families, CYP1, CYP2, CYP3 and CYP4. The induction of one 
cytochrome P450 population may suppress the expression of another 
cytochrome P450 family (Dannan etal., 1983; Thomas etal., 1987).
In addition to the induction of cytochrome P450 enzymes, inducing agents are 
also capable of enhancing the activities of other enzymes such as phase 2  
conjugating enzymes eg. phenobarbitone, polycylic aromatic hydrocarbons, 
pregenolone-16-a carbonitrile and polychlorinated biphenyls all induce rat 
liver microsomal epoxide hydrolase activity aswell as cytochrome P450 
isozymes (Bentley and Oesch, 1982). Rat hepatic UDP-glucuronosyl 
transferase is induced on phenobarbitone and 3-methylcholanthrene 
treatment (Owens, 1977) whilst cytosolic glutathione-S-transferase activity is 
induced by these inducers aswell as 2-acetylaminofluorene (Hales and 
Niems,1977; De Pierre etal., 1984).
1.7.1 The CYP1 familv
The CYP1 family consists of a single subfamily comprising two isoforms, 
namely, CYP1A1 and CYP1A2. Substrates for this cytochrome P450 family 
tend to be planar in structure eg. benzo[a]pyrene (Lewis at a!., 1986). The two 
isoforms, CYP1A1 and CYP1A2 are generally involved in the oxidation of 
aromatic carbons and exocyclic nitrogen atoms, respectively. A feature of the 
CYP1 A family is its propensity to facilitate the metabolism of chemicals 
through pathways that generate highly reactive electrophiles which are 
capable of interacting with cellular macromolecules such as RNA, DNA and 
proteins to cause deleterious effects. Although CYP1A appears to be 
essentially involved in activation processes, deactivation by this family has 
also been reported as in the case of 1,3-dinitropyrene (Shimada and 
Guengerich, 1990).
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Primary structure
Rat CYP1A1 and CYP1A2 differ in their NH2 - and COOH- terminal amino acid 
sequences (Botelho et ai, 1982) but still exhibit 6 8 % homology in their 
primary structure (Sogawa et ai, 1985; Kawajiri et al., 1983; Kawajiri et ai, 
1984). In the mouse, 3-methylcholanthrene-induced CYP1A1 and CYP1A2 
proteins share 73% homology. Furthermore, the two murine CYP1A isoforms 
show 93% homology with their respective rat counterparts (Kimura et a i, 
1984). Homologies in protein sequence between human CYP1A and mouse 
1A2, rat 1A1 and 1 A2  are 6 8 , 79 and 6 8 %, respectively (Jaiswal et ai, 1985).
Substrate binding site
The substrate binding site of CYP1A is narrow in specificity (Phillipson et ai,
1982). Computergraphic analysis of the preferred substrates of the CYP1A 
proteins have revealed that the molecules are rigid and planar in structure, 
small in depth, with a large area to depth ratio (Lewis etal., 1986; Lewis et ai, 
1987). Compounds such as phenobarbitone and DDT which are nonplanar 
and bulky in structure with a small area/depth ratio do not interact with 
CYP1 A. Moreover, RGBs which are substituted in the meta and para positions 
are good CYP1A inducers whilst monochlorine substitution at the ortho 
position, causing deformation from planarity, induces CYP2B in addition to 
CYP1 A with the latter being induced to a lesser extent (Safe et ai, 1985). The 
need for molecular planarity for CYP1A induction has also been demonstrated 
for azo compounds; induction was only observed for compounds with three 
fused rings which could assume coplanar structures through hydrogen 
bonding (Fujita et ai, 1984). Furthermore, these compounds possess 
molecular areas of 90-140Â2 (Fujita et a i, 1984) which is similar to that 
obtained for polycyclic aromatic hydrocarbons (85-150Â2) and other CYP1A 
inducers (70-125Â2) ( Arcos et ai, 1961; Lewis ef a/., 1986).
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CYP1A induction
In untreated animals constitutive levels of CYP1A comprise less than 5% of 
the total cytochrome P450 population in untreated animals (Pickett et al., 
1981; Luster et a/., 1982). However treatment of animals with
3-methylcholanthrene and other polycyclic aromatic hydrocarbons elevates 
CYP1A whilst depressing the phenobarbitone-induced cytochrome P450, 
CYP2B in both untreated animals and those treated with phenobarbitone itself 
(Yeowell etal., 1985; Dannen etal., 1983; Vlasuk etal., 1982a; Vlasuk etal., 
1982b). Furthermore, 3-methylcholanthrene and hexachlorobiphenyl 
decreased constitutive male-specific CYP2C2 (Yeowell et al., 1987). In 
addition to the induction of CYP1 A, inducing agents for this cytochrome P450 
family may also induce other cytochrome P450 isoforms eg. 3 -methyl­
cholanthrene induces CYP2A aswell as CYP1A (Parkinson et al., 1980). 
Regulation of CYP1 A induction has been associated predominantly with the 
Ah receptor though a 4S carcinogen binding protein has also been implicated.
1.7.2 Epoxide hvdrolase
Epoxide hydrolase (EC 3.3.2.3) has been detected in fish, amphibia, birds, 
rodents, mammals as well as in insects, fungi and plants. In the rat, epoxide 
hydrolase activity is highest in the liver, testis, kidney and ovary whilst 
extrahepatic tissues such as the skin and trachea display low activity 
(Oesch et al., 1977). The function of epoxide hydrolase is essentially in 
detoxication; reactive epoxides and arene oxides are hydrated to trans 
dihydrodiols which are subsequently conjugated with glucuronic acid. Epoxide 
hydrolase-catalysed hydration occurs at the sterically least hindered epoxide 
carbon atom (Hanzlik et al., 1976); regiospecific discrimination is not 
abolished until near symmetry occurs around the epoxide ring as in the case 
of benzo[a]pyrene 4,5-oxide (Thakker ef a/., 1977). Epoxide hydrolase-
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catalysed hydration is thought to occur by nucleophilic attack at the least 
sterically hindered epoxide carbon atom by an -OH radical derived from the 
histidine imidazole deprotonation of water, which opens the epoxide ring away 
from the incoming ion to form a trans dihydrodiol product (DuBois et al.,
1978).
In mammals, epoxide hydrolase (EH) appears to exist in at least four forms, 
however, only two are involved in xenobiotic metabolism. These are known as 
microsomal epoxide hydrolase (mEH) and cytosolic epoxide hydrolase (cEH), 
on account of their subcellular localisation (Thomas and Oesch, 1988; 
Wixtron and Hammock, 1985; Meijer and DePierre, 1988). Both cEH and 
mEH possess broad substrate specificity in contrast to the other two forms 
which are specifically involved in the hydration of leukotriene A4  and A-5 
steroid epoxides respectively. mEH and cEH are immunologically distinct, and 
possess different substrate and inhibitor specificties. mEH is selective for the 
substrates c/s-stilbene oxide and benzo[a]pyrene 4,5-oxide whereas cEH is 
selective for frans-stilbene oxide (Hammock and Hasagawa, 1983). However, 
based on substrate specificity, there appears to be some overlap between 
these two forms; mEH has been located in liver cytosol aswell as the nuclear 
envelope and in serum whilst cEH activity has been observed in microsomes, 
nuclear membranes, peroxisomes and mitochondria (Wixtron and Hammock, 
1985; Thomas and Oesch, 1988).
Purified liver mEH appears to be a single polypeptide in the presence of SDS 
with a molecular weight of 50 kD whilst in the absence of SDS It aggregates 
at approximately 600 kD. On amino acid analysis, mEH appears to contain 
high levels of tryptophan and tyrosine (Lu etal., 1975; Bentley et al., 1976) 
whereas the amounts of metals detected were negligible, implying that a 
prosthetic group (haeme or flavin) is not involved in EH-mediated catalysis
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(Lu et al., 1975). mEH is located on the endoplasmic reticulum in close 
proximity to the cytochrome P450 monooxygenase system (Oesch et al., 
1970; Oesch and Daly, 1971) and deep in the hydrophobic membrane 
(Burchell etal., 1976; Seidegard etal., 1978). Thus, when polycyclic aromatic 
hydrocarbons are presented to these enzyme systems, the combination of 
epoxide hydrolase and the cytochrome P450 monooxygenase system can 
potentially lead to the formation of reactive bay-region diol epoxides which 
function as the ultimate carcinogens. Furthermore, as in the case of the 
cytochrome P450 monooxygenase system, hepatic mEH can be induced by 
compounds such as phenobarbitone and to a lesser extent by 3-methyl­
cholanthrene (Oesch ef a/., 1973), thus increasing the carcinogenic risk posed 
by these types of compounds.
Elevated levels of mEH, brought about by increased transcription of the EH 
gene, have been identified in hyperplastic and neoplastic nodules in the livers 
of rats which had been previously treated with chemical carcinogens. 
Furthermore, these increased levels of EH were sustained throughout the 
carcinogenic process (Ding etal., 1990; Enomoto et al., 1981; Kondo et al., 
1990) implying that EH may play a role in the carcinogenic process. 
Moreover, the persistent augmented levels of mEH may be a good indicator 
of hepatocellular carcinomas, especially in humans (Moody etal., 1989)
1.8 Ah RECEPTOR
1.8.1 Introduction
The aromatic hydrocarbon receptor (Ah) receptor is an intracellular protein 
which interacts with polycyclic aromatic hydrocarbons, hence its name. The 
receptor is also known as the TODD receptor, since it has the propensity to
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bind the  halogenated hydrocarbon, 2 ,3 ,7 ,8 -te trach lo rod ibenzo-p -d iox in  
(TCDD) with high affinity and low binding capacity (KD=0.3nM).
Expression of the Ah receptor is mediated by the Ah locus located on 
chromosome 12 in the mouse. This in turn is responsible for the regulation of 
the cypl a-1 and cyp1 a- 2  genes on chromosome 9. The products of these 
genes the CYP1A1 and 1A2 proteins are known to play a major role in the 
activation of chemicals to mutagens and carcinogens (Figure 1.5). In addition 
to its role in genotoxicity, the Ah locus has also been associated with other 
toxic effects. These include bone marrow toxicity, hepatic necrosis, ocular 
toxicity, porphyria, immunotoxicity, atherosclerosis, ethanol resistance and 
teratogenesis (Nebert, 1989).
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Much of the work concerned with the Ah receptor has been carried out using 
the mouse strains C57BL/6 and DBA/2 . The difference in ability of
3-methylcholanthrene to induce the CYP1A1-associated activity, aryl 
hydrocarbon hydroxylase (AHH) in the two mouse strains led to them being 
known as "responsive" and "non-responsive" respectively; 3-methyl- 
cholanthrene was found to induce AHH activity in the C57BL76 strain but not 
in the DBA/2 (Nebert, 1972). Crosses between the two strains showed that 
AHH induclbility segregated as an autosomal dominant trait. These 
observations and the later finding, that TCDD could induce AHH activity in 
both strains but with the dose required for DBA/2 being twenty times greater 
than that for C57BL/6 mice, led to the hypothesis that a receptor was 
responsible for mediating these effects. Subsequently, a protein was detected 
in the liver of C57BL/6 mice which was found to bind TCDD and manifest the 
properties of a receptor (Poland et al., 1976). Since then the Ah receptor has 
been purified (Bradfield ef a/.,1990) and part of its N-terminal sequence has 
been elucidated (Poland et al., 1990).
The Ah receptor has been identified in both mammalian and non-mammalian 
species. Species possessing comparatively high concentrations of the 
receptor (1 0 -1 0 0 fmol/mg cytosolic protein) include inbred strains of rodents, 
rabbits, ground hog, sheep, cats, ferrets and certain types of birds and 
primates (Denison et al., 1986a). The receptor has also been identified in 
humans; either in tissues or human derived cell lines. It is present in many 
tissues including liver, lung, kidney, placenta, B-lymphocytes (Waithe et al., 
1990) and tonsils (Lorenzen and Okey, 1990). In the rat, the receptor has 
been found in thymus, lung, liver, kidney, brain, testis and skeletal muscle but 
not in the pancreas, adrenal glands or ventral prostrate (Carlsted-Duke,
1979).
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1.8.2 Molecular properties of the Ah receptor
Sucrose density gradient separation of cytosol has shown that the 
sedimentation coefficent of the cytosolic form of the receptor ranges from 
8-9 8  and that it is multimeric. Under conditions of moderate ionic strengh, 
receptors derived from Sprague-Dawley rats sedimented at 8 . 8  8  whilst that 
from C57BL/6 mice sedimented at 9.4 8 . This corresponded to Stoke's radii of
7.0 and 7.1nm, respectively. Calculated molecular weights for these receptors 
were 277 kD and 257 kD, respectively. Furthermore, at high ionic strengh the 
rat receptor was found to dissociate into a 5.6 8  species with a molecular 
weight of 121 kD (Denison et a/., 1986b). Receptors from the mouse 
hepatoma cell line, Hepa-1 were characterised by similar dimensions (Cuthill 
etal., 1987; Prokipak and Okey, 1988).
The ligand-binding component of the receptor is a 95-120 kD protein (Poland 
and Glover, 1987) and is the same in the cytosolic and nuclear forms of the 
receptor (Landers etal., 1989). Trypsin digestion of Ah receptors derived from 
Hepa-1 cells has revealed that the actual ligand-binding portion of the 
receptor is a 16 kD fragment which is incapable of binding to DNA (Prokipak 
et al., 1990). A heatshock protein (Hsp 90) is an integral part of the multimer 
in the rat and in responsive Hepa-1  mouse hepatoma cells (Okey et al.,
1989). The receptor is believed to be either a trimer, with two ligand binding 
subunits and a Hsp 90 unit (Landers and Bunce, 1990) or a complex 
comprising a single ligand-binding subunit and a number of Hsp 90 units, 
analogous to the glucocorticoid receptor (Denis et al., 1988). A further 
similarity between the Ah receptor and the glucocorticoid receptor is their 
requirement for molybdate. Molybdate is thought to be necessary for the 
interaction with sulphydryl groups and Hsp 90 in the unliganded receptor.
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Ah receptor obtained from nuclear extracts of Hepa-1 cells, on sucrose 
density gradient separation has been shown to sediment at 6  S, possess a 
Stoke's radius of 6  nm and a molecular weight of 167 kD (Prokipak and Okey, 
1988). Thus, on comparison of the physicochemical properties of the cytosolic 
form Ah receptor with that of the nuclear form, it may be inferred that the 
receptor undergoes a transformation step on entering the nucleus. The 
involvement of a transformation step is also suggested by in vitro work using 
hepatic cytosol from Syrian hamsters (Rucci and Gasiewicz, 1988).
1.8.3 Ligand specificitv of the Ah receptor
Structure-activity relationship studies using halogenated hydrocarbon such as 
PODD have revealed that the ligand binding site of the Ah receptor is 
hydrophobic and prefers planar molecules (Poland etal., 1976; Safe, 1986), 
thus, explaining the high affinity of TCDD for the receptor. PODDs and PODFs 
with chlorine substitution at three out of the four lateral positions, 2,3,7,8 
appears to facilitate binding (Safe, 1986; Bandiera et al., 1984; Poland and 
Knutson, 1982). In contrast, removal of groups from lateral positions or 
addition of chlorines to non-lateral positions reduces binding affinity. The 
binding site of the receptor is postulated to be approximately 0.7nm x 1.4nm 
from studies using substituted indoles (Gilner etal., 1985), polycyclic aromatic 
hydrocarbons (Piskorska-Pliscizynsk etal., 1986) and dyes (Lubet et al., 
1983).
1.8.4 Ligand binding
In vitro, optimal conditions for binding to the Ah receptor are physiological pH, 
a highly reduced environment, and protection against Ca2+-dependent 
proteases since these can degrade the 95 kD binding site to a 70 kD peptide 
which is an artefact (Poland and Glover, 1988). ATP also appears to be
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required for ligand binding (Gudas and Hankinson, 1986). It has been 
suggested ATP may be required for cyclic phosphorylation/dephosphorylation 
of the receptor, induced by the bound TCDD (Whitlock, 1987). Furthermore, 
reactive sulphydryl groups have been shown to be a prerequisite for ligand 
binding; they are believed to stabilise the receptor in the unliganded state 
(Denison etal., 1987; Kester and Gasiewicz, 1987). Despite the elucidation of 
the conditions needed for binding to the Ah receptor, the receptor has been 
found to undergo rapid thermal inactivation in vitro which impairs its ligand- 
binding capacity (Bunce etal., 1988).
1.8.5 Ah receptor transformation
The difference in molecular weight of Ah receptors derived from cytosol and 
from nuclear extracts indicate that the receptor undergoes a transformation 
step on entering the nucleus. The change in size, from a 270 kD protein to 
176 kD, involves the loss of the Hsp 90 subunit as indicated by 
immunochemical analysis of the 9 S and 6  S forms. This may occur in order 
to facilitate binding to DNA as in the case of the glucocorticoid receptor where 
a dimeric Hsp 90 subunit maintains the receptor in an inactive state by 
interacting with the C-terminal portion of the receptor, thus obscuring the 
DNA-binding region (Radanyi ef a/., 1989). Futhermore, a protein known as 
the Ah receptor nuclear translocator protein (Arnt) has been identified as a 
component of the DNA-binding complex (Reyes ef a/., 1992).
In vitro, temperature appears to be involved in the transformation step of Ah 
receptor; incubation of the complex at 20^0 aids binding to DNA whilst 
incubation at 4°C prevents binding (Okey etal., 1980; Gasiewicz and 
Bauman, 1987). The role of the temperature-dependent transformation may be 
to increase the affinity of the complex for the DNA, presumably by conversion
24
of the unliganded receptor to one which is less negatively charged, thus, 
increasing its affinity for DNA (Okey etal., 1980).
1.8.6 Receptor-DNA interactions
The Ah receptor-liganded complex binds to the dioxin responsive element 
(DRE) located at the 5' end of the of the cyp1a1 gene, approximately 1500 
base pairs upstream from the transcription site of the cyp1a1 gene itself 
(Jones et al., 1985). DRE sequences have been identified in C57BL/6 mice 
(Gonzalez and Nebert, 1985), rat (Fujisawa-Sehera etal., 1986) and humans 
(Kawajiri et al., 1986), implying that ligands such TCDD act in a similar 
manner in all these species.
Analysis of the DRE sequences has revealed that it contains the core 
sequence 5'- TA/TGCGTG-3' (Denison etal., 1988; Shen and Whitlock, 
1992). The liganded receptor complex is thought to bind to the major groove 
of the DNA and appears to be in contact with four guanine residues in the 
core sequence (Shen and Whitlock, 1989; Shen and Whitlock, 1992). Three 
base pairs outside the core sequence also appear to contribute to receptor 
binding; mutation in this region still facilitates binding but not enhancer 
function whilst mutation in the core region abolishes both binding and 
enhancer function (Shen and Whitlock 1992). Further work in intact mouse 
hepatoma cells revealed the existence of six bona fide binding sites which 
extended beyond the core sequence which is in agreement of the findings of 
Shen and Whitlock (1992). Furthermore, these sites varied in binding affinity 
for the receptor liganded complex and the extent of binding did not correlate 
to their ability to activate transcription (Lussaka et al., 1993).
The ultimate effect of receptor-enhancer interaction is a change in chromatin 
structure so that the CYP1A1 promotor becomes more accessible to
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transcription factors (Durrin and Whitlock, 1989; Wu and Whitlock, 1992; 
Morgan and Whitlock, 1992).
1.8.9 Other Ah receptor associated activities
In addition to the Ah receptor's role in CYP1A induction and chemical 
carcinogenicity, the Ah receptor is also involved in other forms of toxicity 
(Table 1.1) and may also participate in the induction of other enzymes and 
proteins induced by polycyclic aromatic hydrocarbons and TCDD (Table 1.2).
1.9 4 S BINDING PROTEIN
1.9.1 Introduction
In addition to the Ah receptor, another intracellular protein termed the 4 S 
binding protein also known as the carcinogen binding protein (GBP) has been 
implicated in CYP1A1 induction. This protein binds polycyclic aromatic 
hydrocarbons and has been found to interact with the CYP1A1 gene (Houser 
et al., 1987; Bresnick et al., 1988). The 4 S protein, unlike the Ah receptor, 
does not bind TCDD or TCDF (Houser et al., 1985; Houser et al., 1986) but 
manifests saturable, high affinity binding towards 3-methylcholanthrene and 
benzo[a]pyrene (Houser et al., 1986). The 4S protein has been detected in 
mice, rats, rabbits and humans (Peryt etal., 1992). In DBA mice, the highest 
concentration was found in the liver (600 fmol per mg protein) followed by the 
kidney and testis. Lower concentrations were found in the uterus, vagina, 
spleen, stomach, heart, urinary bladder, skin, large and small intestine, and 
lungs (Zytkovicz, 1987). Pretreatment of male rats with phenobarbitone and 
isosafrole increased the specific binding of pH]-benzo[a]pyrene to the cytosol 
compared to untreated animals (Houser et al., 1986)
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1.9.2 Molecular properties
As the name implies, this intracellular protein sediments at approximately 4 S 
(3.3-4.2 S) on sucrose density gradient analysis and possesses a Stokes 
radius of 2.75 nm as determined by gel filtration. Gel filtration analysis also 
reveals that the 4 8  binding protein is a 44.6 kD protein (Tierney et al., 1980; 
Houser et al., 1985). Furthermore, sodium molybdate does not affect ligand 
binding unlike the steroid hormone receptors (Houser et al., 1986; Raha et al.,
1990).
1.9.3 Ligand specificitv of the 4 8  binding protein
As previously indicated the 4 8  binding protein does not bind TCDD or TCDF 
(Houser et al., 1985; Houser et al., 1986). In addition to 3-methyl­
cholanthrene and benzo[a]pyrene, interaction with the 48 binding protein also 
occurs with 5,6-benzoflavone, 7,8-benzoflavone, 1-nitropyrene, 1-amino- 
pyrene, benz[a] anthracene, chrysene, pyrene and benzo[e]pyrene (Houser et 
al., 1986). However, for anthracene and phenanthrene, weak and no binding 
were observed respectively (Tierney et al., 1980). Furthermore the two ring 
compound, 3,3',4,4'-tetrachlorobiphenyl (TCBP) does not bind to the 4 8  
binding protein . Thus, it has been speculated that at least a three ring system 
is required for interaction with the 4 8  protein, despite the fact that both TCDD 
and TCDF fulfil this structural requirement yet they do not bind to the protein, 
implying that other factors may be involved (Houser et al., 1986).
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Table 1.1 Other activities associated with the Ah locus
Actvity Compound References
Bone marrow Benzo[a]pyrene Nebert etal., 1977 
Nebert etal., 1979 
Nebert etal., 1980
Hepatic
necrosis
2-Acetylaminofluorene Thorgeirsson etal., 1975
Ocular
toxcity
Paracetamol (acetaminophen) 
Naphthalene
Shichi etal., 1978 
Shichi etal., 1980.
Ovarian
toxicity
Polycyclic aromatic 
hydrocarbons
Mattisson and Thorgeirsson, 1978a 
Mattisson and Thorgeirsson, 1978b 
Mattisson and Thorgeirsson, 1979.
Experimental
porphyria
TCDD Jones and Sweeney, 1980 
Greig etal., 1984; Hahn ef a/., 1988
Immunotoxicity TCDD Levy et al.. 1977 
Silkworth and Grabstein, 1982 
Lubet ef a/., 1984 
Poland and Glover, 1980 
Vecchi etal., 1983 
Nagarkatti etal., 1984 
Holsapple ef al., 1984 
Tucker ef a/., 1986
Atherosclerosis 3-Methylcholanthrene
TCDD
Paigen etal., 1986 
Poll etal., 1980 
Lesca etal., 1987
Ethanol
resistance
Ethanol French etal., 1979 
Bigelow ef a/., 1989 .
Teratogenesis Benzo[a]pyrene
TCDD
Lambert ef al., 1977 
Shum etal., 1979 
Hoshino ef a/., 1981 
Dencker efaf, 1981 
Hassoun etal., 1984 
Bimbaum ef aL, 1985 
Legraverend etal., 1984 
Manchester and Jacoby, 1984
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Table 1.2 Other enzyme activities and proteins induced by 
polycyclic aromatic hydrocarbon or TCDD
Increases in enzyme, protein, 
or gene expression
Demonstrated member of the 
[Ah] gene battery
NAD(P)H menodione oxidoreductase Yes
UDP glucuronosyltransferase Yes
Glutathione transferase Ya Yes?
Aldehyde dehydrogenase Yes?
Phosphatidylcholine biosynthesis
Arachidonic acid metabolism
Lipid déacylation
Phospholipase A2
Y -Glutamyltranspeptidase
Protein kinase C
Human chorionic gonadotrophin
Tyrosine kinase
P450a (CYP2A1)
60-kD esterase
c-erb-A
(taken from Nebert, 1989)
1.9.4 4 S binding protein translocation
Evidence for translocation of the 4 S binding protein as with the Ah receptor 
involves the incubation of the 4 S binding protein with nuclei and
3-methylcholanthrene: increased uptake of the carcinogen was seen in the 
presence of the 4 S binding protein compared with that seen in its absence. 
Furthermore, the translocation of the complex appears to be time and 
temperature dependent (Tierney etal., 1980). Immunostaining techniques, 
utilising antibodies raised to the 4 S binding protein, have revealed that the 
protein is at a lower concentration in the nuclei of rat hepatocytes than in the
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cytoplasm and that exposure to 3-methylcholanthrene Increases the specific 
content of the binding protein in the nucleus implying that translocation has 
occurred (Arnold etal., 1988).
1.9.5 Binding to the 4 S protein and CYP1 A induction
Although the 4 S protein is capable of binding polycyclic aromatic 
hydrocarbons and interacting with the CYP1A1 gene, its precise role in 
CYP1 A induction has not been completely elucidated. Structure-activity 
relationships using polycyclic aromatic hydrocarbons and ellipticines revealed 
that correlations did not exist between binding to the 4 8  protein and AHH 
induction (Kamps and Safe, 1987; Roy etal., 1988). Furthermore, Sprague- 
Dawley rats, devoid of 4 S binding proteins were still capable of eliciting AHH 
induction on treatment with 3-methylcholanthrene, benzo[a]pyrene and 
perylene indicating that the 4 S protein may not be involved in CYP1 A1 
induction (Harris et al., 1988). However recent studies have revealed that 
benzo[e]pyrene does actually induce CYP1A1 activity (Houser et al., 1992) 
which correlates to its binding to the 4S protein which is contrary to a previous 
report (Kamps and Safe, 1987).
1.10 AIMS OF THE PRESENT WORK
The aim of the work described in this thesis is to determine the role of CYP1A 
induction in chemical carcinogenesis, since in previous studies it had been 
suggested that CYP1A induction may be a prerequisite for chemical 
carcinogenesis. It was observed that, of the polycyclic aromatic hydrocarbons 
and aromatic amines investigated the CYP1A induction potential of these 
compounds correlated to their documented carcinogenic potential (Ayrton et 
al., 1990a and 1990b). Thus it was thought appropriate to investigate whether 
this concept extends to other structurally diverse series of planar chemical
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carcinogens. Furthermore, the role of the cytosolic Ah receptor in the 
induction of CYP1A by these compounds was also investigated, in order to 
ascertain whether a relationship exists between binding to Ah receptor and 
CYP1A induction. Finally, the possible role of metabolites in the induction of 
CYP1A also was studied.
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CHAPTER 2
Materials and Methods
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2.0 MATERIALS AND METHODS
2.1 Materials
Aldrich Chemicals. Gillingham. Dorset. U.K.
4-Amino-3,3-dimethylazobenzene (o-aminoazotoluene), aminoazobenzene 
(4-phenylazolaniline),azobenzene, 4-diethylaminoazobenzene (N,N-diethyl-
4-phenylazoaniline), 3-methoxy-4-diaminoazobenzene, 2,3-diaminotoluene, 
2,4-diaminotoluene, 2,5-diaminotoluene, 2,6-diaminotoluene, HEPES buffer 
(sodium salt).
Anderman and Co.. Kingston-upon-Thames. Surrey. U.K.
Nitrocellulose sheets 
Amersham. Burv. Lancs.. U.K.
Lab M agar (No. 1).
Becton Dickinson Ltd.. Oxford. Oxon. U.K.
Minimal agar plates.
Biorad Laboratories Ltd.. Hemel Hempstead. Herts.. U.K.
Hydroxyapatite (DNA grade).
British Drug Houses Ltd.. Poole. Dorset. U.K.
4-Nitrocatechol, p-nitrophenol, Triton X-1 0 0 .
Canberra Packard. Pangbourne. Berks.. U.K.
Pico-Fluor 40
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Community Bureau of References. Commission of the European 
Communities. Brussels. Belgium.
Benzo[b]chrysene, benzo[c]chrysene, 1-methylchrysene, 2 -methylchrysene, 
3-methylchrysene, 4-methylchrysene, 5-methylchrysene, 6 -methylchrysene.
Chemsyn Laboratories. Lenexa. Kansas. U.S.A.
pH] 2,3,7,8,-Tetrachlorodibenzo-p-dioxin.
Fluka. Gillingham. Dorset. U.K.
3,3'-Diaminobenzidine, 1,5-diaminpnaphthalene, 1 ,8 -diaminonaphthalene, 
2,3-diaminonaphthalene, 1 -naphthylethylenediamine.
Koch-light ltd.. Hatfield. Herts.. U.K.
6 -Aminochrysene, chrysene.
Molecular Probes Ltd.. Eugene. Oregon. U.S.A.
Ethoxyresorufin, methoxyresorufin, pentoxyresorufin, resorufin.
NCI Chemical Carcinogen Reference Standard Repository. NCI.
NIH. Bethesda. MD. U.S.A.
Benzo[a]pyrene-4,5-epoxide, benzo[a]pyrene-4,5-dihydrodiol.
Promochem Ltd.. St.Albans. Herts. U.k.
2,3,7,8,-Tetrachlorodibenzofuran.
Radiochemical Centre. Amersham. U.K.
■•^C-Laurie acid
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Sigma Chemical Company Ltd.. Poole. Dorset. U.K.
3,3'-Diaminobenzidine hydrochloride, dithiothreitol, ethylenediaminetetra 
acetic acid, glucose-6 -phosphate, glucose-6 -phosphate dehydrogenase, 
horseradish peroxidase-labelled anti-sheep antibody, hydrogen peroxidase, 
NADP (sodium salt), NADPH (tetrasodium salt, type 1), Tween 80.
Unioath Ltd.. Basingstoke. Hampshire. U.K.
Oxoid nutrient broth no.2.
All other chemicals used were at least of analytical grade.
Zeneca. Macclesfield. Cheshire. U.K.
Aroclor 1254
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2.2 METHODS 
2.2.1 Animals and animal pretreatment.
Male Wistar albino rats (180-200 g) were purchased from the Experimental 
Biology Unit, University of Surrey, Guildford, Surrey. Animals were housed in 
groups of four in cages with sawdust bedding, and were allowed water and 
food (Lab diet no.1. Animal dietary services, Betchworth, Surrey, U.K.) 
ad libitum. The animals were maintained at 45-55% humidity and 23°C 
throughout the study period. A 12 hour light/dark cycle was also in operation 
in the unit.
Aroclor 1254-induced animals were obtained by the administration of a 
single intraperitoneal dose of Aroclor 1254 (500 mg/kg) in corn oil 
(200 mg/ml). Animals were killed 5 days after dosing. Alternative dosing 
regimes are described in the relevant experimental chapters.
2.2.2 Preparation of hepatic subceiiuiar fractions
All equipment and solutions were autoclaved at 120°C for 20 minutes. 
Samples were prepared in a Class 3 lamina flow cabinet as far as possible 
in order to ensure sterility.
Preparation of S9 fraction
This was carried out according to the method of loannides and Parke (1975). 
Animals were killed by cervical dislocation and livers were removed 
immediately, washed twice in sterile ice-cold 1.15% (w/v) KCI, in order to 
remove excess blood, and then placed in sterile containers on ice. Livers 
were scissor-minced to aid homogenisation and were then homogenised in 
10 ml of sterile ice-cold 1.15% (w/v) KCI using a motor driven
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Potter-Elvehjem glass teflon homogeniser on ice. The homogenate was 
adjusted to 25% (w/v) using sterile 1.15% (w/v) KCI and subsequently 
centrifuged at 9,000g (10,000 rpm) for 20 minutes using a JA-17 (14 x 50 ml 
aluminium angle-head) rotor in a Beckman J2-21 centrifuge. The 
supernatant (S9 fraction) was decanted off, aliquoted out and stored at 
-2 0 °C until required.
Preparation of microsomal fraction
The microsomal fraction (105,000g pellet resuspended) was produced by 
centrifugation of the S9 fraction at 45,000 rpm for 60 minutes using a 
Beckman L7 ultracentrifuge equipped with a Ti-70 (12 x 10 ml titanium angle 
head) rotor. The resulting supernatant is known as the cytosolic fraction, and 
the pellet is the microsomal pellet. The latter may then be resuspended in an 
equilvalent volume of 1.15% (w/v) KCI, and homogenised to give a 
25% (w/v) microsomal fraction.
2.2.3 Spectrophotometric assays
All spectrophotometric assays were carried out using a Kontron Uvikon 860 
spectrophotom eter.
Protein determination
Total protein content was determined according to the method of Lowry 
et a l ., (1951). Bovine serum albumin (fraction V) 0-250 pg was used as the 
standard.
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Reagents: 0.5M Sodium hydroxide
Bovine serum albumin 
Folin-Ciocalteau phenol reagent 
“Copper reagent”: prepared by mixing copper sulphate 
(1 % w/v), sodium potassium tartrate (2 % w/v) and sodium carbonate 
(2 % w/v) at a ratio of 1 :1 :1 0 0 .
Protein samples were diluted with sodium hydroxide (0.5M); microsomal 
samples (1 in 25) and cytosolic samples (1 in 100). An aliquot (0.5 ml) of this 
dilution was taken and mixed with 0.5M NaOH (0.5 ml). Freshly prepared 
"copper reagent" (5 ml) was added to both samples and standards. Tubes 
were left to stand at room temperature for 10 minutes. Then an aliquot 
(0.5ml) of Folin-Ciocalteau phenol reagent (50% v/v) was added to each 
tube, vortexed and left to stand for 30 min at room temperature for the colour 
to develop and absorbances were then read at 720 nm.
Total cvtochrome P450 content
Cytochrome P450 was measured from the difference spectrum of reduced 
cytochrome P450-CO bound complex against reduced cytochrome P450 as 
essentially described by Omura and Sato (1964).
Microsomal fraction (25% w/v) was diluted (1:5) using 0.1 M potassium 
phosphate buffer,pH 7.4 to give a final volume of 3 ml. A few granules of 
sodium dithionite were added to the microsomes, vortexed and divided 
equally between two 1.5 ml cuvettes. A baseline was recorded between 390 
and 500 nm. Carbon monoxide was then passed through the test cuvette 
(30 bubbles at approximately 1 bubble/second) and the difference spectrum 
was recorded. Total cytochrome P450 content was calculated from the 
difference spectrum A4 5 0 .4 9 0  nm using the extinction coefficient 91mMcm-i.
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Cvtochrome bg content
The method used was as essentially that as described by Omura and Sato 
(1964) by measurement of the difference spectrum of reduced microsomes 
against oxidised microsomes.
An aliquot (0.5 ml) of the microsomal fraction (25%) was diluted (1:6 ) with 
0.1M potassium phosphate buffer, pH 7.4 to give a final volume of 3 ml and 
then divided between two 1.5 ml cuvettes. A baseline was recorded between 
390 and 500 nm. A few granules of sodium dithionite were added to the test 
cuvette and mixed, and the difference spectrum was recorded. Cytochrome 
bg content was calculated from the absorbance difference A 4 2 6 - 4 1 0  n m  using
an extinction co-efficient of 185mMcm-"*
Ervthromvcin N-demethvlase
Determination of this activity was carried out essentially according to the 
method of Wrighton et a l (1985) using formaldehyde (0-90 nmole) as the 
standard, the formation of which was measured as described by Nash 
(1953).
Incubation mixture:
0.05M Phosphate buffer, pH 7.25 0.40 ml
0.15M Magnesium chloride 0.10 ml
0.01 M Erythromycin 0.10 ml
Microsomal supernatant (25% w/v) 0.20 ml
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Tubes containing the reaction mixture were preincubated at 37°C for 
3 minutes prior to initiation of the reaction with 12.5mM NADPH (0.10 mi), so 
producing a final incubation mixture volume of 0.9 ml. Following incubation 
for 1 0  minutes (37°C), the reaction was terminated by the addition of an 
aliquot (0.5 mi) of trichloroacetic acid (12.5% w/v). Tubes were subsequently 
centrifuged at 2000g (3000 rpm) using a Beckman J-6 B centrifuge for 
10 minutes in order to precipitate the protein. A aliquot (1.0 ml) of the 
supernatant was mixed with an equivalent volume of freshly prepared 
NASH reagent (4M ammonium acetate containing 0.4% acetylacetone). The 
mixture was then incubated for 4 minutes at 37°C in a shaking waterbath 
and absorbances were read at 412 nm.
Formaldehyde standards (0-90nmol) were treated similarly. 
p-Nitrophenol oxidase
The oxidation of p-nitrophenol to 4-nitrocatecol was determined according to 
the method of Reinke and Moyer (1985).
Incubation mixture:
0.20M Potassium phosphate buffer, pH 6 . 8  0.65 ml
I.OmM p-Nitrophenol (in buffer) 0.10 ml
1.0mM Ascorbate 0.10 ml
Microsomal supernatant (25% w/v) 0.05 ml
The incubation mixture was preincubated for 3 minutes at 37°C in a shaking
waterbath before the addition of lOmM NADPH (0.10 ml) to initiate the 
reaction. Following a further 10 minute incubation, the reaction was 
terminated by the addition of 0 .6 N perchloric acid (0.5 ml). Tubes were then
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centrifuged at 2000g (3000 rpm) using a Beckman J-6 B centrifuge for 
10 minutes. An aliquot of the supernatant (1.0 ml) was added to ION sodium 
hydroxide (0.1 ml) and absorbances measured at 536 nm. A standard curve 
was constructed (0-50 pmol) using 4-nitrocatechol.
2.2.4 Fluorimetric assays
Ail fluorimeteric assays were carried out using a Perkin Elmer LS-5 
luminescence spectrophotometer.
Determination of microsomal alkoxvresorufin 0-dealkviase activities
The 0-deaikylation of ethoxyresorufin, methoxyresorufin and pentoxy- 
resorufin were carried out based on the method of Burke and Mayer (1974), 
Burke and Mayer (1983) and Lubet et a/., (1985) respectively. The 
0 -dealkylation of the alkoxyresorufin substrates were determined by 
monitoring the formation of resorufin after initiation of the reaction by 
NADPH.
The spectrophotometer was set to an excitation wavelength of 510 nm and 
emission wavelength of 586 nm. The emission and excitation slits widths 
were 2.5 nm and 10 nm respectively.
Elkay ultra U.V disposable cuvettes contained:
O.IMTris-HCI, pH 7.8 2.00 ml
(maintained at 37*’C)
microsomal fraction (25%w/v) 0.05 ml
and
0.53mM Ethoxyresorufin 3/vl
or I.OOmM Methoxyresorufin 5/y|
or I.OOmM Pentoxyresorufin 5/vl
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A baseline was recorded and an aliquot (10 /yl) of 50mM NADPH 
(in 1 % w/v NaHCOg) was then added to the test cuvette to initiate the 
reaction which was followed for approximately 5 minutes. The initial reaction 
rate was ascertained from the slope. Calibration was carried out using 5 /vl 
aliquots of 0 .1  mM resorufin standard (in DMSO).
Determination of microsomal epoxide hvdroiase activitv
Determination of this activity was carried out essentially according to the 
method of Dansette et ai, (1979). The production of benzo[a]pyrene-4,5- 
dihydrodiol from benzo[a]pyrene-4,5-epoxide on incubation with hepatic 
microsomes is monitored.
The spectrophotometer was set at an excitation wavelength of 310 nm and 
emission wavelength of 385 nm. The slit widths were set to 2.5 nm and 5 nm 
respectively.
Elkay ultra U.V. cuvettes contained:
0.015M Tris-HCI, pH 8.7 (maintained at 37°C) 2.00 ml
microsomal fraction (25% w/v) 0.05 ml
A baseline was recorded, then the reaction was initiated by the addition of 
an aliquot (5 /yl) of 2mM benzo[a]pyrene-4,5-epoxide (in acetonitrile). 
Calibration was performed using aliquots (5 /yl) of 2mM benzo[a]pyrene-4,5- 
dihydrodiol.
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2.2.5. Determination of microsomai iauric acid hydroxylase 
activity
This was carried out essentially using the TLC method of Parker and 
Orton (1980) whereby the metabolism of Iauric acid to œ and œ-1 
hydroxylaurates were measured.
Incubation mixture;
ImM Laurie acid 2 0 0  pi
[14C] Laurie acid (1 OpCi /ml) lOpI
Microsomes (25% w/v) 2 0 0  pi
Tris-HCi buffer (0.5M, pH 7.5) 1.5 ml
Plastic tubes (15 ml) containing the above mixture were preincubated for 
5 minutes at 37°C in a shaking waterbath prior to the addition of an aliquot 
(40 pi) of NADPH (12.5 mM). Incubation was allowed to proceed for a further 
10 minutes before termination of the reaction by the addition of 0 . 2  ml of HCI 
(3 M). The hydroxylated Iauric acid and the parent compound were extracted 
with diethylether (10 ml) on a rotating wheel for 10 minutes. Tubes were then 
allowed to stand for 5 minutes in order to clarify the phases. Centrifugation at 
3000 rpm in a Beckman J-6 B centrifuge may also be used to aid separation 
of the aqueous and organic phases. Once separation had occurred an 
aiiquot of the organic phase (7.5 ml) was removed and transferred to dry 
clean glass test tubes. These were then evaporated to dryness under 
nitrogen and residues of the samples were reconstituted in methanol (60 pi). 
A fraction (25 pi) was appiied as a single spot on to silica gel TLC plates 
using a Hamilton syringe. Each plate had a capacity of 8  sampies when 
placed at 2 cm intervals. Plates were developed in an equiiibriated tank 
containing a solvent system of ;
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hexane: diethylether: acetic acid 
70:28:1.5
The plates were finally scanned using a Berthold linear TLC analyser.
2.2.6 Discontinuous sodium dodecyl sulphate (S.D.S.) gel 
electrophoresis and Western blot analysis of hepatic microsomal 
proteins
PREPARATION OF SAMPLES
(i) Solubilisation buffer
0.1M Potassium phosphate buffer, pH 7.4 containing 2% (w/v)
Emulgen 911 and 10%(w/v) sodium cholate.
(ii) Sample buffer
0.4M Tris-HCI buffer, pH 6.25 25 ml
10% (w/v) SDS solution 40 ml
glycerol 2 0  ml
2 -mercaptoethanol 1 0  ml
bromophenol blue 2  mg
distilled water 5 ml
Microsomal fractions were prepared as described previously and total 
protein was determined by the method of Lowry et a l ., (1951). Hepatic 
microsomal proteins were solubilised by the addition of 1 0  pi of 
soiubiiisation buffer per miliigram of protein and stirring on ice for 
40 minutes. Sample buffer was then used to dilute the proteins to a final 
concentration of 2  mg/ml.
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Discontinuous S.D.S gel electrophoresis
The method of Laemmli (1970) was employed.
Buffers:
(i) Upper gel buffer: 0.5M Tris-HCI containing 0.4% (w/v) SDS, pH6 .8 .
(ii) Lower gel buffer: 1.5M Tris-HCI containing 0.4% (w/v) SDS, pH8 .8 .
(iii) Electrode buffer: 0.025M Tris-HCI, 0.192M glycine, 0.1% SDS, pH 8.3. 
Gel stock: 30% (w/v) acrylamide
0 .8 % (w/v) N,N'-methylene-bisacrylamide 
Ammonium persulphate: 10% (w/v) in distilled water
LOWER GEL
Acrylamide (30%, w\v) 8.11 ml
N,N'-methylene-bisacrylamide (0.8%, w\v) 3.38 ml
Lower gel buffer 6.25 ml
Distilled water 7.14 ml
Ammoniun persulphate 125 pi
N,N,N'N'-tetramethylethylenediamine (TEMED) 20 pi
UPPER GEL
Acrylamide (30% w\v) 1.00 ml
N,N'-methylene-bis-acrylamide (0.9%, w\v) 400 pi
Upper gel buffer 2.50 ml
Distilled water 6.00 ml
Ammonium persulphate 100 pi
N,N,N'N'-tetramethylethylenediamine (TEMED) 20 pi
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Procedure
Discontinuous SDS gel electrophoresis was carried out employing a 
Hoeffer SE 400 slab gel unit. Glass plates were initially washed with 
detergent and tap water, followed by several washes with distiiled water. 
Finally the plates were cleaned with acetone. Side-spacers were placed on 
the shorter sides of a glass plate and a second plate was placed on top. The 
unit was then clamped together at the shorter sides using the clamps 
provided. Cello-seal was applied to the bottom edge of the unit which was 
then placed in the gel setting compartment of the apparatus and secured 
with a cam on either side.
A lower gel (running gel) containing 10% (w/v) acrylamide was prepared as 
above with TEMED and ammonium persulphate added finally to the 
cocktail. The gel mixture was pipetted into the gel unit using a pasteur 
pipette until it was approximately 4 cm from the top edge of the glass plates. 
A layer of distilled water was placed on top of the gel so as to form a flat 
interface between the running and stacking gels. When the running gel had 
set (30-60 min), the upper or stacking gel was prepared. A perspex comb 
was inserted into the stacking gel in order to form the sample wells before 
the gel had set. Polymerisation of the stacking gel takes approximately one 
hour. Once the sample wells had formed the comb was removed and the 
wells were filled with electrode buffer to retain their integrity. The glass slab 
was removed from the casting compartment and piaced in the 
electrophoresis compartment of the apparatus. The welis and gei interface 
were marked on the glass plate using a marker pen. Solubilised microsomal 
samples in sample buffer were introduced into the sample wells using a 
Hamilton syringe. The two outer sample wells were not used as these are 
prone to curvature. Prior to loading, the samples were placed in boiling
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water for 3 minutes to ensure dénaturation of the proteins. Electrode buffer 
was placed in the assembled upper and lower tank (300 ml) and the 
protective guard was put in piace. The slab gel unit was connected to a 
Pharmacia power supply, model EPS 500/400, and electrophoresis was 
carried out at a constant current supply of 20 mA through the stacking gel 
and 40 mA through the running gel until the dye front was within 2 cm from 
the bottom edge of the glass plate.
Electrophoretic transfer onto nitrocellulose and Immunoblotting
Transfer Buffer:
0.20M Tris-HCI, methanol (13.3 % v/v), 0.15M glycine,pH 8.3
Phosphate buffered saline:
Sodium chioride
Potassium dihydrogen phosphate 
Sodium hydrogen phosphate 
Potassium chloride
8.0% (w/v) 
0.2% (w/v) 
2.9% (w/v) 
0.2% (w/v)
Wash buffer:
PBS
Triton X-100 
Bovine serum albumin
1.0% (v/v) 
0.2% (v/v) 
1.0% (w/v)
Pre-substrate wash: 
PBS 10% (v/v)
Substrate solution:
0.1M Tris-HCi, pH 7.5
3,3'- Diaminobenzidine hydrochloride
30% (w/v) Hydrogen peroxide
100 ml 
100 mg 
40 /7l
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Electrophoretic transfer and immunoblotting were carried out essentiaily 
according to Towbin et ai, (1979). After completion of discontinuous gel 
electrophoresis, the gel apparatus was dismantled, the gel removed and 
placed in transfer buffer (50 ml) for 40 minutes with gentle shaking in order to 
remove salts and shrink the gel. Electrophoretic transfer was carried out 
using a Biorad transfer system. The transfer cassette was set up under 
transfer buffer as follows:
1. Scotch brite
2. Two layers of filter paper
3. Gel
4. Nitrocellulose
5. Two layers of fiter paper
6. Scotch brite
During each layer addition air bubbles were removed. After the last scotch 
brite layer was in place, the cassette was closed and placed in the transfer 
tank with the nitrocellulose sheet nearest the anode. Electrophoretic transfer 
was achieved using a constant voltage of 60 volts for one hour. The 
nitrocellulose sheet was subsequently removed from the cassette and 
placed in wash buffer (50 ml) for two hours prior to immunodetection. The 
cytochrome P450iA polyclonal antibody was added in wash buffer (50 ml), 
the dilution factor being 1:10,000. The nitrocellulose was incubated with the 
antibody for an hour with gentie agitation. On completion of the incubation 
period the antibody was removed and the nitrocellulose sheet was blocked 
with fresh wash buffer for 30 minutes. The second antibody, donkey anti­
sheep peroxidase antibody was added in a futher aliquot of wash buffer 
(50 ml) the final dilution being 1:2000. Incubation with this antibody was 
also for one hour.
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The nitrocellulose sheet was futher washed with wash buffer (50 ml) for 
30 minutes after the incubation with the second antibody, followed by a 
10 minute wash with PBS (10% v/v) (50 ml). The blot was developed by 
incubation with freshly prepared substrate solution for 3 minutes. When the 
bands became visible, the substrate solution was removed and the 
nitrocellulose sheet was washed with ice-cold distilled water, three times. 
The blot was stored in the dark at 4°C.
2.2.7 Ames Salmonella mutagenicity assay
Mutagenicity potential was assessed using the Ames test ( Maron and Ames, 
1983). All procedures were carried out in a ciass 3 flow cabinet and all 
equipment were autoclaved at 120°C for 20 minutes prior to use.
Bacterial strains
Two different Salmonella typhlmurium bacterial strains were used in this 
assay, namely TA-98 and TA-100.The former is sensitive to frameshift 
mutagens whilst the latter detects primarily base-pair substitution mutagens.
Preparation of overnight cultures
All bacteria strains were stored as frozen permanents in DMSO at -80°C until 
required. Overnight cultures were prepared by innoculating nutrient broth 
(10 ml) in the presence of ampicillin (nutrient broth, 2.5% w/v containing 
ampiciliin, 25 ^g/ml). The cultures were subsequently incubated at 37°C in a 
shaking waterbath for 12 hours.
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(a) Histidine requirement
The requirement for histidine is used to test for the presence of the mutation 
in the histidine operon.
An aliquot (0.1 ml) of L-histidine (0.1 M) and biotin (0.5mM) were spread on a 
minimal agar plate. The bacterial culture was streaked across the plate.The 
same procedure then repeated in the abscence of the L-histidine and biotin 
solution. Plates were incubated at 37°C for 24 hours.
(b) Crystal violet test
This test is used to ascertain the presence of the deep rough (rfa) mutation 
and the abscence of the lipopolysaccharide coat on the bacteria surface.
Bacterial culture (0.1 ml) was added to nutrient agar (2.0 ml) containing 
L-histidine (0.1M) and biotin (0.5mM) and poured onto minimal agar plates. 
When the top agar had solidified, a sterile filter disc containing an aiiquot 
(10/ii) of crystai violet (1 mg/ml) was placed in the centre of the agar plate. 
Plates were incubated at 37°C for 24 hours.The rfa mutation was indicated 
by a ciear zone of inhibition of growth around the filter disc.
(c) Ampiciliin resistance R factor
The ampicillin test was used to ascertain whether the bacteria possessed the 
ampiciliin resistant plasmid which renders replication of the bacteria 
error-prone.
Bacteria (0.1 ml) were added to agar (2 ml) supplemented with L-histidine 
(0.1 M) and D-biotin (0.5mM) and the agar was allowed to solidifiy. A sterile
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filter disc containing an aliquot (10 p\) of ampicillin (8 mg/ml in 0.02 N NaOH) 
was placed in the centre of the plate and were then incubated at 37°C for 
24 hours. Strains lacking the R factor displayed a zone of inhibition around 
the filter disc.
(d) Viability test
Bacterial culture (0.1 ml) was added to nutrient broth, 2.5% (w/v) containing 
ampicillin (25 /yg/ml) and vortexed for 3 minutes. An aliquot (0.1 mi) was 
transferred to another sterile tube containing nutrient broth (10 ml) and 
vortexed. This procedure was repeated twice and an aiiquot of the finai 
dilution was transferred to a steriie tube containing agar (2 m l) 
supplemented with L-histidine (0.1 M) and D-biotin (0.5mM), vortexed and 
poured onto a minimal agar plate. When the agar had solidified, plates were 
incubated at 37°C for 24 hours.
Mutagenicity testing utilising the piate incorporation method
Activation svstem per plate (0.5 ml):
Potassium phosphate buffer (0.2M, pH7.4) 0.25 ml
Potassium chloride (0.33M) 0.05 ml
Magnesium chloride (80mM) 0.05 ml
Co-factor solution containing NADP (20 /vmol/mi) and 0.10 ml
glucose-6-phosphate (25 /ymol/ml)
Microsomal fraction 0.05 ml
Glucose-6-phosphate dehydrogenase 1 unit / plate
The activation system was kept on ice until required.
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Test svstem:
Compound 0.1 ml
Bacterial suspension (2-3x108) 0.1 ml
Activation system 0.5 ml
Molten agar (2 ml) containing 0.2 ml L-histidine (0.5mM) and 
D-biotin (0.5mM) was placed into steriie tubes which were maintained in a 
waterbath at 45°C. The compound under test was added to the tubes in a 
volume of 0.1ml followed by the bacteria (0.1 mi). Activation system (0.5 mi) 
was finaily added followed by immediate mixing and plating out onto 
minimal agar plates. Plates were allowed to solidify before being inverted 
and piaced in a 37°C incubator for 48 hours.
Mutagenicity testing employing a preincubation step
The activation system was prepared as described above and kept on ice 
until required.
Test system:
Activation system 0.5 mi
Bacterial suspension (2-3x10^) 0.1 ml
Test compound 0.1 ml
Test system was incubated at 37°C for 30 minutes in a shaking waterbath 
and then removed and kept at room temperature. Moiten agar (2 ml) 
containing an aliquot (0.2 ml) of L-histidine (0.5mM) and D-biotin (0.5mM) 
was added to the tubes, vortexed and poured immediately onto minimal agar 
plates. Plates were allowed to solidify before being inverted and placed in a 
37°C incubator for 48 hours.
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2-Amlnoanthracene (2 /yg/plate) was used as the positive control in both 
variations of the test.
2.2.8 Metabolic activation of Glu-P-1 to mutagens in the Ames 
mutagenicity assay
This was carried out as described above except that the preincubation 
period was increased to 60 minutes.
2.2.9 Binding to the Ah receptor
This was essentialiy performed as described by Gasiewicz and Neal (1982), 
using the hydroxyapatite assay.
Cvtosol preparation
Male Wistar albino rats (170-200g) were purchased from the Experimental 
biology unit. University of Surrey.
Animals were killed by cervical dislocation. Livers were excised immediately 
and washed twice in HEDG buffer [25mM Hepes, pH 7.4; 1.5mM EDTA; 
ImM dithiothreitol and 10% giyceroi (v/v)]. Subsequently, livers were 
homogenised in 3 volumes of ice-cold HEDG buffer using a motor-driven 
Potter-Elvhjem glass teflon homogeniser. The homogenate was centrifuged 
at 9000g (10,000 rpm) for 20 minutes using a JA-17, 14 x 50 ml aluminium 
angle-head rotor in a Beckman J2-21 centrifuge. The resulting supernatant 
was further centrifuged at 105,000g (45,000 rpm) for 60 minutes using a 
Beckman L7 ultracentrifuge equipped with a Ti-60 (8 x 30 ml titanium angie- 
head rotor). The iipid layer was removed using a pasteur pipette at each 
centrifugation step. The cytosol was removed without disturbing the
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microsomal pellet and pooled. This was then aliquoted out into 1 ml portions 
and stored at -80°C until required.
Hvdroxvlaoatite (HAP) preparation
HAP (DNA grade) was wash with HEDG, pH 7.4 until the washings were 
pH 7.4: normally 5 washes were sufficient. HAP (10g/75ml of HEDG buffer) 
was used throughout the assay.
Ligand preparation
pH]-TCDD and TCDF were evaporated to dryness under a gentle stream of 
nitrogen and were subsequently reconstituted to their original volume using 
dioxane. Further dilutions were also carried out using dioxane.
Competing ligands were also made up in dioxane. Where this was not 
possible, DMSO was used.
Binding to the Ah receptor
Reagents: HEDG buffer
HEDG buffer containig 0.5% (w/v) Tween 80 
Cytosol (protein concentration 2mg/ml) 
pH]-TCDD (66nM)
TCDF (40mM)
Cytosol (985 p\), previously diluted with HEDG buffer to a protein 
concentration of 2 mg/ml, was pipetted into cold test tubes kept on ice. An 
aliquot (5 p\) of pH]-TCDD (66nM) was added to the cytosol followed by the 
competing ligand. For determination of total binding in the absence of a 
competitive ligand, [3H]-TCDD (5 p\) was added followed by 10 p\ of
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dioxane. Non-specific binding was determined by the addition of pH]-TCDD 
(5 p\), an aliquot (5 p\) of TCDF (40mM) and an aliquot of dioxane 
(5 ^1).Other competing ligands were added in a volume of p\ of dioxane 
or DMSO. After ligands had been added, tubes were mixed using a vortex 
mixer and incubated for 2 hours at 20°C in a shaking waterbath. On 
completion of incubation, the tubes were placed on ice and an 0.2 ml aliquot 
of the incubation mixture was removed and incubated with 0.25 ml of HAP 
on ice for 40 minutes. During the latter incubation, tubes were gently shaken 
at 10 minute intervals. The incubation was terminated by the addition of 
ice-cold HEDG buffer containing 0.5% (w/v) Tween 80 (1 ml). The HAP was 
washed three times by the addition of the Tween 80 containing HEPES 
buffer, mixing, centrifugation at 3000 rpm using a J6B centrifuge and 
decanting of the supernatant. After the third wash, absolute ethanol (1 ml) 
was added to the pellet, mixed and transferred to a plastic scintillation viai 
(6 ml). Pico-Fluor 40 scintillant (4 ml) was then added and radioactivity was 
determined using a Waliac 1410 scintillation counter.
2.2.10 Statistical analysis
Statistical analysis was carried out using the Student's t-test.
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CHAPTER 3
Mutagenicity of chrysene, its methyl and benzo derivatives, and 
their interaction with cytochrome P450 and the Ah receptor: 
relevance to their carcinogenic potency.
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3.1 Introduction
OCCURRENCE
Chrysene and Its methyl isomers are polycyciic aromatic hydrocarbons 
which are widespread environmental pollutants formed as a consequence of 
incomplete combustion of organic matter. Methyl- and benzo- substituted 
isomers, along with the parent hydrocarbon, have been detected in coal tar, 
petroleum oils, cigarette smoke and exhaust fumes . Their presence has 
also been reported in foodstuffs such as charcoal-broiied steaks, smoked 
meats, vegetables and coffee.
STRUCTURES
10
12
Chrysene
Benzo[b]chrysene Benzo[c]chrysene
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MUTAGENICITY AND CARCINOGENICITY
Skin painting experiments have shown the parent hydrocarbon, chrysene to 
be a weak carcinogen, with weak initiation and promotional properties. In 
short-term tests, the compound displayed positive responses in the 
Salmomella typhimurium assay for mutagenicity, sister chromatid exchange 
and chromosomal aberration assays. In contrast, a negative response was 
observed in unscheduled DNA synthesis using primary hepatocytes, and 
mutation in V79 cells (lARC, 1983).
The monomethyl isomers were weak carcinogens in mouse skin studies with 
the exception of 5-methylchrysene which was a potent carcinogen (Hecht et 
a/., 1974; Hoffman ef a/., 1974; Hecht et aL, 1976). Mutagenicity studies 
employing Salmonella typhimurium and S9 preparations as activation 
systems showed that 5-methyl chrysene and 6-methylchrysene were the 
most and least mutagenic respectively (Coombs etal., 1976); this appears to 
correlate with their carcinogenicity potential. The benzo- substituted 
compounds, namely, benzo[b]- and benzo[c]-chrysene are classed as 
non-and weak carcinogens respectively (Hartwell, 1951).
METABOLISM
Polycyciic aromatic hydrocarbons, such as the chrysenes, are believed to be 
activated to carcinogens by the formation of a bay region dihydrodiol 
epoxide (Jerina, 1976). The major ultimate carcinogen of chrysene appears 
to be the 1,2- dihydrodiol 3,4-epoxide (Wood etal., 1977; Levin etal., 1978). 
This is formed in a three step process involving the cytochrome P450 
monooxygenase system (the CYP1A family) and epoxide hydrolase. CYP1A 
is the major cytochrome P450 protein catalysing the first epoxidation at the 
1,2- position (Yang and Bao, 1987). Subsequently epoxide hydrolase
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converts this to the dihydrodiol and a second epoxidation at the 3,4-position 
generates the 1,2-dihydrodiol 3,4-epoxide. The latter metabolite has been 
found to form DNA adducts (Hodgeson etal., 1983; Phillips etal., 1986).
Constitutive levels of CYP1A, the cytochrome P450 isoform responsible for 
the metabolic activation of polycyciic aromatic hydrocarbons is low; it 
comprises less than 5% of the total cytochrome P450 population in the livers 
of untreated rats (Pickett et al., 1981, Luster et a i, 1982). Therefore, 
induction of CYP1A may enhance the metabolic activation of these 
compounds with a consequent increase in their carcinogenic potential. It has 
been proposed that GYP1A induction may be a prerequisite for 
carcinogenicity of the polycyciic aromatic hydrocarbons (Ayrton et a i, 
1990a). Thus, it was thought apposite to investigate whether the difference 
in carcinogenic potential of chrysene and its substituted isomers may be 
attributed to the reactivity of the species generated on metabolic activation to 
cause DNA damage and/or CYP1A induction.
The doses chosen for this study were based on the findings of Iwasaki et ai, 
1986, where maximum hepatic induction of CYP1A monitored by the 
0-deethylation of ethoxyresorufin, following treatment of rats with 
benzo[a]pyrene occurred at lOmg/kg. Thus, it was thought appropriate to 
use this dose, as well as one above and one below it, for this study.
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3.2 Materials
All materials were obtained from the sources cited in chapter 2.
3.3 Methods
Animals were treated with a single i.p. dose of chrysene, methylchrysene, 
benzo[b]-, benzo[c]-, or 6-aminochrysene at three dose levels, 5, 10 or 
20 mg/kg, using corn oil as the vehicle. Control animals received the 
corresponding volume of the vehicle only. All animals were killed 24 hours 
after dosing and hepatic S9 fractions and microsomes were prepared as 
described in section 2.2.2. The following hepatic microsomal determinations 
were carried out as described in section 2.2; total protein content, total 
cytochrome P450 content, cytochrome bg content, alkoxyresorufin 
0-deaikylase activities, SDS-PAGE electrophoresis and immunoblotting, 
metabolic activation of Glu-P-1 to mutagens in the Ames test, and the 
metabolic activation of chrysene and its derivatives to mutagens in the Ames 
test. Furthermore, their binding to the hepatic cytosolic Ah receptor was 
determined (section 2.2.9)'.
Aroclor 1254-induced animals were dosed as described in section 2.2.1.
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3.4 Results
3.4.1 MONOMETHYL SUBSTITUTION OF CHRYSENE
6-Methylchrysene was the only isomer which increased total cytochrome 
P450 content significantly at all dose levels used, but no dose dependent 
effect was evident (table 3.4.3). 3-Methylchrysene also showed a significant 
elevation in total cytochrome P450 content but only at the 5mg/kg dose 
(table 3.4.2). Levels of the electron donor, cytochrome bs were found to be 
significantly decreased by treatment with 1-methylchrysene (20mg/kg),
5-methylchrysene (5mg/kg) and 6-methylchrysene at the top dose ( tables
3.4.1 and 3.4.3). The activity of the enzyme responsible for chrysene 1,2- 
dihydrodiol formation, epoxide hydrolase, increased following treatment with
6-methylchrysene at the 5 and 20mg/kg doses only (table 3.4.3).
CYP1A activity was monitored fluorimetricaily by the 0-dealkylations of 
ethoxyresorufin and methoxyresorufin. These were used to ascertain
CYP1A1 and CYP1A2 ievels respectively. It may be noted that considerable 
variation exists between the control values of the different groups; these are, 
however, nominal when compared with the level of induction seen following 
treatment with the compounds.
Dose dependency of CYP1A1 induction, as exempiified by the 
0-deethylation of ethoxyresorufin and expressed per nmol P450, was not 
evident, indicating that maximum induction has been attained at the lower 
doses of the various inducing agents (figures 3.4.1, 3.4.2 and 3.4.3). 
The 3- and 5- methyl isomers appear to be the most potent inducers of 
CYP1A1, causing an 86- and 94-fold induction at the 20mg/kg dose level 
respectively when compared with control animals. In addition, CYP1A2 was 
induced by all six methylchrysene isomers, as demonstrated by the
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O-demethylation of methoxyresorufin, but the response evoked was not as 
marked as for CŸP 1A1. As with CYP1A1 induction, dose dependency was 
not observed for the induction of the 1A2 isoform, implying that maximum 
induction had been attained at the iower doses of methylchrysene 
administration. CYP1A2 induction, monitored by the metabolic activation of 
Glu-P-1 to mutagens catalysed by hepatic microsomes, showed that the 
methylchrysene-treated animals elicited a greater mutagenic response than 
that obtained with control animals, thus confirming the induction of this 
enzyme (table 3.4.4).
Immunoblot analysis of hepatic microsomes utilising poiyclonal antibodies 
against rat CYP1A1 revealed that the all methylchrysenes induced CYP1A1 
apoprotein levels as depicted by the upper band on the blot which is absent 
in untreated animals (figure 3.4.4).
The activation of the methylchrysenes to mutagens in the Ames test by 
hepatic microsomes derived from control, (lOmg/kg) and methylchrysene- 
treated animals showed no positive response (figures 3.4.5, 3.4.6 and 3.4.7). 
However, when Aroclor 1254-induced microsomes were used as the 
activation system in order to ascertain the genotoxic potential of these 
compounds, 5-methylchrysene was found to provoke a marked (5-fold) 
mutagenic response (figure 3.4.7). 4-Methyichrysene also elicited a 
mutagenic response (figure 3.4.6) whereas 2-methylchrysene only produced
a weak response, a doubling of the spontaneous reversion rate (figure 
3.4.5). 1-,3- and 6-Methylchrysene were non-mutagenic (figures 3.4.5, 3.4.6. 
and 3.4.7).
The displacement of pH]-TCDD from the cytosolic hepatic Ah receptor was 
used as a measure of binding of the methylchrysenes to the receptor. All the 
monomethylchrysenes displaced pH]-TCDD from the cytosolic receptor of
62
untreated rats (figures 3.4.8, 3.4.9 and 3.4.10). The EC5 0  value for these 
compounds ie. the concentration at which 50% displacement was achieved 
ranged from 5x10’ iOM to 6 .5 x1 (table 3.4.5).
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a. Ethoxyresorufin 0-deethylase activity
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b. Methoxyresorufin 0-demethylase activity
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Figure 3.4.1 The effect of 1-methylchrysene and 2-methylchrysene 
treatment on rat hepatic microsomal aikoxyresorufin 0-dealkylase 
activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; ** PcO.OI : *** PcO.OOl.
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a. Ethoxyresorufin 0-deethylase activity
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Figure 3.4.2 The effect of 3-methyichrysene and 4-methyichrysene 
treatment on rat hepatic microsomal aikoxyresorufin 0-dealkyiase 
activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing .
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; ** P<0.01 : *** PcO.001.
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Figure 3.4.3 The effect of 5-methylchrysene and 6-methylchrysene 
treatment on rat hepatic microsomal aikoxyresorufin 0-dealkylase 
activities.
Animais received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses 
represent fold induction.
* PcO.05; P<0.01 : P<0.001.
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Table 3.4.4 Metabolic activation of Glu-P-1 to mutagens in the Ames test 
by methylchrysene-treated rat hepatic microsomal preparations.
Mutagenicity studies were conducted using Salmonella typhimurium strain 
TA98, Glu-P-1 (2pg) and 10%(v/v) microsomal activation systems derived 
from rats pretreated with methylchrysenes. Plates were supplemented with 1 
unit of glucose-6-phosphate dehydrogenase. Activation system, mutagen and 
bacteria were incubated for 1 hour at 370C in a shaking waterbath. Each 
study was repeated, using a sample from another but similarly-treated animal, 
with similar results.
Treatment Dose
(mg/kg)
Histidine revertants per nmol 
P450
Control 2 7 1 0 ±  184
1 -Methylchrysene 5 15290 ± 4 2 6 (5)
10 13952 ± 562 (4)
20 12189 ±1279 (3)
Control 5577 ± 85
2-Methylchrysene 5 22440 ± 697 (3 )
10 1 2 6 8 6 ±  174 (1)
20 12745 ± 4 7 7 (1)
Control 5577 ± 85
3-Methylchrysene 5 10583 ± 206 (1)
10 1 5 4 5 9 ±  181 (2)
20 13424 ± 4 7 8 (1)
Control 2800 ± 6
4-Methylchrysene 5 2828 ±1 (0)
10 4400 ±7 (0 .5)
20 6 0 6 8 ± 172 (1)
Control 2710 ±184
5-Methylchrysene 5 1 0 0 3 6 ± 192 (3)
10 14785 ± 397 (4)
20 1 7 8 3 7 ±  129 (6)
Control 2800 ± 6
6-Methylchrysene 5 2 3 1 4 ±  116 (0)
10 5 1 2 0 ± 4 (1)
20 5660 ± 237 (1)
Results are expressed as Mean ± SEM of triplicates. Numbers in parentheses 
represent fold induction.
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Figure 3.4.5 Metabolic acitvation of 1- and 2-methyichrysene to 
mutagens by rat hepatic microsomes.
The mutagenicity of 1 - and 2-methylchrysene was determined in the Ames test employing 
Salmonella typhimurium strain TA 100 and 10% (v/v) microsomal activation systems derived 
from control { O ), 1- or 2- methylchrysene-treated (lOmg/kg A  ), and Aroclor 1254-treated 
( ■  ) animals. Plates were supplemented with 1 unit of glucose-6-phosphate dehydrogenase. 
Activation system, mutagen and bacteria were preincubated for 30 minutes at 37® C in a 
shaking waterbath. The study was repeated, using a sample from another but similarly- 
treated animal, with similar results. Results are expressed as Mean ± S.E.M. of triplicates.
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Figure 3.4.6 Metabolic acitvation of 3- and 4-methyichrysene to  
mutagens by rat hepatic microsomes.
The mutagenicity of 3- and 4-methylchrysene was determined in the Ames test employing 
Salmonella typhimurium strain TA 100 and 10% (v/v) microsomal activation systems derived from 
control ( O ), 3- or 4-methylchrysene-treated (lOmg/kg a  ), and Aroclor 1254-treated ( ■  ) animals. 
Plates were supplemented with 1 unit of glucose-6-phosphate dehydrogenase. Activation 
system, mutagen and bacteria were preincubated for 30 minutes at 37° C In a shaking waterbath. 
The study was repeated, using a sample from another but similarly-treated animal, with similar 
results. Results are expressed as Mean ± S.E.M. of triplicates.
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Figure 3.4.7 Metabolic activation of 
mutagens by rat hepatic microsomes.
5- and 6-methylchrysene to
The mutagenicity of 5- and 6-methylchrysene was determined in the Ames test employing 
Salmonella typhimurium strain TA 100 and 10% (v/v) microsomal activation systems derived from 
control (O ), 5- and 6-methylchrysene-treated (lOmg/kg A  ), and Aroclor 1254-treated animals ( ■  ) 
Plates were supplemented with 1 unit of glucose-6-phosphate dehydrogenase.Activation 
system, mutagen and bacteria were preincubated for 30 minutes at 37° C in a shaking waterbath. 
The study was repeated, using a sample from another but similarly-treated animal, with similar 
results. Results are expressed as Mean ± S.E.M. of triplicates.
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Figure 3.4.8 Displacement of [3H]-TCDD from the Ah receptor by 1-methylchrysene and
2-m ethyichrysene
Ttie specific binding of [3H|-TCDD to rat hepatic cytosol was determined using the HAP assay. The concentration of [3H]-TCDD used was 
0.30nM .
Results are expressed as Mean ± SEM of triplicates. -7 C
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Figure 3.4.9 Displacement of [3H]-TCDD from the Ah receptor by 3-methylchrysene and 
4-m ethyichrysene.
Ttie specific binding of (3H]-TCDD to rat tiepatic cytosol was determined using ttie HAP assay. Ttie concentration of {3H)-TCDD used was 
0.30nM .
Results are expressed as Mean ±  SEM of triplicates. 76
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Figure 3.4.10 Displacement of pH]-TCDD from the Ah receptor by 5-methylchrysene and 
6-m ethylchrysene.
The specific binding of pHJ-TCDD to rat hepatic cytosol was determined using the HAP assay. The concentration of (3H)-TCDD used was 
0.30nM .
Results are expressed as Mean ±  SEM of triplicates. 77
Table 3.4.5 Displacement of pH]-TCDD from the rat hepatic cytosolic 
receptor by monomethylchrysene isomers.
At least eight concentrations of the displacer were employed in each assay. 
Each concentration was performed in triplicate.
Compound Displacement of pH]-TCDD 
EC50  (M)
1-Methylchrysene 5.0x10-10
2-Methylchrysene 1.5x10-9
3-Methylchrysene 3.0x10-9
4-Methylchrysene 6.5x10-9
5-Methylchrysene 7.0x10-10
6 -Methylchrysene 2.5x10-9
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3.4.2 BENZO[b]- and BENZO[c]- SUBSTITUTION OF CHRYSENE
Benzo[b]chrysene treatment caused a significant increase in total 
cytochrome P450 content at all dose levels, but a dose-dependent effect 
was not evident (table 3.4.6). Benzo[c]chrysene also increased total 
cytochrome P450 levels but the effect was not statistically significant (table 
3.4.6). Benzo[c]chrysene, but not benzo[b]chrysene, elevated epoxide 
hydrolase activity at all dose levels, but not in a dose dependent manner.
Both benzo[b]- and benzo[c] chrysene were potent inducers of CYP1A1 as 
demonstrated by ethoxyresorufin 0-deethylase activity, with the benzo[c]- 
isomer being more effective (figure 3.4.11). Moreover, the induction of 
CYP1A1 by both compounds appears to be dose dependent. Furthermore, 
CYP1A2 was elevated by these treatments as indicated by methoxyresorufin 
0-demethylase activity, once again benzo[c]chrysene was the more effective 
of the two isomers. CYP1A2 induction, measured by the metabolic activation 
of Glu-P-1 to mutagens in the Ames test showed that microsomes derived 
from animals treated with the two benzo- derivatives were more effective 
than control animals in converting Glu-P-1 to mutagens, thus, confirming the 
induction of CYP1A2 activity (table 3.4.7).
Immunoblot analysis of hepatic microsomes utilising polyclonal antibodies 
against rat CYP1A1 revealed the presence of CYP1A1 in all treated samples 
which was absent from control animals. Moreover, both benzo- substituted 
compounds induced the CYP1A2, as depicted by the darker lower band, 
(figure 3.4.12).
Both benzo[b]- and benzo[c]chrysene were found to displace [3HJ-TCDD 
from the cytosolic Ah receptor (figure 3.4.13). Of the two isomers 
benzo[c]chrysene was the more effective displacer (table 3.4.8).
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In the Ames Salmonella typhimurium mutagenicity assay, microsomal 
activation systems derived from control, (10 mg/kg) benzo- and Aroclor 
1254- treated animals all failed to elicit a positive mutagenic response.
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Figure 3.4.11 The effect of benzo[b]chrysene and benzo[c]chrysene 
treatment on rat hepatic microsomal aikoxyresorufin 0-dealkylase 
activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Number in parentheses represent 
fold induction.
* P<0.05; P<0.01; PcO.001.
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Table 3.4.7 Metabolic activation of Giu-P-1 to mutagens in the Ames test 
by benzochrysene-treated rat hepatic microsomal preparations.
Mutagenicity studies were conducted out using Salmonella typhimurium 
strain TA98, Glu-P-1 (2pg) and 10%(v/v) microsomal activation systems 
derived from rats pretreated with benzochrysenes. Plates were supplemented 
with 1 unit of glucose-6-phosphate dehydrogenase. Activation system, 
mutagen and bacteria were incubated for 1 hour at 37°C in a shaking 
waterbath. Each study was repeated, using a sample from another but 
similarly-treated animal, with similar results.
Treatment Dose
(mg/kg)
Histidine revertants per nmol 
P450
Control 6359 ± 59
Benzo[b]chrysene 5 11865 ±255 (1)
10 15221 ±239 (1)
20 15203 ±427 (1)
Benzo[c]chrysene 5 12985 ±156 (1)
10 16409 ±198 (2)
20 12350 ±276 (1)
Results are expressed as the Mean ± S.E.M. of triplicate plates. Numbers in 
parentheses represent fold induction.
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Figure 3.4.13 Displacement of [3H]-TCDD from the Ah receptor by benzo[b]chrysene and 
benzo[c]chrysene.
Ttie specific binding of (SHj-TCDD to rat hepatic cytosol was determined using the HAP assay. The concentration of pH]-TCDD used was 
O.SOnlVI.
Results are expressed as Mean ±  SEM of triplicates.
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Table 3.4.8 Displacement of pH]-TCDD from the rat hepatic cytosolic 
receptor by benzochrysene isomers.
At least eight concentrations ot the displacer were employed in each assay. 
Each concentration was performed in triplicate.
Compound Displacement of pHJ-TCDD
EC5o(M)
Benzo[b]chrysene 1.5x10-9
Benzo[c]chrysene 2.0x10-10
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Figure 3.4.14 Metabolic acitvation of benzo[b]chrysene 
benzo[c]chrysene to mutagens by rat hepatic microsomes.
and
The mutagenicity of benzo(b)chrysene and benzo(c)chrysene was determined in the Ames test 
employing Salmonella typhimurium strain TA 100 and 10% (v/v) microsomal activation systems 
derived from control ( O ), benzo[b]- or benzo[c]chrysene-treated (lOmg/kg a  ), and Aroclor 
1254-treated ( ■  ) animals. Plates were supplemented with 1 unit of glucose-6-phosphate 
dehydrogenase. Activation system, mutagen and bacteria were preincubated for 30 minutes at 
37° C in a shaking waterbath. The study was repeated, using a sample from another but similarly- 
treated animal, with similar results. Results are expressed as Mean ± S.E.M. of triplicates.
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3.4.3 CHRYSENE AND 6-AMINOCHRYSENE
Chrysene increased hepatic microsomal cytochrome P450 content at the 
10mg/kg and cytochrome bs content at the two higher doses, but no dose- 
dependent increase was observed (table 3.4.9). The same treatment did not 
influence epoxide hydrolase activity and was found to be comparable to that 
of control animals (table 3.4.9).
CYP1A1 and CYP1A2 levels were increased both by the parent 
hydrocarbon, chrysene and 6-aminochrysene at all dose levels as 
exemplified by the aikoxyresorufin 0-dealkylase activities (figure 3.4.15). 
The 0-dealkylation of ethoxyresorufin was markedly more induced than the 
0-demethylation of methoxyresorufin by both compounds. CYP1A2 
induction, monitored by the activation of Glu-P-1 to mutagens in the Ames 
test confirmed that both chrysene- and 6-aminochrysene-treated animals 
possessed higher levels of CYP1A2 (table 3.4.9).
Immunoblot analysis of hepatic microsomes using polyclonal antibodies 
raised against CYP1A1 revealed the presence of both the CYP1A1 and 1A2 
bands in pretreated animals, whilst only the CYP1A2 band was present in 
control animals (figure 3.4.16).
Displacement of pH]-TCDD from the Ah receptor was seen with both the 
parent hydrocarbon and the 6-amino substituted compound (figure 3.4.17 
and table 3.4.10).
Chrysene was found to be metabolically activated to mutagens in the Ames 
test by hepatic microsomes derived from Aroclor 1254-pretreated animals, 
but no activation was seen with either control or chrysene (lOmg/kg)- 
pretreated animals. In contrast, when 6-aminochrysene was used as the
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promutagen, activation to mutagens did not occur in the presence of 
microsomes derived from Aroclor 1254-treated animals. However, a marked 
positive mutagenic response was observed in the presence of microsomal 
activation systems derived from control and (lOmg/kg) 6-aminochrysene- 
treated animals (figure 3.4.18).
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Figure 3.4.15 The effect of chrysene and 6-aminochrysene treatment on 
rat hepatic microsomal aikoxyresorufin 0-dealkylase activities.
Animais received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; ** PcO.OI; ***P<0.001.
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Table 3.4.9 Metabolic activation of Giu-P-1 to mutagens in the Ames test 
by chrysene- and 6-aminochrysene-treated rat hepatic microsomal 
preparations.
Mutagenicity studies were conducted out using Salmonella typhimurium 
strain TA98, Glu-P-1 {2pg) and 10%(v/v) microsomal activation systems 
derived from rats pretreated with chrysene and 6-aminochrysene. Plates were 
supplemented with 1 unit of glucose-6-phosphate dehydrogenase. Activation 
system, mutagen and bacteria were incubated for 1 hour at 37°C in a shaking 
waterbath. Each study was repeated, using a sample from another but 
similarly-treated animal, with similar results.
Treatment Dose
(mg/kg)
Histidine revertants per nmol 
P450
Control 1138 ±46
Chrysene 5 25277± 1740 (21)
10 10021± 183 (8)
20 18537± 181 (15)
6-Aminochrysene 5 5700 ± 236 (4)
10 39319± 1000 (25)
20 37142 ±1041 (32)
Results are expressed as Mean ± SEM of triplicates. Numbers in parentheses 
represent fold induction.
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Figure 3.4.17 Displacement of [3HJ-TGDD from the Ah receptor by chrysene and 6-amino- 
chrysene.
Ttie specific binding of pH j-TCD D  to rat tiepatic cytosol was determined using the HAP assay. The concentration of [3H]-TCDD used was 
0.30nM .
Results are expressed as Mean ± SEM of triplicates.
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Table 3.4.10 Displacement of pH]-TCDD from the rat hepatic cytosolic 
receptor by chrysene and 6-aminochrysene.
At least eight concentrations of the displacer were employed in each assay. 
Each concentration was performed in triplicate.
Compound Displacement of pH]-TCDD
EC5 0  (M)
Chrysene 7.0x10-9
6 -Aminochrysene 8.0x10-9
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Figure 3.4.18 Metabolic activation of chyrsene and 6 - a m i n o -  
chrysene to mutagens by rat hepatic microsomes.
The mutagenicity of chrysene and 6-aminochrysene was determined in the Ames test employing 
Salmonella typhimurium strain TA 100 and 10% (v/v) microsomal activation systems derived from 
control ( O ), chrysene and 6-aminochrysene-treated (lOmg/kg A ), and Arodor 1254-treated ( ■  ) 
animals. Plates were supplemented with 1 unit of glucose-6-phosphate dehydrogenase. 
Activation system , mutagen and bacteria were preincubated for 30 minutes at 37® C in a shaking 
waterbath. The study was repeated, using a sample from another but similarly-treated animal, with 
similar results. Results are expressed as f^ean ± S.E.M. of triplicates.
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3.5 Discussion
Polycyclic aromatic hydrocarbons are activated by two oxidations, carried 
out by the cytochrome P450 monooxygenase system, and a hydration by 
epoxide hydrolase, to yield a reactive did epoxide, which is considered to 
be the ultimate carcinogen of this class of compounds. It has been 
postulated that selective induction of enzymes involved in the activation of 
polycyclic aromatic hydrocarbons may be related to their carcinogenic 
potential (Ayrton et ai, 1990a). Furthermore, a similar relationship appears 
to exist for aromatic amines (Ayrton et ai, 1990b). 5-Methylchrysene is a far 
more potent carcinogen than the other isomers and the parent compound, 
and it was thought of interest to investigate whether this marked difference in 
carcinogenic potential could be ascribed to the genotoxicity of the DNA 
species and/or the induction of CYP1A1, the enzyme responsible for the 
activation of these compounds and especially for the second oxidation, the 
conversion of the dihydrodiol to the diol-epoxide.
CYP1A INDUCTION
Chrysene and its six methyl isomers were all potent inducers of 
ethoxyresorufin 0-deethylase activity, thus indicating that methyl substitution 
does not influence the induction potential of CYP1A1 by these compounds. 
Similarly, amino substitution at the 6-position did not markedly influence the 
induction of this cytochrome P450 subfamily. The most potent induction of 
CYP1A1 was achieved by the fusion of another benzo ring to the parent 
hydrocarbon, especially at the [c]-position. Both benzo derivatives, namely, 
benzo[b]- and benzo[c]chrysene, are structural isomers of the potent 
CYP1A1 inducer, benzo[a]pyrene (Ayrton at ai, 1990a; Iwasaki at ai, 1986), 
Benzo[e]pyrene, another isomer of benzo[a]pyrene is a relatively poor 
CYP1A1 inducer (Ayrton at ai, 1990a) indicating that the point of fusion of
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the fifth ring is critical. I m mu noblot analysis of solubilised hepatic 
microsomes probed with anti-CYP1A1 antibodies confirmed that chrysene, 
the monomethylchrysenes, the benzo derivatives and 6-aminochrysene ail 
increased CYP1A1 apoprotein levels. The blots revealed a band which was 
absent or undetectable in control animals which corresponds to the CYP1A1 
band (Rodrigues et al., 1987).
CYP1A2 levels were induced to a lesser extent than CYP1A1 when 
monitored by assays regarded as specific probes for this isoform; the 
0-demethylation of methoxyresorufin (Namkung et al., 1988) and the 
metabolic activation of Glu-P-1 to mutagens in the Ames test (Yamazoe et 
a!., 1984). Both probes demonstrated the induction of the CYP1A2 isoform, 
but there appears to be a discrepancy between the magnitude of induction 
obtained between the two methods. This difference may be attributable to 
the fact that the dealkylation of methoxyresorufin, to a small extent is 
catalysed by CYP1A1 (Namkung et a!., 1988). The most potent inducer of 
methoxyresorufin 0-demethylase activity was benzo[c]chrysene, but this was 
not reflected in the number of induced histidine revertants produced on the 
metabolic activation Glu-P-1. Since benzo[c]chrysene was one of the most 
potent CYP1A1 inducers, this marked increase in the 0-demethylation of 
methoxyresorufin may be partly ascribed to dealkylation mediated by 
CYP1A1. Immunoblot analysis of hepatic microsomes, loaded on the basis 
of protein content, showed that both benzochrysenes augmented CYP1A2 
apoprotein levels when compared with control animals. Although amino 
substitution at the 6-position of the parent hydrocarbon did not manifest itself 
to be a potent CYP1A2 inducer as monitored by the 0-demethylation of 
methoxyresorufin, hepatic microsomes derived from these animals caused a 
marked increase in the mutagenicity of Glu-P-1. Initially, it was considered 
possible that this observation may be due to the presence of residual
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6 -aminochrysene in the liver, potentiating the mutagenic effect of the 
Glu-P-1 , since 6 -aminochrysene is itself highly mutagenic in this bacterial 
strain. However, microsomal preparations from 6 -aminochrysene-treated 
animals failed to elicit a positive mutagenic response in the absence of 
added mutagens. It may be that 6 -aminochrysene treatment induced 
enzymes, in addition to cytochrome P450, which can activate th is 
carcinogen, but this remains to be established.
INTERACTION WITH THE Ah RECEPTOR
Induction of CYP1A1 is thought to be mediated by the Ah receptor. When 
cells are exposed to an inducer, the chemical binds avidly to the Ah receptor 
in the cytosol which then translocates into the nucleus where it enhances the 
transcription of mRNA coding for CYP1A1 along with other genes in the Ah 
battery (Nebert, 1989). Correlations appear to exist between the inductive 
potential of PCBs, PAHs and ellipticines with their binding affinity to the Ah 
receptor (Bigelow et al., 1982; Bandiera et al., 1982; Roy et al., 1988). The 
present study has established that chrysene and all the substituted isomers 
used bind avidly to the receptor. Of these compounds, benzo[c]chrysene 
was the most potent inducer of CYP1A1 as exemplified by its ability to 
0 -deethylate ethoxyresorufin and, furthermore, this isomer displayed the 
highest affinity for the Ah receptor, as demonstrated by its displacement of 
pH]-TCDD from the receptor. However, no correlation could be ascertained 
between binding affinity and CYP1A induction in this study, since maximal 
CYP1A1 was achieved in some cases at the lowest doses and the range of 
EC5 0  values was narrow.
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MUTAGENIC POTENTIAL OF CHRYSENES
The potent carcinogenicity of 5-methylchrysene when compared with the 
other methyl isomers, may, at least partly, be due to the high biological 
activity of its diol-epoxide, the ultimate carcinogen. As the diol-epoxides of 
these compounds were not available, it was considered appropriate to 
ascertain the mutagenicity of the parent compounds, in the presence of a 
very active metabolic system, such as the Aroclor 1254-induced 
microsomes, as a means of indirectly measuring the biological activity of the 
reactive intermediates, namely, the diol-epoxides. Under these 
circumstances, it is assumed that the various methyl isomers are 
metabolised at similar rates in vitro . This is at least true for 5- and 
6-methylchrysene where the diol-epoxides are formed at the same rate and 
the difference in their tumourgenicity lies in the biological activity of their 
diol-epoxides (Amin et a!., 1985). Of the methylchrysenes used in the study, 
5-methylchrysene was found to the most mutagenic which is in accordance 
to a previous study, where S9 preparation was used as the activation system 
rather than isolated microsomes (Coombs et a/., 1976). The parent 
hydrocarbon, chrysene, was also found to be highly mutagenic, but this may 
not be entirely due to diol-epoxide activity, since it is known that phenolic 
metabolites of chrysene may be converted to triol-epoxides which are even 
more mutagenic than the diol-epoxides (Glatt et a/., 1986; Hodgson et a/., 
1983).
Both benzo- substituted chrysenes displayed marginal mutagenic activity 
when compared to their isomer, benzo[a]pyrene (benzo[def]chrysene) (Hyde 
et ai, 1987). Of all the compounds used in the study, 6-aminochrysene was 
by far the most mutagenic, when activated by microsomes derived from 
untreated animals. This was not surprising since the amino group provides
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another site for activation, namely through N-hydroxylation. Aroclor 1254- 
induced microsomes were found to suppress its mutagenic response, which 
is in agreement with findings using other aminocompounds, such as 
2-aminoanthracene and 2-aminofluorene (Leist et al., 1992; Ayrton et a!., 
1992). Microsomes from untreated rats failed to activate any of the other 
chrysenes which is in accordance with previous studies employing other 
polycyclic aromatic hydrocarbons (Phillipson et a!., 1989). In addition, it has 
been reported that microsomes from control animals are unable to generate 
the diol-epoxide from the parent hydrocarbon, chrysene (Jacob et a!., 1982).
The high mutagenic potential of 5-methylchrysene may be partly responsible 
for the high carcinogenic activity of this compound. The 1R,2S-diol-3S,4R 
epoxide of 5-methylchrysene manifests high tumourgenicity in mouse skin 
and newborn mice studies. This has been ascribed to the prescence of the 
methyl group in the same bay-region as the epoxide (Hecht et a!., 1987), 
thus, altering the conformation of the diol-epoxide and enhancing its 
biological activity compared with that of the unsubstituted parent 
hydrocarbon (Sayer etal., 1981). The prescence of a methyl group in the 
bay-region is believed to introduce steric requirements which allow 
5-methylchrysene-1R,2S-diol-3S,4R epoxide to react with mutational hot 
spots in S. typhimurium DNA (Amin et ai., 1988) that cannot be facilitated by 
methyl substitution at other positions. However, chrysene displayed a similar 
mutagenic response to 5-methylchrysene in this study, implicating that other 
factors could be involved in the high carcinogenicity of 5-methylchrysene, 
such as tendency of the diol-epoxides and triol-epoxides to be deactivated; 
the diol-epoxide derived from chrysene may be more readily deactivated 
through glutathione conjugation than the diol-epoxide derived from 
5-methylchrysene, thus contributing to the higher carcinogenic potential of 
the latter.
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AUTOINDUCTION OF METABOLIC ACTIVATION OF CHRYSENES
Neither chrysene nor any of the substituted isomers used in this study 
enhanced its own activation in the Ames test, inspite of their marked ability to 
induce CYP1A1. It may be inferred that limiting levels of epoxide hydrolase 
were responsible for this effect, since Aroclor 1254-induced microsomes 
were capable of activating some of the methylchrysene isomers, namely, 4- 
and 5-methylchrysene to mutagens in the Ames test. Aroclor 1254 treatment 
is known to be a potent inducer not only of CYP1A activity but also 
microsomal epoxide hydrolase activity (Parkinson et al., 1983), the enzyme 
which converts primary epoxides of polycyclic aromatic hydrocarbons to 
dihydrodiols, the precursor of the diol-epoxides. Thus, modulation of the 
activity of this enzyme may influence binding of the compound to DNA as 
previously reported for benzo[a]pyrene (Guenthner et a!., 1981). Of the 
compounds used in this study, only benzo[c]chrysene showed dose- 
dependent induction of epoxide hydrolase, but the increase was slight in 
comparison to that evoked by Aroclor 1254 at the dose used in this study 
(Parkinson et a!., 1983). From this study it may be inferred that CYP1A1 
induction alone is not sufficient to cause an increase in the bibactivation of 
polycyclic aromatic hydrocarbons possibly due to limiting epoxide hydrolase 
levels.
3.6 Conclusion
The high carcinogenicity of 5-methylchrysene cannot be attributed to its 
ability to induce CYP1A1 and its avidity for the cytosolic Ah receptor, since 
chrysene and all derivatives used in this study were found to induce 
CYP1A1 and bind to Ah receptor to similar extent. However, the high
102
carcinogenicity of 5-methylchrysene, may at least partly be ascribed to its 
high mutagenic potential.
Most of the carcinogenicity studies to date on the various chrysenes have 
been performed on mouse skin, a different species and tissue to that used in 
the present study, however due to lack of carcinogenicity data for the rat, it 
was considered reasonable to relate the mouse carcinogenicity data to the 
present findings for the rat. At least in the case of the more extensively 
studied carcinogen, benzo[a]pyrene, both animal species were susceptible 
to its toxic properties (Soderman, 1982). Furthermore, since the chrysenes 
are a highly lipophilic group of compounds, it is most likely that they are 
readily absorbed and distributed to the liver where they are metabolised by 
hepatic enzymes such as the cytochrome P-450 monooxygenase system.
Thus, it is highly probable that reactive intermediates produced on metabolic 
activation in the liver also contribute to the tumours produced in skin- 
painting experiments. In addition, recent studies by Wall et al., (1991) have 
shown using the 7,8-diol-9,10-epoxide of benzo[a]pyrene, that reactive 
intermediates generated in the liver may be distributed to other tissues 
through the systemic circulation, indicating that reactive Intermediates 
originating in the liver may be responsible for the production of tumours at 
sites distant to the liver.
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CHAPTER 4
Mutagenicity and CYP1A induction by azobenzenes: 
correlation to their carcinogenic potential.
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4.1 Introduction
Azobenzene and its derivatives are essentially used as intermediates in the 
manufacture of dyes and, in some cases, they are actually the colouring 
agents themselves. Azo compounds are used to colour foods, cosmetics, 
textiles, leather and paper. In addition, the parent compound, azobenzene is 
used in the manufacture of insecticides.
The genotoxic and carcinogenic potential of these azo compounds in short­
term mutagencity tests and long-term carcinogenicity studies appear to be 
dependent on the nature of the substituent(s) introduced onto the parent 
compound, azobenzene and the position of substitution. For example, the azo 
compound, N,N-diethylaminoazobenzene is a non-carcinogen whilst 
replacement of the diethyl group with a dimethyl substituent renders it 
carcinogenic (Garner etal., 1984). Furthermore, the introduction of a methoxy 
group at the 3-position of 4-aminoazobenzene enhances its carcinogenicity 
(Odashima and Hashimoto, 1968; Garner etal., 1984).
METABOLISM
The metabolic activation of these azocompounds may proceed via two 
pathways:
(1) Anaerobic azo reduction catalysed by mammalian azoreductases and by 
microorganisms in the gastrointestinal tract (Walker, 1970; Hartman et al., 
1978): The degradation products arising from azo reduction may further 
undergo oxidative metabolism to form reactive intermediates which are 
genotoxic. However, this is not always the case; when no oxidative 
metabolism occurs to form a reactive intermediate after azoreduction,
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azoreduction is regarded as a deactivation pathway (Miller, 1957). Studies 
with aminoazobenzenes have revealed that DNA adducts formed by these 
compounds possess intact azo bonds, suggesting that azo reduction is not a 
means of activation for this class of compounds (Beland et al., 1980; 
Tarpley et al., 1980). Ring hydroxylation also occurs, but this is essentially a 
deactivation pathway.
(2) The critical step in the activation of compounds containing amino groups 
such as the aminoazobenzenes is N-hydroxylation. This activation pathway is 
catalysed by the cytochrome P450 mixed-function oxidases and to a lesser 
extent by the flavin monooxygenases. The cytochrome P450 family 
responsible for N-hydroxylation has been revealed to be CYP1A, particularly 
CYP1 A2  (Degawa etal., 1982; Kimuraefa/., 1985; Yamazaki etal., 1991). 
Constitutive levels of this cytochrome P450 isoform are low in untreated 
animals; it comprises about 5% of the total cytochrome P450 content 
(Pickett et al., 1981 ; Luster etal., 1982). However, treatment with azo 
compounds, such as in long term carcinogenicity studies, may augment levels 
of CYP1A, thus, enhancing the formation of reactive intermediates which may 
ultimately lead to genotoxicity. In the light of these findings by previous 
workers and the postulate that CYP1A induction may be a prerequisite for 
carcinogenicity (Ayrton et al., 1990a; 1990b), it was considered pertinent to 
investigate whether CYP1A induction by azobenzenes may be correlated to 
their carcinogenic potential.
In addition to the ability of a compound to induce the enzymes responsible for 
its activation, the reactivity of the intermediates per se produced on metabolic 
activation, are likely to have an important influence on its carcinogenic 
potential. The genotoxicity of these compounds would be best ascertained 
using the intermediates themselves, namely, the hydroxylamines produced on
106
N-hydroxylation. But since these are not avaiiable, an aiternative approach 
was used, whereby Aroclor 1254-induced microsomes were used in the Ames 
Salm onella  assay as a means of generating the various reactive 
intermediates. Aroclor 1254-induced microsomes are an appropriate enzyme 
source since they are rich in CYP1 A (Parkinson etal., 1983), the cytochrome 
P450 family responsible for the initial step in the activation of planar 
compounds such as the azobenzenes. The genotoxicity of these compounds 
was subsequently evaluated using the Ames test.
STRUCTURES
Q k n = n h Q h n h 2
Diethylaminoazobenzene (DEAB) 4-Aminoazobenzene (4 AAB)
CH3
CH3
Azobenzene (AzB) 2-Methyl-N,N-dimethyl-4-aminoazobenzene (2Me4MAB)
 .OCH3  CH3 __CH3
3-Methoxy-4-aminoazobenzene (3MeOAB) o-Aminoazotoluene (OAT)
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4.2 Materials
All materials were obtained from the sources cited in chapter 2.
4.3 Methods
Animals received a single i.p. dose of azobenzene (AzB),
4-aminoazobenzene (4AAB), 4-diethylaminoazobenzene (DEAB), 
o-aminoazotoluene (OAT), 3-methoxy-4-aminoazobenzene (3 MeOAB) or 
2-methyl-4-dimethylaminoazobenzene (2Me4MAB) at three dose levels, 
1 0 , 20 or 40mg/kg, using corn oil as the vehicle. Control animals received the 
corresponding volume of the vehicle. All animals were killed 24 hours after 
dosing and hepatic microsomes were prepared as described in section 2 .2 .2 . 
The following determinations were carried out on the microsomal fractions as 
described in section 2 ,2 ; total protein content, cytochrome bg content, total 
cytochrome P450 content and aikoxyresorufin 0-dealkylase activities. In 
addition, SDS-PAGE electrophoresis of solubilised hepatic microsomes was 
carried out, followed by immunoblotting with polyclonal anti-CYPI A 
antibodies.
The metabolic activation of the diaminoazobenzene to mutagens was 
ascertained in the Ames test using Salmonella tyhimurium strain TA98. In 
the case of the parent compound, azobenzene,Salmonella tyhimurium strain 
TA 100 was used since this compound does not possess a free amino group. 
Aromatic amines are known to induce primarily frameshift mutations, which 
are readily detected by TA 98, whilst unsubstituted azo compounds such as 
azobenzene tend induce basepair substitutions which are readily detected by 
TA 100. All promutagens were dissolved in DMSO. Furthermore, the 
metabolic activation of Glu-P-1 in the Ames test was used as a measure of
1 0 8
CYP1A2 induction (section 2.2.8). Binding of azobenzene and its substituted 
isomers to the Ah receptor was determined as described in section 2.2.9.
Arocior 1254-induced animals were dosed as described in section 2.2.1.
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4.4 Results
Variations in basal activities were observed among different groups of 
untreated animals in certain assays, but these were relativeiy minor when 
compared to the changes induced by treatment with azobenzenes. All 
azobenzenes used in the study failed to evoke dose-dependent changes in 
microsomal protein, cytochrome bs and total cytochrome P450 content 
(tables 4.4.1, 4.4.2 and 4.4.3).
The 0-deethylation of ethoxyresorufin was induced most markedly by OAT 
and 3MeOAB (figures 4.4.2 and 4.4.3). Treatment with AzB also elevated 
ethoxyresorufin 0 -deethylase activity at all dose levels but the effect was 
weak (figure 4.4.1). 4AAB also increased this activity but only at the two lower 
dose levels (figure 4.4.1) whilst 2Me4MAB only evoked a significant increase 
at the top dose level (figure 4.4.3). Methoxyresorufin 0-demethylase activity 
was most potently induced by 3MeOAB and to a lesser extent by OAT (figure
4.4.2 and 4.4.3). Treatment with AzB modestly elevated this activity but only 
at the two lower dose levels (figure 4.4.1). DEAB and 2Me4MAB only 
provoked an increase at the 2 0 mg/kg dose level (figure 4.4.2 and 4.4.3). The 
other aikoxyresorufin activity measured, namely, pentoxyresorufin 
0-depentylase, was enhanced by both OAT and 3MeOAB at all dose levels, 
with the latter provoking a greater effect (figures 4.4.2 and 4.4.3). 2Me4MAB 
was found to elicit a weaker effect (figure 4.4.3). However, overall the 
0 -depentylation of pentoxyresorufin provoked by the azobenzenes was less 
pronounced than the other two 0-dealkylase activities measured. The other 
probe of specific cytochrome P450 activity (CYP1A2), the metabolic activation 
of Glu-P-1 to mutagens in the Ames test revealed that OAT and 3MeOAB 
were the most potent inducers of this activity, and to a lesser extent AzB, but 
only at the highest dose level (table 4.4.4).
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Immunoblot analysis of solubilised hepatic microsomes derived from 
azobenzene pretreated animals probed with anti-CYP1 A1 antibodies revealed 
that both CYP1A1 and CYP1A2 were induced by OAT and 3MeOAB in a 
dose-dependent manner (figures 4.4.4 and 4.4.5). In addition, 2Me4MAB 
induced CYP1A2 at all dose levels but to a lesser extent and , at the highest 
dose only, the CYP1A1 apoprotein was detectable (figure 4.4.5). No marked 
changes were observed in the case of AzB, 4AAB and DEAB (figure 4.4.4).
All azobenzenes used in the study displaced ^H-TODD from the cytosolic Ah 
receptor but to different extents (figures 4.4.6, 4.4.7 and 4.4.8). OAT and 
3MeOAB were the most effective displacers (table 4.4.5).
In the Ames Salmonella typhimurium mutagenicity assay, activation systems 
derived from control animals failed to evoke a positive mutagenic response 
with all azobenzenes used in the study (figures 4.4.9, 4.4.10 and 4.4.11). 
However in the presence of Aroclor 1254-induced hepatic microsomes, 
3MeOAB elicited a strong mutagenic response (figure 4.4.11). OAT also 
displayed mutagenicity but to a lesser extent than 3MeOAB (figure 4.4.10 
and 4.4.11). A very weak mutagenic response, a doubling in the spontaneous 
reversion rate, was provoked by AzB and 2Me4MAB (figures 4.4.9 and 
4.4.11). None of the azocompounds auto-induced its own activation.
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Figure 4.4.1 The effect of azobenzene and 4-aminoazobenzene 
treatment on rat hepatic microsomal a lkoxyresorufin  
0-dealkylase activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction. hhc
* P<0.05; ** P<0.01.
i
O
Ec
o
Q.
C
01o
Eo.
a. Ethoxyresorufin 0-deethylase
(10)
500 -
400 -
300 -
200 -
100  -
control 10 20 
Dose (mg/kg)
SMeOAB
2Me4MAB
I
0
Ec
1
I
Ia.
b. Methoxyresorufin 0-demethylase
(14)
800 -1
600 -
400 -
200 -
SMeOAB
2M04MAB
control 10 20
Dose (mg/kg)
I
0
Ec
1
c
0
1
0
1
c. Pentoxyresorufin 0-depentylase
80-1
60 -
40 -
2 0 -
control 10 20 
Dose (mg/kg)
SMeOAB
2Me4MAB
Figure 4.4.3 The effect of 3-methoxy-4-aminoazobenzene and 
2-methyl-N,N-dimethyl-4-aminoazobenzene treatment on rat 
hepatic microsomal alkoxyresorufin 0-dealkylase activities.
Animais received a singie i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; ** P<0.01; *** P<0.001.
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Figure 4.4.2 The effect of 4 -d iethyiam inoazobenzene and 
0-am inoazotoluene treatment on rat hepatic m icrosom al 
alkoxyresorufin 0-dealkyiase activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; “  P<O.OT, *** P<0.001.
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Figure 4.4.6 Displacement of pH]-TCDD from the Ah receptor by azobenzene 
and 4-am lnoazobenzene.
The specific binding of [^HJ-TCDD from rat hepatic cytosol was determined using the HAP assay. The concentration of p H |- TCDD
used was 0.30nM.
Results are expressed as Mean ± SEM of triplicates.
121
4 -D ie th y la m in o a z o b e n z e n e
120 1
100
80 -
60 -
40  -
20  -
-3
Competitor concentration (M)
0-A m inoazoto luene
100 n
80 -
60  -
40  -
2 0 -
-4 -3
Competitor concentration (M)
Figure 4.4.7 Displacement of [^HJ-TCDD from the Ah receptor by 4-diethylamino- 
azobenzene and 0-am inoazotoluene.
The specific binding of pH]-TCDD from rat hepatic cytosol was determined using the HAP assay. The concentration of pH ]- TCDD
used was 0.30nfv1.
Results are expressed as Mean ± SEM of triplicates.
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Figure 4.4.8 Displacement of pH]-TCDD from the Ah receptor by 3-methoxy-4- 
aminoazobenzene and 2-m ethyl-N,N-dim ethylam inoazobenzene.
The specific binding of (^HJ-TCDD from rat hepatic cytosol was determined using the HAP assay. The concentration of pH ]- TCDD
used was 0.30nM.
Results are expressed as K^ean ±  SEM of triplicates.
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Table 4.4.5 Displacement of ^ H-TCDD from rat hepatic cytosolic 
receptor by azobenzenes.
At least nine concentrations of the displacer were employed in each study, 
each performed in triplicate.
Compound Displacement of 3HTCDD 
ECso (M)
AzB 3x10-6
4AAB 2x^C^e
DEAB 2x10-6
OAT 6 x 1 0 -8
SMeOAB 2x10-7
2M04MAB 2x10-6
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Figure 4.4.9 Metabolic activation of azobenzene and 4-aminoazobenzene 
to mutagens by rat hepatic microsomes.
The mutagenicity of azobenzene and 4-aminoazobenzene were determined in the Ames test 
employing Salmonella typhimurium strain TA 100 and TA 98 respectively, 10% (v/v) 
microsomal activation systems derived from control ( O ), azobenzene and 4-aminoazo­
benzene (20mg/kg A ), and Aroclor 1254-treated ( ■  ) animals. Plates were supplemented 
with 1 unit of glucose-6-phosphate dehydrogenase. Activation system, mutagen and bacteria 
were preincubated for 30 minutes at 37°C in a shaking waterbath. The study was repeated, 
using a sample from another but similarly-treated animal, with similar results. Results are 
expressed as Mean ± S.E.M. of triplicates.
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Figure 4.4.10 Metabolic activation of 4-diethylaminoazobenzene and 
o-aminoazotoiuene to mutagens by rat hepatic microsomes.
The mutagenicity of 4-diethylaminoazobenzene and o-aminoazotoluene were determined in 
the Ames test employing Salmonella typhimurium strain TA 98 and 10% (v/v) microsomal 
activation systems derived from control ( O ), 4-diethylaminoazobenzene and o-aminoazo­
toluene (20mg/kg ▲ ), and Aroclor 1254-treated ( ■  ) animals. Plates were supplemented 
with 1 unit of glucose-6-phosphate dehydrogenase. Activation system, mutagen and bacteria 
were preincubated for 30 minutes at 37°C in a shaking waterbath. The study was repeated, 
using a sample from another but similarly-treated animal, with similar results. Results are 
expressed as Mean ± S.EM. of triplicates.
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Figure 4.4.11 Metabolic activation of 3-methoxy-4-aminoazobenzene 
and 2-methyl-N,N-dimethyl-4-aminoazotoiueneto mutagens by rat 
hepatic microsomes.
The mutagenicity of 3-methoxy-4-aminoazobenzene and 2-methyl-N,N-4-aminoazobenzene 
were determined in the Ames test employing Salmonella typhimurium strain TA 98 and 10% 
(v/v) microsomal activation systems derived from control ( O ), 3-methoxy-4-aminoazoben- 
zene and 2-methyl-N,N-4-aminoazobenzene (20mg/kg A ), and Aroclor 1254-treated ( ■  ) 
animals. Plates were supplemented with 1 unit of glucose-6-phosphate dehydrogenase. 
Activation system, mutagen and bacteria were preincubated for 30 minutes at 37°C in a 
shaking waterbath. The study was repeated, using a sample from another but similarly- 
treated animal, with similar results. Results are expressed as Mean ± S.E.M. of triplicates.
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4.5 Discussion
Azo compounds such as the azobenzenes possess two potential routes of 
activation: (1) Anaerobic reduction catalysed by mammalian azo reductases: 
microorganisms residing in the gastrointestinal tract can also reduce these 
compounds. The products formed by azo reduction may be subsequently 
oxidised to reactive intermediates which are capable of interacting with DNA.
(2) N-Hydroxylation of the parent compound ie. N-hydroxylation of the 
compound with the azo bond intact. As with other aromatic amines such as 
2-naphthylamine (Hammons et al., 1985), the N-hydroxylation of the 
azobenzenes is catalysed by the cytochrome P450 mixed-function oxidases 
and to a lesser extent by the flavin monooxygenases (Kimura et a!., 1985; 
Degawa et a!., 1982). Of the two possible routes of activation, the second 
pathway is considered the most likely for the azo compounds used in this 
study; mutagenicity studies with N,N-dimethylaminoazobenzene and its 
cleavage products have revealed that a positive mutagenic response is only 
elicited by the parent compound and not the cleavage products ie. the 
mutagenic species possessed intact azo bonds (Ashby, 1983). Further 
evidence for the reactive species retaining its azo bond is the detection of 
DNA adducts formed in 32p.postlabeling experim ents with 
N-methylaminoazobenzene; in vitro DNA adducts formed using synthetic 
benzoyl monomethyl aminoazobenzene were found to be similar to that 
detected in vivo on administration of N-methylaminoazobenzene 
(Beland et ai., 1980).
In this study, the role of constitutive cytochrome P45ÜS, flavin 
monooxygenases and hepatic azoreductases in activating these compounds 
may be dismissed, except in the case of SMeOAB. This is indicated by the 
inability of microsomes from control animals to activate the various
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azobenzenes to mutagens in the Ames test. In the case of SMeOAB, the 
mutagenicity seen with control microsomes as activation system may be 
ascribed to CYP1A2 activity since previous studies have suggested CYP1A2 
to be involved in the activation of this azobenzene (Degawa et al., 1985; 
Degawa et al., 1986). Furthermore, Western blot analysis of microsomes 
derived from untreated animals have revealed the presence of constitutive 
CYP1A2 (this study and chapters S, 5, and 6). Thus, if the reactive 
intermediates generated from SMeOAB by constitutive CYP1A2 are highly 
genotoxic, this may account for the positive mutagenic response elicited by 
this compound in the presence of control microsomes. Although the other 
aminoazo compounds may also be activated to some extent by CYP1A2, the 
low genotoxic potential of their reactive intemediates, precludes detection of 
their mutagenic potential perse.
The rationale for this study is based on previous studies (Degawa et al., 1982; 
Mori et al., 198S; Degawa et al., 1985 and Yamazaki, 1991) where the 
cytochrome P450 mixed-function oxidases were implicated in the activation of 
azo compounds to genotoxic species. Furthermore, SMeOAB has been 
shown to induce CYP1A (Degawa et al., 1985; Degawa ef a/., 1986). In 
conjunction with the postulate, that CYP1A induction is a prerequsite for 
carcinogenicity (Ayrton et ai, 1990a and 1990b), it was considered of interest 
to investigate whether induction of the cytochrome P450s responsible for the 
metabolic activation of azobenzenes compounds may be related to their 
carcinogenic potential.
In addition to the ability of a compound to induce the enzymes required for its 
metabolic activation, the reactive intermediates generated on metabolic 
activation must display genotoxic potential; the binding of the ultimate 
mutagen to DNA and the arisng mutagenic response are regarded as the first
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events in the onset of carcinogenesis. Ideally, the determination of the 
genotoxic potential of the reactive intermediates derived from the 
azobenzenes used in this study would be carried out using the intermediates 
themselves, but since these were not available an alternative approach was 
used, whereby Aroclor 1254-induced microsomes were used to generate 
these in the Ames Salmonella mutagenicity assay. Aroclor 1254-induced 
microsomes are considered an appropriate activation system under these 
circumstances, since they are rich in CYP1A (Parkinson et aL, 1983), the 
principal enzyme system responsible for the activation of these compound to 
mutagens.
CYTOCHROME P450 INDUCTION
The induction of three cytochrome P450 isoforms by the azobenzenes used in 
this study were monitored fluorimetrically by the 0 -dealkylation of a series of 
alkoxyresorufins. The induction of the CYP1 A family was measured by the
O-dealkylations of ethoxy- and methoxyresorufin. The 0-dealkylation of these 
alkoxyresorufins serve as markers for CYP1A1 and CYP1A2, respectively 
(Burke and Mayer, 1974; Burke and Mayer, 1983). The induction of the 
phenobarbitone-induced cytochrome P450 isoform, CYP2B was ascertained 
by the 0-depentylation of pentoxyresorufin (Lubet et a i, 1985). All three 
cytochrome P450 isoforms have been implicated in the activation of 
azobenzenes by previous workers (Degawa et ai, 1985; Degawaef a/., 1986). 
The most potent inducers of both of CYP1A isoforms, namely, CYP1 A1 and 
CYP1A2 were 3MeOAB and OAT, whilst DEAB was found to influence neither 
activities. AzB exhibited a weak effect on CYP1A1 and CYP1A2 levels whilst 
4AAB and 2Me4MAB were found to exert a minimal effect on these 
parameters. CYP1A2 induction was also monitored by the metabolic 
activation of Glu-P-1 to mutagens in the Ames test (Yamazoe et ai, 1984).
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The results obtained in this assay were comparable to those seen with the
0-demethylation of methoxyresorufin, with SMeOAB and OAT being the most 
potent inducers. On the basis of these results, it may be concluded that 
SMeOAB and OAT are the most potent inducers of both CYP1A isoforms. 
Western blot analysis of solubilised hepatic microsomes derived from 
azobenzene-treated animals probed with anti-CYP1A1 polyclonal antibodies 
confirmed the results of the enzyme activities. Thus, it appears that the 
presence an unsubstituted amino group and substitution at the 3- position are 
required for CYP1A induction.
Levels of the phenobarbitone-induced cytochrome P450, CYP2B (Lubet etaL, 
1985) were only found to be enhanced by SMeOAB and OAT. However, the 
degree of induction of this isoform was markedly less pronounced than that 
seen for CYP1A. The extent of CYP2B induction evoked by SMeOAB and 
OAT is consistent with that seen for other potent CYP1A inducers and is 
unlikely to reflect true CYP2B induction (Lubet etal., 1985).
All six azobenzenes used in this study were capable of displacing pH]-TCDD 
from the cytosolic Ah receptor, albeit to different extents as demonstrated by 
their EC5 0  values. SMeOAB and OAT were the most effective at displacing 
the radioligand from the receptor. From these findings it may be proposed that 
CYP1A induction by this group of compounds may be mediated by the Ah 
receptor. However, although correlation exists for this group of azobenzenes 
further investigation is required utilising compounds with a wider EC5 0  range.
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MUTAGENIC POTENTIAL OF AZOBENZENES
The genotoxicity of the various azobenzenes used in this study was 
determined by their ability to revert Salmonella typhimurium to histidine 
autotrophy in the Ames Salmonella mutgenicity assay in the presence of 
Aroclor 1254-induced microsomes. A strong mutagenic response was elicited 
by OAT and especially SMeOAB which may be contributory to their strong 
carcinogenic potential. This observation may be interpretated as representing 
high rates of N-hydroxylation and/or the potent genotoxic activity of the 
ultimate mutagens. A weak mutagenic response was evoked by 2Me4MAB, 
which is activated by oxidative déméthylation followed by N-hydroxylation, this 
being in accordance with its weak carcinogenic response (Miller and 
Miller, 195S). 4AAB was found to be non-mutagenic in the present study. 
Although 4AAB was originally thought to be a non-carcinogen, subsequent 
studies employing high doses were found to induce liver tumours in rats 
(Garner et al., 1984). Studies by other workers have shown 4AAB to be 
mutagenic, but the 89 fraction was used as activation system as opposed to 
microsomes (Purchase et ai, 1978). DEAB was non-mutagenic in the Ames 
test which is most likely due to the presence of the ethyl groups which prevent 
formation of the ultimate mutagens and thus, may account for the 
non-carcinogenic nature of this compound (Soderman, 1982). AzB is at best a 
weak carcinogen (lARC, 1975), and displayed no mutagenic response, 
presumably, due to the absence of an amino group.
Although some of the azobenzenes induced CYP1A and exhibited a positive 
mutagenic response in the Ames test when Aroclor 1254-induced rats were 
used as the source of activation system, they were however, unable to 
enhance their own activation. This discrepancy may possibly be ascribed to 
the low affinity of these compounds for CYP1A activity and the degree of
1S2
CYP1A Induction required for the activation of these compounds; the level of 
CYP1A induction achieved by the dose of Aroclor 1254 employed in this study 
is far greater than that attained by the azocompounds in the present study 
(Hyde etal., 1987).
4.6 Conclusion
On the basis of the results obtained in this study, a correlation appears to 
exist between CYP1A induction, mutagenicity and the carcinogenic potential 
of these azo compounds, even though the carcinogenicity data for the 
compounds are based on repeated oral administation as opposed to a single 
intraperitoneal dose, as in this induction study. However, the highly lipophillic 
nature of the azobenzenes most likely facilitates absorption of these 
compounds without appreciable metabolism by gastro-intestinal microflora 
(Chung et al., 1978; Walker et al., 1970). OAT and SMeOAB, the most potent 
carcinogens were also the most potent mutagens and CYP1A inducers whilst 
DEAB a non-carcinogen, was neither genotoxic nor an inducer of CYP1A. 
The remaining azobenzenes which are classed as weak carcinogens, were 
weak CYP1A inducers and/or poor mutagens.
In addition, it appears the CYP1A induction by the azo compounds used in 
this study is mediated by the Ah receptor, since a relationship appears to exist 
between CYP1A induction and the binding affinities of these compounds to 
the cytosolic receptor.
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CHAPTERS
Mutagenicity and CYP1A induction by diaminonaphthalenes 
and reiated aromatic amines
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5.1 Introduction
Naphthalene, an unsubstituted two-ring aromatic hydrocarbon is described as 
a non-carcinogen (Soderman, 1982). With regards to its mutagenic 
properties, naphthalene is classed as a non-mutagen in the Ames Salmonella 
assay (McCann etal., 1975). Monoamino substitution of naphthalene at the 
1- and 2- position, yielding 1-and 2-naphthylamine respectively, completely 
alters the genotoxic profile. 2-Naphthylamine is a potent mutagen in the Ames 
test in the presence of an activation system whereas the 1-isomer is at best a 
weak mutagen. Similarly, 2-naphthylamine is a potent carcinogen whereas 
the 1-isomer is considered to be devoid of carcinogenic activity. Furthermore 
as a result of strong epidemiological evidence, 2-naphthylamine is classed as 
a human carcinogen (IARC, 1974; Radomski, 1979).
Apart from monoamino substitution altering genotoxic potency, diamino 
substitution has also been observed to produce similar effects. This is 
exemplified by the diaminotoluenes, whereby substitution at the 2,4- position 
renders the compound carcinogenic (Ito etal., 1969) whilst its 2,6- isomer is 
considered to be a non-carcinogen (NTR 1980). The family of compounds 
which encompasses both these features, naphthyl ring structure and diamino 
substituents are the diaminonaphthalenes (DAN). Literature on these 
compounds is very limited, and only the 1,5-DAN isomer appears to have 
received any attention. 1,5-DAN is a synthetic compound used in the 
manufacture of 1,5-naphthalene diisocyanate, an intermediate in the 
production of polyurethane elastomers, and in the synthesis of organic dyes.
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MUTAGENICITY AND CARCINOGENICITY
Of the compounds used in this study mutagencitydata areavailable only for
1.5-DAN, 3,3'-DAB and 1-NED in the Ames Salmonella assay. 1,5-DAN was 
reported to be positive in this assay using the bacterial strain, TA 100 in the 
absence of metabolic activation (lARC, 1982) whilst 3,3'DAB was mutagenic 
in both TA100 and TA98 but only in the presence of a S9 activation system 
(You et ai, 1993). 1-NED is also classed as positive in the Ames test in the 
presence of an activation system (NTP, 1981 ).
Long-term carcinogenicity studies appear to have only been carried out for
1.5-DAN and 1-NED. In the case of 1,5-DAN, these studies were performed 
in both mice and rats. However the results obtained in the rat study were 
considered to be inadequate for evaluation (lARC, 1982). When 1,5-DAN was 
administered to the diet of mice, over a two year period, it was found to 
induce c-cell carcinoma of the thyroid gland in female mice, in addition to 
neoplasms of the thyroid gland which were observed in both sexes. 
Hepatocellular carcinomas were also induced by 1,5-DAN in female mice as 
well as alveolar/bronchiolar adenomas and carcinomas (lARC, 1982).
1-NED is considered to be a non-carcinogen on oral administration in both 
rats and mice (NTP, 1978).
METABOLISM
All the compounds discussed so far, namely the naphthylamines, 
diaminotoluenes and diaminonaphthalenes are classed as aromatic amines. 
The mutagenicity and carcinogenicity of aromatic amines is mediated through 
reactive intermediates which are capable of covalently binding with DNA. The 
initial step in the metabolic activation of the aromatic amines involves
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N-hydroxylation carried out by the cytochrome P450 mixed-function oxidases 
(Miller, 1978) and to a lesser extent by the FAD-monooxygenase system. 
Ring hydroxylation of these compounds also occurs but this is regarded as a 
detoxication pathway (Hammons etal., 1985). The hydroxylamine formed by 
N-hydroxylation can be converted to more potent electrophilic species by 
acétylation, conjugation with sulphate or glucuronic acid (Miller, 1978). The 
ultimate carcinogen of the aromatic amines which intercalates with DNA is 
postulated to be the nitrenium ion (Miller, 1978; Loew et al., 1979; Ford and 
Herman, 1991). Since there is no literature on the metabolism of 
diaminonaphthalenes, by analogy to other aromatic amines it is assumed that 
they are metabolically activated in the same manner.
Since monoamino substituted compounds such as 1- and 2-naphthylamine 
are metabolised by the cytochrome P450 family especially CYP1A 
(Hammons etal., 1985), it is most likely that the diaminonapthalenes are also 
metabolised by this enzyme family. Thus, it was considered appropriate to 
investigate the effect of these compounds on the induction of CYP1A, the 
cytochrome P450 isozyme responsible for the activation of chemical 
carcinogens.
Constitutive levels of CYP1A are very low in untreated animals; it typically 
comprises about 5% of the total hepatic cytochrome P450 population in these 
animals (Pickett et al., 1981; Luster etal., 1982). Induction of CYP1A may 
enhance the metabolic activation of these compounds, thus resulting in an 
increase in their metabolic potential. Previous studies have postulated that 
CYP1A induction may be a prerequisite for the carcinogenicity of the aromatic 
amines (Ayrton et al., 1990b). It was thus thought appropriate to extend these 
s t u d i e s  to another group of aromatic amines namely, the 
diaminonaphthalenes. It was also of interest to investigate another 2-ring
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system, 3,3'-diaminobenzidine, where the two rings are not fused. The ability 
of these compounds to induce CYP1A and their genotoxicity in the Ames test 
were tentatively used to predict the possible carcinogenicity of these 
compounds.
Apart from the ability of a compound to induce the enzymes responsible for its 
metabolic activation, the reactivity of the intermediates per se produced on 
activation may also have important bearing on its carcinogenic potential. The 
ability of these intermediates to cause DNA damage would ideally be 
ascertained using the intermediates themselves but since these are not 
available an alternative approach was used. The Ames Salmonella assay in 
the presence of Aroclor 1254-induced microsomes was used as a means of 
generating the various reactive intermediates, since these microsomes are a 
rich source of CYP1 A, the cytochrome P450 family responsible for the initial 
step in the activation of planar aromatic amines. The ability of these 
intermediates to cause DNA damage was determined in the Ames test.
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STRUCTURES
NHg
1,5-Diaminonaphthalene 1 -Naphthylethylenediamine
3,3'-Diaminobenzidine
139
5.2 Materials
All materials were obtained from the sources cited in chapter 2.
5.3 Methods
Rats received a single i.p. dose of 1,8-DAN, 2,3-DAN, 1,5-DAN, 1-NED or 
3,3'-DAB at three dose levels, 10, 20 or 40mg/kg, using corn oil as the 
vehicle. Control animals received the corresponding volume of the vehicle. 
All animals were killed 24 hours after dosing and hepatic microsomes were 
prepared as described in section 2.2.2. The following determinations were 
carried out on the microsomal fractions as described in section 2.2: protein 
content, cytochrome bg content, total cytochrome P450 content and 
alkoxyresorufin 0-dealkylase activities. In addition, SDS-PAGE 
electrophoresis of solubilised hepatic microsomes was carried out, followed 
by immunoblotting with polyclonal anti-CYPIAI antibodies.
The metabolic activation of the diaminotoluene isomers to mutagens in the 
Ames test was ascertained using Salmonella tyhimurium strain TA98, as 
aromatic amines are known to induce primarily frameshift mutations which are 
readily detected by this particular strain. Ali promutagens used in the test 
were dissolved in DMSO. Binding of all compounds to the Ah receptor was 
determined as described in section 2.2.9.
Aroclor 1254-induced animals were dosed as described in section 2.2.1.
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5.4 Results
Total cytochrome P450 content levels were increased significantly by the 
administration of 1,5-DAN at the top dose level (table 5.4.2) and 3,3'-DAB at 
all dose levels,but the effect was not dose-dependent (table 5.4.2). 2,3-DAN 
was found to significantly decrease total cytochrome P450 levels at the 
20mg/kg dose level (table 5.4.1) whilst 1-NED and 1,8-DAN did not affect 
cytochrome P450 levels at any of the three dose levels used (table 5.4.1 and 
5.4.3).
CYP1A levels were monitored fluorimetrically by the 0-dealkylations of 
ethoxyresorufin and methoxyresorufin. 1,8-DAN induced CYP1A1 at all dose 
levels, as exemplified by the 0-deethylation of ethoxyresorufin expressed per 
nmol P450, but no dose-dependent increase was evident since maximum 
induction appears to have been attained at the 20 mg/kg dose (figure 5.4.1).
2,3-DAN also increased CYP1A1 levels at all doses, but statistical 
significance was only attained at the top two doses (figure 5.4.1). 
Furthermore, the 1,5- isomer induced CYP1A1 at all dose levels in a dose- 
dependent manner, whilst 3,3’-DAB elevated CYP1A1 levels moderately at 
the lowest dose only (figure 5.4.2).
CYP1A2 levels, ascertained by the 0-demethylation of methoxyresorufin, 
revealed that both 1,8- and 2,3-DAN induced this isoform at all dose levels, 
with maximum induction being achieved at the 20mg/kg dose level 
(figure 5.4.1). 1,5-DAN, at the highest dose also elevated the 0-demethylation 
of methoxyresorufin (figure 5.4.2) whilst 3,3’-DAB significantly inhibited this 
activity at the top two doses (figure 5.4.2).
1-NED perturbed neither CYP1A1 nor CYP1A2 levels (figure 5.4.3).
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Western blot analysis of hepatic microsomes derived from aromatic amine- 
treated animals utilising polyclonal antibodies against rat CYP1A1 revealed 
that CYP1A1 was induced by 1,8-, 2,3-DAN at all dose levels and to a lesser 
extent by the 1,5- isomer, as depicted by the presence of the upper band, 
which is absent in untreated animals, and corresponds to the CYP1A1 protein 
(figure 5.4.4). Furthermore, CYP1A2 was also induced by all the 
diaminonaphthalenes as shown by the darker intensity of the lower band 
when compared with that seen in the control sample (figure 5.4.4). 
Immunoblot analysis also revealed that 3,3’-DAB and 1-NED had no 
detectable effect on CYP1A apoprotein levels (figures 5.4.4 and 5.4.5).
The displacement of pH]-TCDD from the cytosolic Ah receptor was used as a 
measure of binding of these aromatic amines to the receptor. 1,8-, 2,3- and
1,5-DAN were all found to displace pH]-TCDD from the receptor (figures 5.4.6 
and 5.4.7). Meanwhile, 3,3'-diaminobenzidine and 1-naphthyl- 
ethylenediamine failed to displace pH]-TCDD from the cytosolic receptor at 
the concentrations used (figures 5.4.7 and 5.4.8). The 2,3- and 1,8-DAN 
isomers bound to the Ah receptor more effectively than the 1,5- isomer as 
demonstrated by their ability to displace 50% of the pH-TCDD] from the 
receptor, ie. their respective EC5 0  values (table 5.4.4).
The genotoxic potential of the diaminonaphthalene isomers, 1-NED and 
3,3'-DAB were evaluated in the Ames test by determining their mutagenicity in 
the presence of hepatic microsomes derived from Aroclor 1254-pretreated 
animals as activation system. 1,8-DAN and to a lesser extent 3,3-DAB and
2,3-DAN elicited a mutagenic response (figures 5.4.9 and 5.4.10). 1,5-DAN 
produced a doubling in the spontaneous reversion rate (figure 5.4.10) 
whereas, under the same conditions 1-NED was negative (figure 5.4.11).
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The ability of these aromatic amines to stimulate their own mutagenicity was 
determined in the presence of microsomes from control and aromatic 
amine-treated rats (20mg/kg) as activation systems. 1,8-DAN, and to a much 
lesser extent 2,3-DAN and 1,5-DAN induced their own activation (figures 
5.4.9 and 5.4.10), whilst 3,3’-DAB and 1-NED failed to evoke a mutagenic 
response under these conditions (figures 5.4.10 and 5.4.11). In the presence 
of control microsomes, 1,8-DAN, 2,3-DAN and to much lesser extent 3,3’-DAB 
elicited a positive mutagenic response (figures 5.4.9 and 5.4.10) whilst
1,5-DAN only provoked a doubling in the spontaneous reversion rate 
(figure 5.4.10). Once again, 1-NED was not activated to mutagens 
(figure 5.4.11).
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Figure 5.4.1 The effect of 1,8- and 2,3-diaminonaphthalene treatment on 
rat hepatic microsomal alkoxyresorufin 0-dealkylase activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; ** P<0.01; *** P<0.001.
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Figure 5.4.2 The effect of 1,5-diaminonaphthalene and 3,3'-diaminobenzi- 
dine treatment on rat hepatic microsomal alkoxyresorufin 0-dealkylase 
activities.
Animais received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; ** P<0.01 : *** PcO.001.
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Figure 5.4.3 The effect of 1 -naphthylethylenediamine on rat hepatic 
microsomal alkoxyresorufin 0-dealkylase activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, com oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals.
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120 -I
100  -
80 -
60  -
40  -
20  -
Competitor concentration (M)
2,3-D iam inonaphthalene
120 -,
100  -
80 -
60  -
40  -
2 0 -
-10 10 ' -3
Competitor concentration (M)
Figure 5.4.6 Displacement of [^Hl-TCDD from the Ah receptor by 1,8- and 2,3-dlamlnonaphthalene.
Tfie specific binding of pH]-TCDD to rat tiepatic cytosol was determined using ttie HAP assay. Ttie concentration of pH]-TCDD used was 0.30nM. 
Results are expressed as Mean ±  SEM of triplicates.
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Figure 5.4.7 Displacement of pH]-TCDD from the Ah receptor by 1,5-dlaminonaphthalene and 
3,3 '-d iam inobenzid ine.
Ttie specific binding of pH]-TCDD to rat tiepatic cytosol was determined using ttie HAP assay. Ttie concentration of pH)-TCDD used was 0.30nM. 
Results are expressed as Mean ± SEM of triplicates.
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Figure 5.4.8 Displacement of pHJ-TCDD from the Ah receptor by 1-naphthylethylenediamine.
Ttie specilic binding ol pH)-TCDD to rat tiepatic cytosol was determined using ttie HAP assay. Ttie concentration of pH]-TGDD used was 0.30nM. 
Results are expressed as Mean ± SEM of triplicates.
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Table 5.4.4 Displacement of pH]-TCDD from rat hepatic cytosolic 
receptor by diaminonaphthalenes and 3,3’-diaminobenzidine.
At least eight concentrations of the dispiacer were employed in each assay. Each 
concentration was performed In triplicate.
Compound Displacement of ^H-TCDD 
EC5 0  (M)
1,8 -Dlaminonaphthaiene 1 .0 x 1 0 '®
2,3-Dlaminonaphthaiene 4.0 X 10"7
1 ,5-Diaminonaphthaiene 4.0x10-6
3,3'-Diaminobenzidine No displacement
1 -Naphthyiethyienediamine No displacement
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Figure 5.4.9 Metabolic activation of 1,8- and 2,3-diaminonaphtha 
lene to mutagens by rat hepatic microsomes.
The mutagenicity of 1,8- and 2,3-diaminonaphthalene were determined in the Ames test 
employing Salmonella typhimurium sXram TA 98 and 10% (v/v) microsomal activation system 
derived from control ( O ), 1,8- or 2,3-diaminonaphthalene-treated (20mg/kg ▲ ), and Aroclor 
1254-treated ( ■  ) animals. Plates were supplemented with 1 unit of glucose-6-phosphate 
dehydrogenase. Each study was repeated using a sample from another but similarly-treated 
animal, with similar results. Results are expressed as Mean ± S.E.M. of triplicates.
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Figure 5.4.10 Metabolic activation of 1,5-diaminonaphthaiene 
and 3 ,3 -diaminobenzidine to mutagens by rat hepatic micro­
somes.
The mutagenicity of 1,5-diaminonaphthaiene and 3,3'-diaminobenzidine were determined in 
the Ames test employing Salmonella typhimurium strain TA 98 and 10% (v/v) microsomal 
activation systems derived from control ( O ), 1,5-diaminonaphthalene- or 3,3’-diamino- 
benzidine- (20mg/kg ▲ ), and Aroclor 1254-treated ( ■  ) animals. Plates were supplemented 
with 1 unit of glucose-6-phosphate dehydrogenase. Each study was repeated, using a 
sample from another but similarly-treated animal, with similar results. Results are expressed as 
Mean ± S.E.M. of triplicates.
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Figure 5.4.11 Metabolic activation of 1-naphthylethylenediamine 
to mutagens by rat hepatic microsomes.
The mutagenicity of 1 -naphthyiethyienediamine was determined in the Ames test employing 
Salmonella typhimurium strain TA 98 and 10% (v/v) microsomal activation systems derived 
from control ( O ), 1-naphthylethylenediamine- (20mg/kg A ), and Aroclor 1254-treated ( ■  ) 
animals. Plates were supplemented with 1 unit of glucose-6-phosphate dehydrogenase. The 
study was repeated, using a sample from another but similarly-treated animal, with similar 
results. Results are expressed as Mean ± S.E.M. of triplicates.
158
5.5 Discussion
The genotoxic properties of aromatic amines are thought to be mediated 
through the nitrenium ion (Miller, 1978; Loew et ai, 1979; Ford and 
Herman, 1991), which is capable of interacting readily with DMA. The 
formation of this ultimate carcinogen occurs in a stepwise manner with an 
initial N-hydroxylation step followed by subsequent acétylation, conjugation 
with sulphate or glucuronic acid (Miller, 1978; Miller, 1985). Breakdown of this 
conjugate leads to the formation of the nitrenium ion.
The first step in the metabolic activation of aromatic amines, namely 
N-hydroxylation is catalysed by the cytochrome P450 mixed-function 
oxidases and to lesser extent by the flavin-monooxygenase system. 
Moreover, the cytochrome P450 family involved in the N-hydroxylation of 
planar aromatic amines has been identified as CYP1A (Astrom and DePierre, 
1985; Goldstein et ai, 1984). Selective induction of this cytochrome P450 
protein is thought to influence the carcinogenic potential of the aromatic 
amines (Ayrton at ai, 1990b). In order to substantiate this hypothesis it was 
thought appropriate to extend the above studies using the 
diaminonaphthalenes and an unfused two ring system, 3,3'-DAB. Ideally, 
benzidine would have been the best example of an unfused two ring system 
since its genotoxic properties have been extensively studied; it is highly 
mutagenic and carcinogenic, but less potent than 2-naphthylamine. However, 
due to the high carcinogenic potential of benzidine in humans, its use and 
availablility has been restricted by the Health and Safety Executive.
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CYP1A INDUCTION
Of the aromatic amines used in this study, the most potent dose-dependent 
inducer of ethoxyresorufin 0-deethylase activity, hence CYP1A1 
(Burke and Mayer, 1974) was 1,5-DAN. Animals treated with 1,5-DAN 
induced CYP1A1 levels up to 28 fold when compared with control animals. 
The 2,3- and 1,8-DAN isomers also induced CYP1A1, but to a lesser extent 
than the 1,5- isomer as exemplified by their ability to 0-deethylate 
ethoxyresorufin. The other naphthyl-based compound, 1-NED did not affect 
CYP1A1 levels. The unfused aromatic amine, 3,3'-DAB caused a relatively 
moderate increase in CYP1A1 levels at the lowest dose, inspite of its ability to 
elevate total cytochrome P450 content at all dose levels. This suggests that 
3,3'-DAB may have induced one or more cytochrome P450 families in 
addition to CYP1A. Western blot analysis of solubilised hepatic microsomes 
derived from these animals, probed with anti-CYPIAI polyclonal antibodies 
confirmed that 2,3- and 1,8-DAN induced CYP1A1 at all dose levels as 
depicted by the presence of the upper band on the blot which is 
absent/undetectable in control animals, and corresponds to CYP1A1 
(Rodrigues et al., 1987). However, immunoblotting of solubilised hepatic 
microsomes from 1,5-DAN pretreated animals did not display the marked 
induction seen on the 0-deethylation of ethoxyresorufin, though the presence 
of CYP1A1 apoproteins was visible. The results obtained on Western blot 
analysis of hepatic microsomes treated with the other two compounds, 1-NED 
and 3,3'-DAB were comparable to their ethoxyresorufin 0-deethylase 
activities.
The other member of the CYP1A family, CYP1A2 was monitored by the
0-demethylation of methoxyresorufin, a specific probe for this isozyme 
(Namkung et al., 1988). Both 1,8- and 2,3-DAN induced CYP1A2 at all dose
160
levels which is in agreement with the results obtained on Western blot 
analysis of solubilised hepatic microsomal samples obtained from these 
animals using anti-CYP1A1 polyclonal antibodies. Increase in staining of the 
lower band, the CYP1A2 apoprotein band, was observed on immunoblotting 
of samples derived from 1,5-DAN treated animals especially at the highest 
dose level which is in accordance with the 0-demethylation of 
methoxyresorufin, the marker for this enzyme (Namkung etaL, 1988). 1-NED 
and 3,3'-DAB treatment did not produce any increases in CYP1A2 levels as 
demonstrated by the 0-demethylation of methoxyresorufin and analysis of 
CYP1A2 apoprotein levels by immunoblotting.
Induction of CYP1A is thought to be mediated through the Ah receptor located 
in the cytosol (Nebert, 1989). Previous studies with PCBs, PAHs and 
ellipticines have suggested that a relationship exists between the inducibility 
of CYP1A1 by these compounds and their binding to the Ah receptor (Bigelow 
etaL, 1982; Bandiera etaL, 1982; Roy etaL, 1988). The present study shows 
that, of all the aromatic amines investigated, 1,8-, 2,3- and 1,5-DAN were all 
capable of binding to the Ah receptor which correlates with their propensity to 
induce CYP1A1, as demonstrated by their ability to O-deethylate 
ethoxyresorufin and the presence of the CYP1A1 apoprotein band revealed 
on immunoblot analysis. However, the order of CYP1A1 induction does not 
always correlate with binding affinity for the Ah receptor, ie. the best inducer 
of CYP1A1 was not necessarily the best displacer of pH]-TCDD. 3,3'-DAB 
and 1-NED which did not enhance CYP1A activity, also failed to displace 
pH]-TCDD.
161
MUTAGENIC POTENTIAL OF DIAMINONAPHTHALENES AND RELATED
AROMATIC AMINES
The genotoxicity of the diaminonaphthalenes, 3,3'-DAB and 1-NED was 
ascertained by their mutagenicity in the presence of Aroclor 1254-induced 
microsomes in the Ames S a lm o n e lla  assay. Generally, all 
diaminonaphthalenes and diaminobenzidines are weak mutagens relative to 
other monoamino substituted compounds such as 2-naphthylamine 
(McCann et ai, 1975): this is illustrated by the number of histidine revertants 
induced by the diaminonaphthalenes and diaminobenzidine used in this 
study. Of the compounds investigated, the greatest mutagenic response was 
elicited by 1,8-DAN followed by 3,3'-DAB. The 2,3-DAN isomer displayed a 
weaker mutagenic response whilst 1,5-DAN only evoked a doubling in the 
spontaneous reversion rate. Meanwhile, 1-NED was found to be 
non-mutagenic under the same experimental conditions. These differences in 
mutagenicity may represent differences in the rate of metabolism of the 
compounds by the CYP1A family, which is responsible for the metabolism of 
both planar amino subsituted molecules or the genotoxic potential of the 
reactive intermediates formed on metabolic activation or both. This however, 
can only be elucidated by the identification and synthesis of the ultimate 
carcinogens.
AUTOINDUCTION OF METABOLIC ACTIVATION OF DIAMINO­
NAPHTHALENES AND RELATED AROMATIC AMINES
Of the compounds studied, 1,8-DAN and to a lesser extent 2,3-DAN 
enhanced their own activation. This observation may be ascribed to increased 
CYP1A levels, especially, the CYP1A2 isoform, which is responsible for 
N-hydroxylation, the first step in the metabolic activation of aromatic amines, 
since both compounds were able to induce this member of the CYP1A family.
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1.5-DAN failed to enhance its own activation to any marked extent; only a 
doubling in the spontanoeus reversion rate was observed despite its marked 
ability to induce CYP1A. This may be attributable to the poor genotoxicity of 
this compound as demonstrated by studies utilising Aroclor 1254 microsomes, 
since Aroclor 1254 is a markedly more potent inducer of CYP1A than
1.5-DAN (Hyde ef a/., 1987).
When microsomes from untreated animals were used as activation systems 
so that the compound was metabolised by constitutive forms of cytochrome 
P450 or the flavin-monooxygenase system, 1,8- and 2,3-DAN elicited a weak 
mutagenic response whilst 3,3’-DAB only achieved a doubling of the 
spontaneous reversion rate.
5.6 Conclusion
For potential carcinogens such as the aromatic amines to exert their 
deleterious effects, the propensity to form reactive intermediates capable of 
DNA damage must exist. Furthermore, the exposed organism must possess 
the necessary enzyme complement required for the formation of these 
reactive intermediates. Based on the premise that 3,3'-dichlorobenzidine and 
monoamino substituted naphthalenes such as 2-naphthylamine are 
metabolised by the CYP1A family (Iba and Thomas, 1988; Hammons et al., 
1985; Tong etaL, 1986), it may be speculated that 3,3'-diaminobenzidine and 
the daminonaphthalenes are also metabolised by this cytochrome P450 
family.
From this investigation it can be ascertained that the introduction of a second 
amino group to the naphthylamine structure alters the CYP1A induction profile 
of these compounds. The presence of a second amino group at the 5- and 8- 
position of 1-naphthlyamine, a poor CYP1A1 Inducer, increases the CYP1A1
163
induction potential of the 1-naphthylamine, especially in the case of 1,5-DAN. 
The degree of CYP1A1 induction by 1,5- and 1,8-DAN is comparable to that 
of the potent CYP1A1 inducer 2-naphthylamine, a known mutagen and 
carcinogen (Ayrton et al., 1990b). The introduction of a second amino group 
at the 3- position of 2-naphthylamine appears to have a limited effect on 
CYP1A1 induction when compared with the parent compound at similar dose 
levels (Ayrton et al., 1990b). Meanwhile, in the case of CYP1A2 , a second 
amino subsitution at the 5- position abolishes the induction of this cytochrome 
P450 isoform whilst a second substitution at the 8- position enhances 
CYP1A2 induction which is also a feature of 1-naphthylamine (Ayrton et al., 
1990b).
The introduction of a second amino group to 1-naphthylamine, a 
non-mutagen/very weak mutagen in the Ames test, appears to enhance the 
mutagenic activity of the diamino isomers, especially in the case of 1,8-DAN. 
This increase in mutagenicity may be partly responsible for the carcinogenic 
properties of 1,8-DAN {vide infra). In the case of 2,3-DAN, it is difficult to 
discern whether the presence of a second amino group on 2-naphthylamine 
affects its mutagenic potential when compared with the parent compound 
(Tong et ai., 1986) since the bacteria strain and source of activation system 
are different to that used in this study.
This study also demonstrates that inspite of the ability of a compound to 
evoke a marked induction of CYP1A, the compound is not necessarily a 
potent carcinogen, since the compound may not be able to form a reactive 
intermediate or the reactive intermediates formed on metabolic activation may 
not be highly genotoxic, as in the case of 1,5-DAN. In view of these findings,
1,5-DAN is likely to be a weak or non-carcinogen. This prediction is supported 
by the literature, where 1,5-DAN has been reported to be equivocal in long
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term carcinogenicity studies, in both mice and rats (lARC, 1982). In the case 
of 1,8- and 2,3-DAN, although these two diaminonaphthalene isomers did not 
induce CYP1A to the same extent as 1,5-DAN they, however, displayed much 
greater genotoxicity than the 1,5- isomer. Thus, it is plausible to assume that 
these two diaminonaphthalene isomers are also carcinogenic, and most likely 
weak carcinogens. The benzidine substituted isomer, 3,3-DAB did not induce 
CYP1A to any marked extent, yet it displayed moderate genotoxic properties, 
suggesting it may be a very weak carcinogen. The other diaminonaphthalene 
related aromatic amine used in these studies, 1-NED neither induced CYP1A 
nor exhibited genotoxic properties. However, in the handbook of identified 
carcinogens and non-carcinogens, 1-NED is listed as mutagenic in the Ames 
test (Soderman, 1982). The discrepancy between this observation and the 
results obtained in this study may be due to differences in the source of the 
activation system; in the previous study the activation system was derived 
from the S9 fraction whilst in the present study the activation system was 
microsomal. In spite of this discrepancy, the results of this study suggests that
1-NED is a non-carcinogen which is supported by the findings of oral 
administration of 1-NED to rats and mice (NTP, 1978; NTP, 1981).
Studies by Ford and Herman have suggested that monoamino substitution at 
a carbon atom adjacent to the point of fusion lowers the mutagenic potential 
of a compound as exemplified by 1-aminoanthracene and 1-naphthylamine 
when compared to their respective isomers substituted at the 2- position (Ford 
and Herman , 1991). The diaminonaphthalenes, however, do not seem to 
behave similarly since the genotoxicities of the diaminonaphthalenes used in 
this study are as follows 1,8-DAN > 2,3-DAN > 1,5-DAN.
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Computer modelling of CYP1A inducers, such as benzo[a]pyrene and TODD 
have demonstrated that these compounds possess small depth and large 
area/depth ratios (Lewis ef a/., 1986; Lewis ef a/., 1987). Computergraphic 
modelling of 1,8-, 2,3- and 1,5-DAN has indicated that these molecules are 
all planar in structure (figure 5.6.1) which fulfils the planarity requirement for 
CYP1A induction; this is substantiated by the experimental data obtained in 
this study. The non-CYPIA inducers, 1-NED on computergraphic modelling 
was found to possess a bulky side-chain, which distorts planarity, accounting 
for its inability to induce CYP1A, since the compound cannot fit into the Ah 
receptor site. Furthermore, its inabilty to be activated to genotoxic 
intermediates may also be ascribed to its molecular dimensions; the optimal 
dimensions for CYP1A substrates appears to be similar to that of Ah receptor 
ligands (loannides and Parke, 1990b). In the case of 3,3'-DAB, although 
computergraphic modelling showed that the molecule exists in a twisted 
configuration around the C-C bond between the aromatic rings, this 
compound however still induced CYP1A1, albeit not substiantially. It is 
thought that the parent compound, benzidine can exist in many configurations 
ranging from a completely planar structure, with the aromatic rings in the 
same plane to one with the aromatic rings at right angles to each other, as 
well as various intermediate states, thus the 3,3'- amino substituted analogue 
may also possess similar properties. If this were the case, the induction of 
CYP1A may be ascribed to the molecules in the planar configuration binding 
to the cytosolic Ah receptor and the subsequent activation of the CYP1A1 
gene.
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CHAPTER 6
Mutagenicity and CYP1A induction by diaminotoluenes: 
correlation to their carcinogenic potential.
1 6 8
6.1 Introduction
Diaminotoluenes are synthetic chemicals used in the manufacture of 
polyurethane foam and dyes; 2,4-diaminotoluene (2,4-DAT) and
2,6-diaminotoluene (2,6-DAT) are industrial intermediates in the synthesis of 
toluene diisocyanate, the precursor of polyurethane foam. The 2,6- isomer 
has also been identified in cigarette smoke. The 2,5-diaminotoluene (2,5- 
DAT) is essentially used in dye production. Diaminotoluene-based dyes are 
used in textiles, leather, furs and hair colouring.
STRUCTURE
NHg
2,4-Diaminotoluene
MUTAGENICITY AND CARCINOGENICITY
2,4-Diaminotoluene is described as a moderate carcinogen (Ito ef a/., 1969; 
Cardy, 1979) and mutagen (Ames ef al.,1975; McCann ef a /., 1975); it 
induces hepatocellular carcinomas and hepatic nodules in both male and 
female Fischer 344 rats and female B6C3F1 mice when administered in the 
diet (NTP 1979). In addition, the compound causes mammary gland 
adenomas in female rats (NTP 1979). In short term tests, 2,4-diaminotoluene 
induces unscheduled DNA synthesis in rat hepatocytes (Bermudez et a /.; 
1979), morphological transformations in hamster embryo cells (Greene at 
a /. ,  1980) and chromosomal aberrations in Chinese hamster ovary cells 
(Coppinger at a i, 1984). Moreover, the compound is positive in the
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drosophila test for mutagens (Blijleven, 1977) and the Ames Salmonella 
mutagenicity assay in the presence of a microsomal activation system 
(Ames et al., 1975; Aune et al., 1977; Dybing et al., 1977., Reddy et al., 
1986). In addition, 2,4-diaminotoluene has been observed to induce 
hepatocellular cell proliferation (Cunningham et al., 1990). Covalent binding 
to DNA has also been observed for this diaminotoluene isomer (Furlong et 
al., 1987; La and Froines, 1992) as well as to protein and RNA (Dybing et al., 
1978).
2,6-Diaminotoluene is classed as a non-carcinogen; it failed to induce a 
positive carcinogenic response in Fischer F344 rats and B6C3F1 mice when 
administered through the diet over a 2 year period (NTP, 1979). In short-term 
tests, however, such as the Ames Salmonella mutagenicity assay a positive 
response was evoked in the presence of S9 or microsomal activation 
systems (Dybing etal., 1977; Florin et ai, 1980; Furlong et ai, 1987; George 
and Westmoreland, 1991). In addition, 2,6-DAT failed to induce 
unscheduled DNA synthesis in rat hepatocytes (Miralis et a i, 1982) and 
hepatocellular cell proliferation (Cunningham et ai, 1990).
2,5-Diaminotoluene provoked a mutagenic response in the Ames 
Salmonella mutagenicity assay (Ames et ai, 1975; Furlong et a i, 1987), The 
carcinogenicity studies carried out on 2,5-diaminotoluene were inconclusive 
due to the presence of contaminating 2,4-diaminotoluene, a known 
carcinogen (lARC, 1978). With regards to 2,3-diaminotoluene, no data are 
available on its mutagenic and carcinogenic properties.
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METABOLISM
The mutagenicity and carcinogenicity of aromatic amines, such as
2,4-diaminotoluene is mediated through reactive intermediates which are 
capable of interacting covalently with DNA. The initial step in the activation 
of these compounds involves N-hydroxylation by cytochrome P450 (Miller, 
1978) and to a lesser extent the FAD monooxygenase system (Ziegler, 
1988). Hydroxylation of the aromatic ring also occurs, but this is essentially a 
deactivation pathway. The hydroxylamine formed by N-hydroxylation can be 
converted to more potent reactive electrophiles by acétylation and 
conjugation with sulphate and glucuronic acid (Miller, 1978). The ultimate 
reactive species is postulated to be the nitrenium ion which interacts with 
DNA (Miller, 1978; Loew etal., 1979; Ford and Herman, 1991).
In vitro studies, have inferred that 2,4-diaminotoluene is activated by the 
cytochrome P450 monooxygenase system (Aune et ai, 1979; Cunningham 
and Matthews, 1990), presumably to the hydroxylamine, though this 
intermediate has not been detected directly, in vivo or in vitro. Furthermore, 
in vitro studies have implicated that 4-acetoxyamino-2-aminotoluene formed 
on 0-acetylation of the hydroxylamine derived from 2,4-diaminotoluene may 
be a proximate mutagen (Cunningham and Matthews, 1990). As with other 
aromatic amines, sulphation is an activation pathway for this compound 
(Furlong et al., 1987). 2,4-DAT may also undergo prostaglandin synthetase- 
catalysed metabolic activation to genotoxic products in cultured human 
fibroblasts (Nordenskjold etal., 1984), but conflicting results were obtained 
using bacteria strains possessing prostaglandin synthetase activity in the 
Ames test (Pan et al., 1992).
Urinary metabolites identified to date for 2,4-DAT, include ring hydroxylated 
products such as 5-hydroxy-2,4-diaminotoluene as well as acetylated
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aminophenols and glucuronide conjugates (Waring and Pheasant, 1976). 
Urinary metabolites of 2,4-DAT such as 4-acetylamino-2-aminobenzoic acid 
and 2,4-diacetylaminobenzoic acid, when tested for mutagenicity in the 
Ames test were found to be non-mutagenic (Reddy et a/., 1986). 
Furthermore, N-acetylated products generated on incubation of 2,4-DAT with 
hepatic cytosol have been identified to be 4-acetylamino-2-aminotoluene 
and 2,4-diacetyl-aminotoluene (Glinsukon etal., 1975).
Metabolites identified in the urine of animals treated with 2,6-DAT include 
3-hydroxy-2,6-diaminotoluene, 2,6-diacetylaminotoluene, 4-hydroxy-2- 
acetylamino-6-aminotoluene and 2-acetylamino-6-aminotoluene. 2,6- 
Diacetyl amino toluene and 4-hydroxy-2-acetylamino-6-aminotoluene were 
later found to mutagenic. Since 2,6-DAT is not a carcinogen, these 
mutagens are thought either to be non-carcinogenic, readily deactivated or 
are not further metabolised to produce genotoxic species (Cunningham et 
al., 1989).
OBJECTIVES OF THE PRESENT STUDY
The initial aim of this study was to ascertain the cytochrome P450 family 
responsible for the metabolic activation of the diaminotoluene isomers. 
Previous studies have shown that the cytochrome P450 monooxygenase 
system is involved in the activation of the 2,4- isomer (Aune et al., 1979; 
Furlong et al., 1987; Cunningham and Matthews, 1990) and it is likely that 
the other isomers are also metabolised by this enzyme system. This was 
achieved by initially inducing animals with the archetypal cytochrome P450 
inducers for the different subfamilies, namely, benzo[a]pyrene (CYP1A), 
phenobarbitone (CYP2B), isoniazid (CYP2E), dexamethasone (CYP3A) and 
clofibrate (CYP4A). Subsequently the metabolic activation of 2,4-DAT in the 
Ames test using microsomes derived from these animals as activation
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system was investigated, it was thought appropriate to use 2,4-DAT as the 
prototype in these initial studies as its carcinogenic and mutagenic 
properties are well documented. Our studies indicated that 2,4-DAT was 
only extensively metabolised in the presence microsomes derived from 
benzo[a]pyrene pretreated animals. It was assumed that the other 
diaminotoluene isomers would be metabolised by the same cytochrome 
P450 family as 2,4-DAT.
The main objective of this investigation was to determine whether the 
induction of enzymes responsible for the metabolic activation of these 
compounds, in this case CYP1A, may be related to their carcinogenic 
potential. Previous studies have suggested that induction of CYP1A is a 
prerequisite for the carcinogenicity of aromatic amines such as the 
naphthylamines and the aminobiphenyls (Ayrton etal., 1990b). Since 
preliminary studies, and studies carried out by Aune et al. (1979) have 
indicated that CYP1A is involved in the metabolic activation of the 2,4-DAT, it 
was considered appropriate to investigate whether the difference in 
carcinogenic potential of the diaminotoluenes lie in their ability to induce 
CYP1A since constitutive levels of this cytochrome P450 family are low. In 
untreated animals, CYP1A comprises less than 5% of the hepatic total 
cytochrome P450 population (Pickett etal., 1981; Luster etal., 1982), thus, 
induction of this cytochrome P450 isoform may enhance the metabolic 
activation of these compounds.
Apart from induction of the enzymes responsible for the metabolic activation 
of chemicals to reactive intermediates, the ability of the reactive 
intermediates to cause DNA damage is also a major factor which would 
influence its carcinogenic potential. The genotoxic properties of these 
compounds would be ideally studied using the reactive intermediates
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themselves, but since these are not available, it was thought appropriate to 
use Aroclor 1254-induced microsomes in the Ames test as an indirect 
means of generating reactive intermediates which may be responsible for 
causing DNA damage.
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6.2 Materials
All materials were obtained from the sources cited in chapter 2.
6.3 Methods
Animals were given a single i.p. dose of 2,3-, 2,4-, 2,5- or 2,6- 
diaminotoluene at three dose levels, 10, 20 or 40mg/kg, using corn oil as the 
vehicle. Control animals received the corresponding volume of the vehicle 
only. All animals were killed 24 hours after dosing and hepatic microsomes 
were prepared as described in section 2.2.2. The following determinations 
were carried out on the microsomal fractions as described in section 2.2: 
total protein content, cytochrome P450, cytochrome bs content and 
alkoxyresorufin 0-dealkylase activities. In addition, SDS-PAGE 
electrophoresis of solubilised hepatic microsomes was carried out, followed 
by immunoblotting with polyclonal CYP1A antibodies using the method 
outlined in section 2.2.
The metabolic activation of the diaminotoluene isomers to mutagens in the 
Ames test was ascertained using Salmonella typhimurium strain TA98 as 
aromatic amines are known to induce primarily frameshift mutations, which 
are readily detected by this particular strain. All promutagens used in the test 
were dissolved in DMSO due to their lack of solubility in water. A 30 minute 
preincubation period was included in the test, in anticipation of the weak 
mutagenicity of these compounds in the presence of hepatic microsomes as 
opposed to S9 which normally induces a better mutagenic response. Aroclor 
1254-induced animals, the source of activation system for the determination 
of the genotoxic potential of the diaminotoluenes were dosed as described 
in section 2.2.1.
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Binding of the diaminotoluene isomers to the Ah receptor was determined as 
described in section 2.2.9.
Induction of the various rat hepatic cytochrome P450 isoforms was achieved 
using the prototype inducers listed in the table below (table 6.2.1). All 
animals received single daily doses of the inducer, on three sucessive days 
and were killed 24 hours after the last dose. Hepatic microsomal fractions 
were prepared as described in section 2.2. Characterisation of the various 
hepatic microsomes with respect to their mixed function oxidase activity was 
also carried out as described in section 2.2.
Table 6.2.1 Induction of various cytochrome P450 Isoforms by 
prototype Inducers.
Cytochrome P450 
subfamily Inducer Dose Route
1A Benzo[a]pyrene 25mg/kg i.p.
2B Phenobarbital-
sodium
80mg/kg i.p.
2E Isoniazid lOOmg/kg intragastric
gavage
3A Dexamethasone- 
21-phosphate
100mg/kg intragastric
gavage
4A Sodium clofibrate 80mg/kg ip
Rats received a single daily dose of the inducing agent, for three days. All 
animals were killed 24 hours after the last administration.
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6.4 Results
Preliminary studies were undertaken in order to identify the cytochrome 
P450 proteins involved in the metabolic activation of the diaminotoluenes. 
This was carried out by investigating the metabolic activation of
2,4-diaminotoluene in the Ames Salmonella mutagenicity assay, using 
hepatic microsomal activation systems derived from control and animals 
treated with various cytochrome P450 inducers, namely, benzo[a]pyrene 
(CYP1A), phenobarbitone (CYP2B), isoniazid (CYP2E), dexamethasone 
(CYP3A) and clofibrate (CYP4A). Only benzo[a]pyrene-induced hepatic 
microsomal preparations could convert 2,4-DAT to mutagens in the Ames 
test (figure 6.4.1). Induction of the various microsomal cytochrome P450 
activities associated with prototype inducers are shown in table 6.4.1. The 
microsomal cytochrome and protein contents in the liver of animals treated 
with the various diaminotoluenes are shown in tables 6.4.2 and 6.4.3.
The inducibility of CYP1A proteins by the diaminotoluenes was monitored 
fluorimetrically by the 0-dealkylations of ethoxyresorufin and 
methoxyresorufin. Of the diaminotoluene isomers used in the study, the most 
potent CYP1 Al inducer was 2,3-DAT, as exemplified by the increases in the 
0-deethylation of ethoxyresorufin at all dose levels, when compared to that 
of control animals, and expressed per nmole P450; the effect was dose- 
dependent (figure 6.4.2). 2,4-DAT and 2,5-DAT treatment also elevated the 
0-deethylation of ethoxyresorufin, but statistical significance was not 
attained (figures 6.4.2 and 6.4.3). CYP1A2 levels, as exemplified by the 
0-demethylation of methoxyresorufin were increased by 2,3-DAT in a dose- 
dependent fashion, but statistical significance was attained only at the 
highest dose (figure 6.4.2). 2,5-DAT also caused a modest increase in this 
activity, but only at the lowest dose level (figure 6.4.3).
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Immunochemical determination of CYP1A apoprotein levels in Western blot 
analysis of hepatic microsomes derived from animals treated with the 
various diaminotoluene isomers, utilising polyclonal antibodies against 
CYP1A1, revealed that 2,3-DAT and to a lesser extent 2,4-DAT induced 
CYP1A1 apoprotein levels, as exemplified by the presence of the upper 
band on the blots which is absent in control animals (figures 6.4.4 and 
6.4.5). Furthermore, treatment with 2,3-DAT increased the staining of the 
band corresponding to the CYP1A2 apoprotein (figure 6.4.5). No detectable 
changes were observed in the animals treated with 2,5- and 2,6-DAT 
(figures 6.4.4 and 6.4.5).
The binding of the diaminotoluene isomers to the Ah receptor was 
determined by ascertaining the degree of displacement of pH]-TCDD from 
the cytosolic receptor by the compounds, and comparison of their EC5 0
values, the concentration of competing ligand required for displacement of 
50% of the pH]-TCDD from the cytosolic receptor (table 6.4.4). 2,3-DAT and
2,4-DAT were the only isomers which displaced pH]-TCDD from the cytosol 
of untreated rats (figure 6.4.6) with the 2,3- isomer being the most effective 
(table 6.4.4). The other two isomers failed to displace pH]-TCDD even at 
concentrations as high as 5 x 1Q-4m (figure 6.4.7).
The genotoxic potencies of the four diaminotoluene isomers were evaluated 
by their mutagenicity in the Ames test using hepatic microsomes from 
Aroclor 1254-treated rats as activation system. The 2,4- isomer, and to lesser 
extent the 2,6- isomer, elicited a strong mutagenic response (figures 6.4.8 
and 6.4.9). The other two isomers, namely, 2,3- and 2,5-DAT also displayed 
a positive, but very weak mutagenic response. Only a doubling in the 
spontaneous reversion rate was seen with these isomers and no clear
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concentration-dependent mutagenic response was evident at the 
concentrations tested (figures 6.4.8 and 6.4.9).
To establish whether the various diaminotoluenes could stimulate their own 
mutagenicity, each diaminotoluene was tested in the presence of 
microsomes from control and diaminotoluene-treated rats. Only 2,4-DAT 
clearly enhanced its own activation (figure 6.4.8). In the presence of control 
microsomes, only 2,3-DAT elicited a positive, albeit weak mutagenic 
response (figure 6.4.8).
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Figure 6.4.1 Metabolic activation of 2,4-diaminotoluene to mutagens by 
rat hepatic microsomes derived from animals treated with various 
cytochrome P450 inducers.
The mutagenicity of 2,4-diaminotoluene was determined in the Ames test employing 
Salmonella typhimurium strain TA 98 and 10%(v/v) microsomal activation systems derived 
from control animals and animals treated with various archetypal cytochrome P450 inducers. 
Plates were supplemented with 1 unit of glucose-6-phosphate dehydrogenase. The 
spontaneous reversion rate of 13 ± 2 has not been subtracted. Results are expressed as the 
Mean ± S. E M. of triplicates.
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Figure 6.4.2 The effect of 2,3- and 2,4-diaminotoluene treatment on rat 
hepatic microsomal alkoxyresorufin 0-dealkylase activities.
Animals received a singie i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals. Numbers in parentheses represent 
fold induction.
* P<0.05; ** P<0.01.
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Figure 6.4.3 The effect of 2,5- and 2,6-diaminotoluene treatment on rat 
hepatic microsomal alkoxyresorufin 0-dealkylase activities.
Animals received a single i.p. dose of the chemical whereas control animals received the 
vehicle, corn oil. All animals were killed 24h after dosing.
Results are expressed as the Mean ± S.E.M. of 4 animals.
* P<0.05.
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Figure 6.4.6 Displacement of [3H]-TCDD from the Ah receptor by 2,3-diaminotoluene and 2,4-diaminotoluene.
Ttie specific binding of pH ]-TCDD to rat hepatic cytosol was determined using the HAP assay. The concentration of (3H]-TCDD used was 0.30n!VI.
Results are expressed as Mean ± SEM of triplicates.
1 8 8
2 , 5 - D i a m i n o t o l u e n e
140 -
120  -
100 -
80 -
60 -
40  -
20  -
-3
Competitor concentration (M)
2,6-Dia mi notoluene
140 -|
120 -
100 -
80 -
60  -
20  -
-3
Competitor concentration (M)
Figure 6.4,7 Displacement of pHj-TCDD from the Ah receptor by 2,5-dlamlnotoluene and 2,6-diamlnotoiuene.
The specific binding of pH]-TCDD to rat hepatic cytosol was determined using the HAP assay. The concentration of (^H]-TCDD used was 0.30nM.
Results are expressed as Mean ± SEM of triplicates.
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Table 6.4.4 Displacement of [3H]-TCDD from rat hepatic 
cytosolic receptor by diamlnotoluenes.
At least seven concentrations of the displacer were employed in each assay. 
Each concentration was performed in triplicate.
Compound Displacement of pH]-TCDD 
ECso (M)
2,3-Diaminotoluene 1.5 X IG'5
2,4-Diaminotoluene 7.0 X 10"5
2,5-Diaminotoluene No displacement
2,6-Diaminotoluene No displacement
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Figure 6.4.8 Metabolic activation of 2,3- and 2,4-diaminotoluene to 
mutagens by rat hepatic microsomes.
The mutagencity of 2,3- and 2,4- diaminotoluene was determined in the Ames test employing 
Salmonella typhimurlum s\ra\n TA 98 and 10% (v/v) microsomal activation systems derived 
from control ( O ), 2,3- and 2,4- diaminotoluene-treated (20mg/kg, ▲ ), and Aroclor 1254- 
treated ( ■  ) animals. Plates were supplemented with 1 unit of glucose 6-phosphate 
dehydrogenase. Activation system, mutagen and bacteria were preincubated for 30 minutes 
at 37°C in a shaking waterbath. The study was repeated, using a sample from another but 
similarly-treated animal, with similar results. Results are expressed as Mean ± S.E.M. of 
triplicates.
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Figure 6.4.9 Metabolic activation of 2,5- and 2,6-diaminotoiuene to 
mutagens by rat hepatic microsomes.
The mutagencity of 2,5- and 2,6- diaminotoluene was determined in the Ames test employing 
Salmonella /yph/mur/t/m strain TA 98 and 10% (v/v) microsomal activation systems derived 
from control ( O ), 2,5- and 2,6- diaminotoluene-treated (20mg/kg, A ), and Aroclor 1254- 
treated ( ■  ) animals. Plates were supplemented with 1 unit of glucose 6-phosphate 
dehydrogenase. Activation system, mutagen and bacteria were preincubated for 30 minutes 
at 37°C in a shaking waterbath. The study was repeated, using a sample from another but 
similarly-treated animal, with similar results. Results are expressed as Mean ± S.E.M. of 
triplicates.
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6.5 Discussion
Aromatic amines containing at least two fused aromatic rings are believed to 
be activated by N-hydroxylation catalysed by the cytochrome P450 
monooxygenase system, more specifically CYP1A, to yield a hydroxylamine 
which can subsequently be acetylated, conjugated with sulphate or 
glucuronic acid, to yield a reactive intermediate, namely the nitrenium ion 
which can bind covalently to DNA. Another enzyme capable of catalysing 
the N-hydroxylation of aromatic amines is the FAD monooxygenase system 
(Ziegler, 1979). 2,4-DAT appears to be preferentially hydroxylated at the p- 
position (Glinsukon e fa /., 1975; Glinsukon et al., 1976) to form the 
hydroxylamine (Furlong et a i, 1987). Consequently DNA interaction has 
been found to be formed at this postion of 2,4-DAT (Citro et ai, 1993).
Most aromatic amines studied to date appear to be activated by the CYP1A 
family, but it may be possible that other cytochrome P450 isoforms 
participate in the activation of the diaminotoluenes. The molecular 
dimensions of the diaminotoluenes make them ideal substrates for the 
CYP2E family, since substrates for this cytochrome P450 family tend to be 
small low molecular weight molecules (loannides et ai, 1993a). In addtition, 
CYP2E has been implicated in the metabolic activation of paracetamol 
which is of a similar size to the diaminotoluenes ( Morgan et ai, 1983). In 
order to gain an insight into the cytochrome P450 family involved in the 
activation of 2,4-DAT to reactive intermediates, the metabolic activation of
2,4-DAT was investigated in the Ames Salmonella mutagenicity assay 
using microsomal activation systems derived from animals treated with 
prototype cytochrome P450 inducers such as benzo[a]pyrene (CYP1A), 
phenobarbitone (CYP2B), isoniazid (CYP2E), dexamethasone (CYP3A) and 
clofibrate (CYP4A). 2,4-DAT was chosen as the prototype as this is the
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isomer with the most documented mutagenicity and carcinogenicity data. 
This preliminary study revealed that only benzo[a]pyrene-induced 
microsomes catalysed the activation of 2,4-DAT to mutagens indicating that 
this diaminotoluene is selectively activated by the CYP1A family. However, it 
is not possible to ascertain whether CYP1A1, CYP1A2 or both isoforms were 
involved in the activation of 2,4-DAT to mutagens. The present study is in 
agreement with previous reports where rats treated with p-naphthoflavone, 
another CYP1A inducer, were more efficient in catalysing the S9-mediated 
mutagenicity of 2,4-DAT in the Ames test (Aune et al., 1979). Though it was 
thought that CYP2E may have been involved in the activation of the 
diaminotoluenes, activation from microsomes from isoniazid-induced 
animals did not evoke a marked mutagenic response. However, it must be 
pointed out that DMSO, the solvent in which the promutagen was dissolved, 
is also a substrate for CYP2E. Thus, the mutagenic response elicited by
2.4-DAT in the presence of isoniazid-induced microsomes may have been 
underestimated. Unfortunately, DMSO was the only solvent in which the 
promutagen was soluble, but the volume was kept to a minimum (lOOpI per 
incubation). As a preincubation step was carried out, where only bacteria 
(100/il), the promutagen (^00p\) and activation system (500^1) are present, 
the volume of the solvent is significant.
GYP 1A INDUCTION
The most potent inducer of ethoxyresorufin 0-deethylase activity, hence 
CYP1A1 (Burke and Mayer., 1974) was 2,3-DAT. The known carcinogen,
2.4-DAT elevated CYP1A1 levels but statistical significance was not 
attained. Neither of the other two isomers caused a dose-dependent 
increase in this activity. Solubilised hepatic microsomes probed with anti- 
CYP1A1 antibodies confimed that 2,3- and to a lesser extent 2,4-DAT
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Increased CYP1A1 apoprotein levels. The blot revealed the presence of a 
band which was absent or undetectable in control animals which 
corresponds to the CYP1A1 band (Rodrigues et al., 1987).
CYP1A2 levels were markedly induced by 2,3-diaminotoluene, as 
exemplified by the increase in the 0-demethylation of methoxyresorufin, 
regarded as a specific probe for this isoform (Namkung et al., 1988). All 
other diaminotoluenes failed to increase levels of this isoform. Immunoblot 
analysis of solubilised hepatic microsomal samples using polyclonal anti- 
CYP1A1 antibodies which also recognise CYP1A2, confirmed these 
findings.
Induction of CYP1A is thought to be mediated through the Ah receptor. 
When cells are exposed to an inducer, the chemical binds avidly to the 
receptor located in the cytosol, and the resulting complex is subsequently 
translocated into the nucleus where it enhances the transcription of mRNA 
coding for CYP1A1 and possibly CYP1A2 proteins along with other genes in 
the Ah battery (Nebert, 1989). A relationship appears to exist between the 
inducibility of CYP1A1 by PCBs, PAH and ellipticines with their binding to 
the Ah receptor (Bigelow et ai, 1982; Bandiera et ai, 1982; Roy et ai, 1988). 
The present study shows that, of the diaminotoluene isomers, only 2,3- and
2,4-DAT bind to the receptor in contrast to the 2,5- and 2,6- isomers. This 
observation appears to correlate to the diaminotoluenes propensity for 
CYP1A1 induction as exemplified by the 0-deethylation of ethoxyresorufin 
and the presence of the CYP1A1 apoprotein band revealed on immunoblot 
analysis. In accordance with the level of CYP1A1 induction evoked by 2,3- 
and 2,4-diaminotoluene, the 2,3-isomer displays a higher affinity for the Ah 
receptor as demonstrated by its ability to displace pH]-TCDD.
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MUTAGENICITY POTENTIAL OF DIAMINOTOLUENES
Of the diaminotoluene isomers used in the study, the highest mutagenic 
response in the presence of Aroclor 1254-induced microsomes was elicited 
by 2,4-diaminotoluene followed by the 2,6- isomer. The other 
diaminotoluene isomers, namely, 2,3- and 2,5-diaminotoluene provoked a 
very weak mutagenic response under the same experimental conditions. It is 
not possible to discern whether these differences in mutagenicity represent 
differences in the rates of metabolism, genotoxic potential or both. This can 
only be elucidated when the ultimate carcinogens have been identified and 
synthesised.
AUTOINDUCTION OF METABOLIC ACTIVATION OF DIAMINOTOLUENES
Of the four isomers only 2,4-DAT enhanced its own activation. The 2,3-DAT 
isomer, despite its ability to induce CYP1A, failed to enhance its own 
mutagenicity. This observation may most likely be ascribed to the poor 
genotoxicity of this compound as evidenced in the studies conducted in the 
presence of Aroclor 1254-induced microsomes, since Aroclor 1254 is a 
markedly more potent inducer of CYP1A than 2,3-DAT (Hyde et a i, 1987).
The weak mutagenic response elicited by 2,3-diminotoluene when it was 
used as the promutagen and the activation system was derived from 
untreated animals indicate that at least this isomer may be metabolised by 
constitutive forms of cytochrome P450 and/or the flavin monooxygenase 
system.
There is a possibility that the weak mutagenic response displayed by 
2,3- and 2,5-DAT could be partly ascribed to the presence of impurities in 
the chemical. The manufacturers specifications indicate that the various
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isomers are 97% pure, therefore, if the impurity was entirely due to the more 
mutagenic isomers, this could partly explain their very weak mutagenic 
response.
6.6 Conclusion
For chemicals such as the aromatic amines to function as carcinogens, the 
propensity to form reactive intermediates which are capable of DNA Injury is 
essential. In addition, the exposed organism must possess the necessary 
enzyme complement to facilitate the formation of these reactive 
intermediates. CYP1A appears to be the principal cytochrome P450 family 
catalysing the metabolic activation of the diaminotoluenes.
Of the diaminotoluenes studied, the 2,4- isomer was the only one that was 
mutagenic in the Ames test and could enhance its own activation, 
presumably as a consequence of CYP1A induction. Thus, this compound 
would have been expected to be a carcinogen, which is indeed the case (Ito 
et al., 1969; Cardy, 1979). Although 2,6-DAT is mutagenic, the fact it does 
not induce CYP1A activity, and is not activated to mutagens by enzyme 
systems derived from untreated animals indicates that it is unlikely to be a 
carcinogen and this is supported by carcinogenicity studies (NTP, 1980). 
The carcinogenic properties of 2,3- and 2,5-DAT have not yet been fully 
investigated; only carcinogenicity studies on 2,5-DAT have been carried out. 
However, it is most likely that the results of that study do not reflect the true 
carcinogenic potential of 2,5-DAT, since It was administered in a mixture 
which contained contaminating 2,4-DAT (lARC, 1978). On the basis of the 
present study, 2,5-DAT was found to be neither an inducer of CYP1A activity 
nor a potent mutagen and is therefore, most likely to be a non-carcinogen. 
Whilst, 2,3-DAT, although a potent inducer of CYP1A activity was a weak 
mutagen and is likely to be, at best, a very weak or non-carcinogen.
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Compared with other CYP1 A inducing agents such as the chrysenes 
(chapter 3) and the azobenzenes (chapter 4), the EC5 0  values for the 
binding of the diaminotoluenes to the Ah receptor are very high, denoting 
poor affinity for the receptor. This is compatible with the diaminotoluenes' 
relatively weak ability to induce CYP1A activity.
These studies further illustrate the role of the Ah receptor in regulating 
CYP1 A induction by structural isomers. It has already been proposed that 
the optimum dimensions for the Ah receptor are 6 .8 Â x 13.7Â; a study using 
indoles showed that all potent receptor ligands fitted into a rectangle with 
these dimensions (Gillner et al., 1985). Furthermore, the calculated 
molecular size of many CYP1A inducers were demonstrated to possess 
similar molecular optimum dimensions (Lewis et al., 1986). T h e  
diaminotoluenes which are considerably smaller molecules, would therefore 
be expected to be poor CYP1 A inducers, which is consistent with the 
findings of this study. Aromatic amines comprising 2 or 3 fused rings may be 
more potent CYP1A inducers (Ayrton et al., 1990b) due to their molecular 
size being closer to that required for optimum Ah binding.
Of the diaminotoluenes, only the 2,3- and to a lesser extent the 2,4- Isomer 
induced CYP1A activity, suggesting that adjacent amino groups may be a 
factor for determining induction potential. Furthermore, CYP1 A induction 
appears to be abolished as the distance between the amino groups is 
increased. However, 2,4- and 2,6-DAT display different CYP1A induction 
characteristics indicating that other factors may be involved. The role of the 
methyl group in the induction potential of these compounds cannot be 
evaluated since all the diaminotoluenes investigated possessed an amino 
group at the 2 - position.
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CHAPTER?
The binding of aromatic amines and their major metaboiites to the 
hepatic cytosoiic Ah receptor: reiationship to their CYP1A induction
potential.
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7.1 Introduction
Aromatic amines are an important class of chemical carcinogens as they are 
extensively used in industry, especially in the manufacture of dyes. These 
exonitrogen compounds are positive in short-term mutagenicity tests such as 
the Ames Salmonella assay (McCann et al., 1975) and in long-term 
carcinogenicity studies (Garner et al., 1984). Aromatic amines require 
metabolic activation in order to exert their genotoxic effects (Miller and Miller, 
1981). The first step in the metabolic activation of these compounds involves 
N-hydroxylation carrried out by the cytochrome P450 mixed-function oxidases 
and to a lesser extent by the FAD-monooxygenases. The hydroxy lamines 
formed by N-hydroxylation are then further metabolised through 0-acetylation, 
N-acetylation, N,0-acyl transfer and conjugation with sulphate and glucuronic 
acid (Worth et ai, 1981 ; Weeks et ai, 1978) to yield the ultimate carcinogen, 
the nitrenium ion on subsequent deconjugation. In addition to N-hydroxylation, 
aromatic amines undergo ring hydroxylation; however this process does not 
yield genotoxic species and is believed to be a detoxication pathway (Masson 
etal., 1983; Tong ef a/., 1986).
The principal enzyme system responsible for the initial activation step of 
aromatic amines is the cytochrome P450 mixed-f unction oxidases which exist 
as a supergene family consisting of many isoforms (Nelson et ai, 1993). The 
cytochrome P450 family involved in the metabolic activation of planar 
chemical carcinogens, including the N-hydroxylation of aromatic amines is the 
CYP1A family (loannides and Parke, 1987) which comprises two proteins, 
CYP1A1 and CYP1A2. It is the CYP1A2 protein which is primarily responsible 
for the N-hydroxylation of aromatic amines (Hammons et a i, 1985).
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The induction of enzyme systems such as the cytochrome P450 
mixed-function oxidases can potentially have a profound effect on the way a 
compound is metabolised, in that it can direct its metabolism towards either 
activation or deactivation or both. In the case of planar aromatic amines, 
induction of CYP1A may enhance their metabolism to genotoxic species. It 
has recently been postulated that CYP1A induction by chemical carcinogens 
such as polycyclic aromatic hydrocarbons and aromatic amines may be 
related to their carcinogenic potential (Ayrton etal., 1990a; 1990b).
The regulation of CYP1A induction has been shown to be mediated by a 9S 
protein known as the cytosolic Ah receptor (Nebert, 1989). However, in some 
cases a 4S protein known as the polycyclic aromatic hydrocarbon protein 
(PBP), also known as the carcinogen-binding protein (CBP), has been 
implicated (Arnold et al., 1988; Zytkovicz, 1987; Barton et al., 1988). Taken 
together, it was the aim of this study to ascertain whether the binding of 
aromatic amines to the Ah receptor may be related to their known CYP1A 
induction potential and genotoxicity.
The role of metabolites of xenobiotic in binding to the Ah receptor and the 
subsequent involvement of these metabolites in CYP1A induction has not 
been extensively investigated. Previous studies have shown that metabolites 
of polycyclic aromatic hydrocarbons, namely the dihydrodiol-epoxides, the 
ultimate carcinogens of these compounds, could bind to the Ah receptor 
(Bigelow and Nebert, 1982) and thus may participate in the induction of 
CYP1A. Consequently, it was thought apposite to Investigate the binding 
ability of the principal metabolites of two potent carcinogens, 2 -naphthylamine 
and 4-aminobiphenyl to the Ah receptor. The metabolites were bound to the 
Ah receptor at the parent compounds' EC5 0  value in order to determine
2 01
whether metabolism of the parent compound leads to loss or increase in 
ligand binding capacity.
2 0 2
7.2 Materials
All materials were obtained from sources cited in section 2.1. The metabolites 
of 2-naphthylamine and 4-aminobiphenyl were a generous gift from 
Prof. J. W. Gorrod, Kings College, London.
7.3 Methods
The binding of aromatic amines to the cytosolic Ah receptor was carried out 
as described in section 2.2.9. The compounds used in this study were chosen 
on the basis of their known CYP1A induction potential (Aryton etal., 1990b).
At least seven concentrations of the competing ligand were used in the assay 
and each concentration was carried out in triplicate. Rat hepatic cytosol 
(protein concentration 2mg/ml) was used as the source of receptor. Total 
binding was ascertained by the binding of [^Hj-TCDD and dioxane to the 
receptor, whilst non-specific binding was determined by the extent of binding 
remaining after competition of pH]-TCDD with TCDF in 200-fold excess. 
Results are expressed as specific binding, % control:
=  (Binding of pH]-TCDD in presence of competing ligand) - (Non-specific binding) x 100
(Total binding )- (Non-specific binding)
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7.4 Results
The binding of parent aromatic amines (figure 7.4.1) to the cytosolic Ah 
receptor revealed that all compounds used in the study were capable of 
attaining 50% displacement of pHJ-TCDD from the receptor with theexception 
of 4AAF (figure 7.4.2-7.4.7), at the concentrations studied. Although 50% 
displacement was achieved by the majority of aromatic amines, in some 
cases full displacement was not evident at the highest concentration 
employed. Total displacement of pH]-TCDD at high ligand concentrations 
(up to 5x10“^M) was not attained by the aminobiphenyls (figures 7.4.3 and 
7.4.4) and by the ami noanthracenes (figure 7.4.5). In the case of 2AA, at the 
top two concentrations, a decrease in binding of this aromatic amine to the 
receptor was observed, instead of the expected increase (figure 7.4.5). 
The assay was repeated on several occasions, each with fresh 2 AA solution, 
with similar results.
Comparison of the various compounds used in this study revealed that 2 AcF 
exhibited the greatest binding affinity (figure 7.4.7) for the receptor, as 
exemplified by its low EC5 0  value (table 7.4.1), followed by 2AAF (figure 7.4.6; 
table 7.4.1). The other acetylaminoflourene used, 4AAF, failed to displace 
pH]-TCDD to any significant extent (figure 7.4.6). The aminoanthracenes, 
1AA and 2AA both displaced pH]-TCDD (figure 7.4.5) with EC5 0  in the lO'^M 
range (table 7.4.1). 2 AF was found to possess an EC5 0  value similar to that of 
1AA (table 7.4.1). The other aromatic amines studied, namely, the 
aminobiphenyls (figure 7.4.3 and 7.4.4) and the naphthylamines (figure 7.4.2) 
displayed EC5 0  values which were slightly higher than those of the other 
compounds used (table 7.4.1). In the case of the naphthylamines, 2NA was 
found to be a better displacer than its 1- isomer (figure 7.4.2 and table 7.4.1).
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Of the aminobiphenyls, 4-aminobiphenyl was found to be the best displacer 
and the 2- isomer the poorest (figures 7.4.3 and 7.4.4; table 7.4.1).
Investigation into the binding affinity of 2-naphthylamine and some of its major 
metabolites (figure 7.4.8) at the parent compound's EC5 0  concentration, 
revealed that N-hydroxy-2-naphthylamine (2 ) and 5-hydroxy-2-naphthylamine 
(3) displaced pHj-TODD to a greater extent than the parent compound as 
demonstrated by their specific binding values (table 7.4.2). Meanwhile, the 
6-hydroxy-2-naphthylamine (4) elicited a response weaker than that of the 
parent compound.
With regards to 4-aminobiphenyl and its metabolites (figure 7.4.8), all 
metabolites displaced pH]-TCDD to a lesser extent than the parent 
compound (table 7.4.3). Of the metabolites, displacement was most 
effectively attained by 3'-hydroxy-4-aminobiphenyl (8 ), but the effect was 
weak (table 7.4.3). The other ring hydroxylated metabolites (7 and 8 ) also 
exhibited displacement of pH]-TCDD from the receptor, albeit weak (table 
7.4.3). Unlike 2-naphthylamine, the N-hydroxy (6 ) derivative of 
4-aminobiphenyl only displaced pH]-TCDD to a slight extent (table 7.4.3).
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1-Naphthylamine (1NA)
NHg
2-Naphthylamine (2NA)
NHg NHg
2-Aminobiphenyl (2AB) 3-Aminobiphenyl (3AB)
4-Aminobiphenyl (4AB)
NHz
1-Amjnoanthracene (1AA) 2-Aminoanthracene (2AA)
NHCOCH3
NHCOCH3
2-Acetylaminofluorene (2AAF) 4-Acetylaminofluorene (4AAF)
^ V - ccx)H3
2-Acetylfluorene (2AcF) 2-Aminofluorene (2AF)
Figure 7.4.1 Structures of aromatic amines used in the present study.
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1-N ap hth y lam ine
TOO 1
80  -
60  -
40  -
20  -
Compefilor concentration (M)
-3
2-Naphthy1amlne
100
60
40
Competitor concentration (M)
Figure 7.4.2 Displacement of pH]-TCDD from the Ah receptor by 1- and 2-naphthylamlne.
The specific binding of pH]-TCDD from rat hepatic 
used was 0.30nM.
Resufts are expressed as Mean ± SEM of triplicates.
 ifi  i i  f ]-  fr  r t ti  cytosol was determined using the HAP assay. The concentration of f^Hl-TCDD  
2‘ Am lnoblpheny l
120 1
100 -
80 -
60  -
40  -
2 0 -
-3
Competitor concentration (M)
3-Am inobiphenyl
140  -1
120 -
100 -
80  -
60  -
4 0  -
20 -
Competitor concentration (M)
Figure 7.4.3 Displacement of pH]-TCDD from the Ah receptor by 2- and 3-aminobiphenyl.
Ttie specific binding of pH ]-TC D D  from rat fiepatic cytosol was determined using ttie HAP assay. Ttie concentration of [^HJ-TCDD
used was O.SOnf/.
Results are expressed as h^ean ± SEM of triplicates.
2 0 8
4-A m inob iphenyl
120  -I
100 -
80 -
60  -
4 0  -
20 -
Competitor concentration (M)
Figure 7.4.4 Displacement of pH]-TCDD from the Ah receptor by 4-aminobiphenyi.
The specific binding of pHJ-TCDD from rat hepatic cytosol was determined using the HAP assay. The concentration of pH ]-TC D D  
used was O.SOnM.
Results are expressed as Mean ±  SEM of triplicates.
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1-A m lno an th rac en e
1
1
40
20
10 -3
Competitor concentration (M)
2-Am inoanthracene
120
100
40
-4 _ - 3
Competitor concentration (M)
Figure 7.4.5 Displacement of pHJ-TCDD from the Ah receptor by 1- and 2-aminoanthracene.
The specific binding of {^Hj-TCDD from rat hepatic cytosol was determined using the HAP assay. The concentration of (^HJ-TCDD
used was O.SOnM.
Results are expressed as Mean ± SEM of triplicates.
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2-A ce ty lam in ofiu oren e
120
100
40
Competitor concentration (M)
-4
4-Acetylam inofluorene
120 -1
1 0 0 -
80 -
60 -
40  -
2 0 -
Competitor concentration (M)
-4
Figure 7.4.6 Displacement of pH]-TCDD from the Ah receptor by 2- and 4-acetylaminofluorene.
The specific binding of [^HJ-TCDD from rat hepatic cytosol was determined using the HAP assay. The concentration of pH ]-TC D D  used
was O.OOnM.
Results are expressed as Mean ± SEM of triplicates.
2 1 1
2-A cety lf luorene
100
80 -
60  -
40  -
20 -
- 4
Competitor concentration (M)
-3
2-Am inofluorene
100 -
8 0 -
6 0 -
40 -
2 0 -
10 '
Competitor concentration (M)
-3
Figure 7.4.7 Displacement of pHJ-TCDD from the Ah receptor by 2-acetylfluorene and 
2-aminofluorene.
The specific binding of pH ]-TCDD from rat hepatic cytosol was determined using the HAP assay. The concentration of pHJ-TCDD used was 
O.SOnM.
Results are expressed as Mean ± SEM of triplicates.
2 1 2
Table 7.4.1 Displacement of ^ H-TCDD from rat hepatic cytosolic 
receptor by aromatic compounds.
At least seven concentrations of the displacer were employed in each study, 
each performed in triplicate.
Compound Displacement of ^ H-TCDD 
ECso (M)
1NA 1.5 X 10-4
2NA 1.6X10-5
2AB 3.0 X 10-4
SAB 7.0x10-5
4AB 4.0x10-5
1AA 6.0x10-5
2AA 2.0x10-6
2AAF 5.0x10-7
4AAF No displacement
2AcF 3.0x10-7
2AF 6.0x10-5
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(1)
c a "
2-Naphthylamine
(3)
NHg
OH
5-Hydroxy-2-naphthylamine
(2)
NHOH
N-hydroxy-2-Naphthylamine
(4)
HO
6-Hydroxy-2-naphthylamine
(5)
4-Aminobiphenyl
(6)
NHOH
N-Hydroxy-4-aminobiphenyl
(7)
2'-Hydroxy-4-aminobiphenyl 3'-Hydroxy-4-aminobiphenyl
(9)
HO NHg
4’-Hydroxy-4-aminobiphenyl
Figure 7.4.8 2-Naphthylamlne and 4-aminobiphenyl metabolite structures.
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Table 7.4.2 Displacement of ^H-TCDD from rat hepatic cytosolic 
receptor by 2-naphthylamine and principal metabolites.
A concentration of 1.0 x IG-^M was employed for 2-naphthylamine and its 
metabolites.
Compound ~Specific^ihdingof 3H-TCDD__ 
(% Control)
2-Naphthylamine (1) 36 ±1
N-hydroxy-2-naphthylamine (2) 3 ±0.9
5-Hydroxy-2-naphthylamine (3) 21 ±0.5
6-Hydroxy-2-naphthylamine (4) 78 ±1
Results are expressed as Mean ± SEM for triplicates.
Numbers in parentheses refer to structure number in figure 7.4.8.
Table 7.4.3 Displacement of ^ H-TCDD from rat hepatic cytosolic
receptor by 4-aminobiphenyl and principal metabolites.
A concentration of 5.0 x lO-^M was employed for 4-aminobiphenyl and its
metabolites.
Compound Specific binding ^H-TCDD
(% Control)
4-Aminobiphenyl (5) 43 ±2
N-Hydroxy-4-aminobiphenyl (6 ) 79 ± 0.6
2'-Hydroxy-4-aminobiphenyl (7) 92 ±0.1
3'-Hydroxy-4-aminobiphenyl (8 ) 71 ±0.3
4'-Hydroxy-4-aminobiphenyl (9) 87 ±0.9
Results are expressed as Mean ± SEM for triplicates.
Numbers in parentheses refer to structure number in figure 7.4.8.
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7.5 Discussion
The cytosolic Ah receptor has been associated with a plethora of toxic effects, 
including im mu notoxicity (Lu bet et al., 1984; Nebert and Jenson, 1979; 
Silkworth etaL, 1986) and teratogenicity (Hassoun, 1987; Ryan at al., 1989). 
However, the most studied facet of Ah receptor- mediated toxicity is its role in 
CYP1 A induction and ensuing carcinogenicity. The induction of CYP1 A, the 
principal member of the cytochrome P450 supergene family involved in the 
metabolic activation of chemicals to genotoxic species (loannides and Parke, 
1987) is thought to be mediated by the Ah receptor (Poland at a/., 1976), 
though other proteins have been implicated such as the polycyclic aromatic 
hydrocarbon protein (PBP), also known as the carcinogen binding protein 
(CBP) (Arnold at a!., 1988; Zytkovicz, 1987; Barton atal., 1988). Induction of 
CYP1 A is thought to involve binding of the inducer to the receptor, followed by 
subsequent translocation of the complex to the nucleus where it interacts with 
the XRE (xenobiotic responsive elements) of the 5' flanking region of the gene 
(Jones atal., 1985) leading to enhanced transcription (Fujisawa-Sehara atal.,
1986). Alternatively, enhancement in transcription rates may result from the 
release of NRE (negative responsive elements) which are responsible for 
repression of gene expression (Jones atal., 1985).
The aim of the present study was to ascertain whether the binding of aromatic 
amines to the cytosolic Ah receptor is related to their propensity to induce 
CYP1 A, thus substantiating the role of the Ah receptor in the induction of this 
member of the cytochrome P450 supergene family. The criteria used for 
comparison of binding affinities for the Ah receptor were the EC5 0  values of 
the aromatic amines' ie. the concentration at which 50% of the pH]-TCDD 
was displaced from the cytosolic receptor by the competing ligand. The 
potential of the aromatic amines used in this study to induce both CYP1 A
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isoforms, namely, CYP1A1 and 1A2 were ascertained in a previous study 
(Ayrton etai, 1990b).
The binding properties of the principal metabolites of two potent carcinogens, 
2-naphthylamine and 4-aminobiphenyl to the cytosolic Ah receptor were also 
investigated. This was carried out in order to ascertain whether metabolic 
intermediates of these carcinogens may participate in the induction of CYP1 A, 
since intermediates of benzo[a]pyrene metabolism have been shown to bind 
to the Ah receptor and therefore may be involved in the induction process 
(Bigelow and Nebert, 1982). The concentration chosen for binding of the 
metabolites to the receptor was based on the EC5 0  values of the parent 
compounds.
DISPLACEMENT OF [3HJ-TCDD BY AROMATIC AMINES
The EC5 0  values of the compounds which displaced pHj-TCDD from the 
receptor ranged from 10'7-10“^M which is poorer than that observed for 
polycyclic aromatic hydrocarbons such as the chrysenes (chapter 3) where 
typical values ranged between lO’ iO-IO'^M but comparable to that of other 
aromatic amines (chapters 4,5 and 6 ). Of the compounds studied which 
possessed exocyclic nitrogens, the aromatic amide 2AAF exhibited the 
greatest propensity to displace pH]-TCDD from the Ah receptor whilst its 
4-isomer failed to displace [3H]-TCDD to any significant extent. 
2-Acetylfluorene, the non-amino analogue displaced pHj-TCDD from the 
receptor even more effectively as indicated by the low EC5 0  value of 2 AcF.
Apart from the binding of compounds to the Ah receptor and the ensuing 
induction of CYP1A, other factors also contribute to the respective 
carcinogenic potential of these compounds, such as their propensity to 
generate metabolic intermediates and their subsequent genotoxic potential. In
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the case of 2AcF, which is a potent displacer of pH]-TCDD but a moderate 
inducer of both CYP1A1 and 1A2 (Ayrton etaL, 1990b) it would be expected 
that 2AcF would be a carcinogen if it could be metabolically converted to 
genotoxic species. Although the genotoxic properties of 2  Ac F are unknown 
(Ayrton at al., 1990b), tentative predictions into the route activation of 2AcF 
can be made based on its molecular structure. The absence of an amino 
group on the molecule renders 2AcF incapable of being activated by 
N-hydroxylation and subsequent carcinogenicity through nitrenium ion 
formation as with aromatic amines. Based on this premise, it may be 
speculated that 2AcF may possess at most, weak genotoxic properties 
through the formation of arene oxides. However, this is unlikely since the 
parent compound fluorene is neither mutagenic nor carcinogenic 
(Ayrton atal., 1990b).
Of the compounds studied containing an exocyclic nitrogen in the form of an 
amino or amide group, 2AF an aromatic amine was found to markedly 
enhance the induction CYP1 A1 but only moderately increase CYP1 A2  levels 
(Ayrton at al., 1990b). Based on these findings it would be expected that 2 AF 
would be a more effective displacer of pH]-TCDD from the Ah receptor even 
more potent than 2 AcF but the EC5 0  values for these compounds show that 
this was not the case. However, both CYP1A1 and CYP1A2 induction by 2 AF 
appears to correlate with its binding affinity for the Ah receptor in relation to 
the other aromatic amines used in this study (figures 7.5.1 and 7.5.2).
The aminoantracenes, 1- and 2AA were found to bind to the Ah receptor to a 
similar extent as 2AF with the 2- isomer displaying a slightly greater binding 
affinity than the 1- isomer. Studies into the CYP1A induction potential of these 
compounds revealed that both isomers induced CYP1 A1 and 1A2, however, 
the 1 - isomer was found to induce CYP1 A2  to a much greater extent than
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Figure 7.5.1 Log-log plot of EROD activity against EC50 values of 
aromatic amines used to displace [^H]-TCDD from the cytosolic Ah 
receptor.
The EC50 values for the displacement of pH]-TCDD were determined using the HAP assay. 
Ethoxyresorufin 0-deethylase activities are expressed as % control activity. For regression 
analysis, 2AAF was not taken into account: r=0.8849.
Abbreviations:
EROD: Ethoxyresorufin 0-deethylase activity. 
1NA: 1-Naphthylamine.
2NA: 2-Naphthylamine.
2AB: 2-Aminobiphenyl.
3AB: 3-Aminobiphenyl.
4AB: 4-Aminobiphenyl.
1AA: 1 -Aminoanthracene.
2AA: 2-Aminoanthracene.
2AAF: 2-Acetylaminofluorene.
2AF: 2-Aminofluorene.
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Figure 7.5.2 Log-log plot of Glu-P-1 mutagenic activity against EC50 
values of aromatic amines used to displace pH]-TCDD from the 
cytosolic Ah receptor.
The EC50 values for the displacement of pH]-TCDD were determined using the HAP assay. 
The metabolic activation of Glu-P-1 activities are expressed as % control activity. For 
regression analysis, 2AAF and 1AA were not taken into account: r=0.8199.
Abbreviations:
INA: 1-Naphthylamine.
2NA: 2-Naphthylamine.
2AB: 2-Aminobiphenyl.
3AB: 3-Aminobiphenyl.
4AB: 4-Aminobiphenyl.
1 AA : 1 -Aminoanthracene. 
2AA: 2-Aminoanthracene. 
2AAF: 2-Acetylaminofluorene. 
2AF: 2-Aminofluorene.
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2AA (Ayrton et al., 1990b). The degree of CYP1A1 and CYP1A2 induction 
exhibited by 1- and 2-AA was essentially in agreement with their binding 
affinities for the Ah receptor as illustrated in figures 7.5.1 and 7.5.2.
In the binding of 2AA to the Ah receptor, at the two top concentrations a 
decrease in the binding of this aromatic amine was observed instead of the 
expected increase. A plausible explanation for this decrease may be 
attributed to the low availability of the 2AA as a consequence of its greater 
affinity for cytosolic components other than the Ah receptor. Possible 
candidates for binding the 2AA include lipoproteins and cytosolic enzyme 
systems, such as the cytosolic oxygenase which is involved in the metabolic 
activation of 2AF and 2AAF (Leist at a!., 1992). The involvement of this 
enzyme system in the sequestering of 2AA is however unlikely since no 
detectable metabolic activation has been found for 2AA in the presence of 
untreated cytosol (Ayrton eta!., 1992) in contrast to 2AF (Leist eta!., 1992).
The naphthylamines are an extensively studied group of compounds since the
2- isomer has been associated with the onset of bladder cancers in both dogs 
and humans; 2-NA was found to be responsible for the development of 
cancers in workers in the aniline dye industry (Radomski,1979,). 2NA is 
metabolically activated by N-hydroxylation, principally catalysed by the 
cytochrome P450 mixed-function oxidases, especially CYP1A2 
(Hammons at a/., 1985). Induction of CYP1A by these compounds indicates 
that 2NA is a far more potent inducer of CYP1A1 than INA, however, 
surprisingly, both isomers induced the 1A2 isoform to similar extents 
(Ayrton at a/., 1990b). The ability of these two compounds to displace 
pH]-TCDD from the Ah receptor varied by an order of magnitude; the EC5 0  
for 2NA being an order of magnitude lower than for the 1- isomer. This finding 
suggests that the induction of both CYP1A isoforms by these compounds may
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be mediated by the Ah receptor and that the much greater carcinogenic effect 
manifested by 2NA may be partly attributed to CYP1A induction. Moreover, 
previous studies have shown that microsomal enzymes are not capable of 
N-hydroxylating 1NA which may further explain the parent compound's lack of 
carcinogenicity properties since N-hydroxylation is the principal route of 
activation for these compounds (Hammons etaL, 1985).
The aminobiphenyls vary in their genotoxic potential depending on the 
position of the amino substitution; only 4AB is a mutagen and potent 
carcinogen (Radomski, 1979; Phillipson and loannides, 1983). Furthermore, 
4AB is a potent inducer of CYP1A2 activity, whilst having no significant effect 
on CYP1A1 levels. The other two isomers, namely, 2- and 3-aminobiphenyl 
also displayed no tendency to induce CYP1A1 as monitored by the 
0-deethylation of ethoxyresorufin (Ayrton et al., 1990b), however, the
3-isomer was shown to enhance both CYP1A1 and moreover CYP1A2 levels 
on immunoblot analysis (Ayrton etaL, 1990b). The order of binding affinities 
of these compounds for the Ah receptor appear to correlate with their 
propensity to induce CYP1A, in that 4AB was found to display the greatest 
binding affinity followed by 3AB and the weakest binding was manifested by 
2AB. However, it is unlikely that the genotoxic properties of the 
aminobiphenyls can be exclusively attributed to their binding affinity for the Ah 
receptor, since the range of the EC5 0  values is narrow. The greater 
carcinogenic potential of the 4AB is most likely to be due to its propensity to 
be N-hydroxylated by CYP1A and its subsequent ability to interact with DNA 
(Masson et al., 1983). 3AB is also N-hydroxylated like the 4- isomer but the 
metabolites formed on N-hydroxylation are non-mutagenic in contrast to those 
derived from the 4- isomer, thus rendering 3AB at best a weak carcinogen 
(loannides et al., 1989). The 2- isomer has been shown not to undergo 
N-hydroxylation as amino substitutiion at the ortho position to the ring ie. at
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the 2- position, renders it non-planar so preventing its metabolism by CYP1A 
to genotoxic species (loannides et ai, 1989).
The two acetylaminofluorenes, 2- and 4-AAF are classed as carcinogenic 
(Morris et a i, 1953; Weisburger et al., 1981) and non-carcinogenic 
respectively (Weisburger etal., 1952). Their ability to induce CYP1A has been 
observed to correlate with their carcinogenic potential; the 2- isomer has been 
found to enhance CYP1A1 levels, as monitored by the increase in 
ethoxyresorufin 0-deethylase activity, and CYP1A2 by the metabolic 
activation of Glu-P-1 to mutagens (loannides ef a/., 1993b). The relative 
affinities of these compounds for the Ah receptor is consistent with their ability 
to induce the CYP1 A; 2AAF was found to be capable of displacing pH]-TCDD 
from the cytosolic Ah receptor whilst 4AAF failed to displace the radioactive 
ligand to any significant extent which is in accordance with their ability to 
induce CYP1A (loannides ef a/., 1993b). Furthermore, the differences in 
carcinogenic properties of these two isomers may also be ascribed to the 
genotoxic potential of the compounds, since the nitrenium ion derived from 
the 2- isomer has been found to possess higher stability than that from the
4-isomer (loannides etal., 1993b).
Investigation into the CYP1A induction potential of the compounds used in 
this study were carried out by Ayrton et al., 1990b and are summarised in 
table 7.5.1 with the exception of 4AAF which was carried out by loannides et 
al., 1993b. In these studies, the activities of the two CYP1A proteins, CYP1A1 
and CYP1A2 were monitored using the 0-deethylation of ethoxyresorufin and 
the metabolic activation of Glu-P-1 to mutagens in the Ames test, 
respectively. These data were then correlated with their binding to the Ah 
receptor by regression analysis since it was thought it may be of interest to 
ascertain whether a relationship exists between the binding of such.
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structurally diverse compounds, and their propensity to induce CYP1A; in 
most cases binding studies are carried out utilising chemical series of 
structurally similar compounds eg. polyhalogenated biphenyls 
(Safe etal., 1985) and ellipticines (Roy etal., 1988).
Regression analysis of ethoxyresorufin 0-deethylase activity against EC5 0  
values for the aromatic amines used in this study indicates a significant 
correlation between binding to the cytosolic Ah receptor and CYP1A1 
induction, as indicated by the correlation coefficient obtained by the log-log 
plot shown in figure 7.5.1. However, 2AAF was not taken into consideration 
since it is an aromatic amide rather an aromatic amine. 2AAF is metabolised 
by deacetylation to 2-aminofluorene, so that its induction properties may be, 
at least partly, due to the non-acetylated metabolite, which is a potent CYP1A 
inducer (Ayrton etal., 1990b).
Regression analysis of the results of the metabolic activation of Glu-P-1 to 
mutagens in the Ames test ie. CYP1A2 activity, also exhibits a significant 
correlation between binding to the Ah receptor and the induction of this 
CYP1A isoform with the exception of 1AA and 2AAF. Again, 2AAF was 
excluded from the correlation for the reasons outlined above. 1 AA appears to 
be an outlier which at present cannot be explained. One possible explanation 
for the anomaly seen with 1AA may be attributed to flaws in the Glu-P-1 
assay used to monitor the CYP1A2 levels. In the metabolic activation of 
Glu-P-1 to mutagens in the Ames test, the activation system used is derived 
from a single animal, thus, rendering the result dependent on the response of 
a single animal, which may not a true reflection of overall induction pattern. 
Alternatively, CYP1A2 levels may be determined utilising a fluorimetrc assay 
which monitors the 0-demethylation of methoxyresorufin which is considered
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to be specific for this activity (Namkung etal., 1988) and this would have been 
more appropriate.
DISPLACEMENT OF pH]-TCDD BY METABOLITES OF 
2-NAPHTHYLAMINE AND 4-AMINOBIPHENYL
The binding of the metabolites of 2-naphthylamine and 4-aminobiphenyl to the 
cytosolic Ah receptor was undertaken in order to ascertain whether 
metabolites of these aromatic amines may be ligands for the Ah receptor and 
hence likely to stimulate CYP1A induction themselves. Competition of 
pH]-TCDD by available metabolites of 2-naphthylamine and 4-aminobiphenyl 
was carried out at a concentration approximately equal to the EC5 0  value of 
the parent compounds.
Of the 2-naphthylamine metabolites, the greatest degree of [3H]-TCDD 
displacement was observed with N-hydroxy-2-naphthylamine (2 ) followed by 
the 5-hydroxy-2-naphthylamine (3), both of which displaced pH]-TCDD to a 
greater extent than the parent compound. Hydroxyl substitution at the 
6 -position, as in the case of 6 -hydroxy-2 -naphthylamine did not enhance the 
displacement of pH]-TCDD which suggests that not all generated metabolites 
are capable of binding to the cytosolic Ah receptor. With regards to 
N-hydroxy-2-naphthylamine, the most potent displacer of pH]-TCDD of the 
2 -naphthylamine metabolites investigated, it must be borne in mind that this 
metabolite is a highly reactive species which may be capable of covalent 
interactions with proteins such as the Ah receptor, ultimately resulting in 
impairment of binding. Thus, the degree of displacement of pH]-TCDD 
manifested by N-hydroxy-2-naphthylamine may not be a true indication of its 
binding to the Ah receptor.
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In the case of 4-aminobiphenyl, the results indicate that only the parent 
compound participates in the binding to the Ah receptor which then leads to 
CYP1A induction, since all the metabolites investigated, including the 
N-hydroxy derivative (6), did not significantly displace pHj-TCDD.
7.6 Conclusion
The results of this study indicate that structurally diverse amino compounds 
such as those used in this study may induce both CYP1A isoforms, namely 
CYP1A1 and 1A2, through the Ah receptor which is in accordance with the 
hypothesis of Poland etal., 1976 who proposed that induction of both 
CYP1A1 and 1A2 were mediated by the Ah receptor and not just of the 1 Al 
isoform. Furthermore, in the case of the aromatic amines, regresssion 
analysis showed a strong positive correlation between binding affinity and 
propensity to induce both CYP1A1 and CYP1A2 activities.
With regards to the role of metabolites in the CYP1A induction process it 
appears that only some metabolites are capable of binding to the cytosolic Ah 
receptor but whether CYP1A induction is enhanced as a consequence of their 
binding requires further investigation.
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CHAPTER 8
General Discussion
228
8.0 General discussion
For a Chemical to express toxicity in a living organism, the chemical must be, 
or must have the potential to be metabolically activated to a reactive 
intermediate which can interact covalently with vital cellular 
macromolecules, such as proteins, DNA and RNA, to cause toxicity. 
Furthermore at the time of exposure, the living organism must possess the 
necessary enzyme systems to generate these reactive intermediates.
The present work was undertaken to Investigate the hypothesis that the 
carcinogenic potential of a chemical may be related to its ability to induce 
the enzyme system(s) responsible for its metabolic activation to reactive 
intermediates. This was carried out by investigating the enzyme induction 
potential of the following major classes of chemical carcinogens, the 
chrysenes, the azobenzenes, the diaminonaphthalenes and related 
aromatic amines, and the diaminotoluenes. These classes of compounds 
were chosen for study due to their structural diversity and the marked 
differences in carcinogenic potential between isomers or structurally related 
derivatives.
The activation of planar chemical carcinogens is carried out by the CYP1A 
family (loannides and Parke, 1987) which in untreated animals is very low 
(Luster et al., 1982; Pickett et al., 1981). Therefore, the induction of the 
CYP1A family by potential carcinogens may be an important factor in the 
onset of carcinogenesis. Such a relationship has already been reported for 
some polycyclic aromatic hydrocarbons and aromatic amines; whereby the 
carcinogenic potential of a chemical could be correlated with their 
propensity to induce CYP1A (Ayrton et al., 1990a and b).
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CYP1A induction is believed to be regulated by the Ah receptor (Poland et 
al., 1976) and experimental studies have established a relationship between 
CYP1A induction and binding to this receptor using essentially polycyclic 
aromatic hydrocarbons (Bigelow and Nebert, 1982), TCDD analogues (Safe 
et al., 1985: Toftgard et al., 1986) and heterocyclic amines (Degawa et al., 
1989; Kleman et al., 1992). However, very little work has been devoted to 
the aromatic amines and consequently. It was thought appropriate to 
investigate the role of the Ah receptor in CYP1A induction by these 
compounds. Studies into the relationship between the binding of aromatic 
amines to the Ah receptor and CYP1A induction would also provide a further 
insight into whether the induction of CYP1A2 is mediated by Ah receptor, as 
is the case with CYP1 A l.
Although previous work has suggested that CYP1A induction may be a 
prerequisite for carcinogenesis (Ayrton et al., 1990a and b), the work using 
the chrysenes as models has indicated that CYP1A induction alone may not 
be sufficient to facilitate a carcinogenic response when other, non­
cytochrome P450 pathways are also involved in the activation of the 
compound to genotoxic species, particularly when the latter pathway is or 
becomes rate-limiting. This is evident from the observation that, in spite of 
the substantial induction of CYP1A by chrysene and all methyl-substituted 
isomers, not all members of this class of compounds are potent carcinogens 
(Coombs et al., 1976). 5-Methylchrysene, the most potent carcinogen of all 
the methyl isomers did not display higher CYP1A induction than the other 
methyl isomers. It is likely that the increased carcinogenicity of the 5-methyl 
isomer may be due to the the high genotoxicity of the diol epoxide 
(5-methylchrysene-1R, 2S-diol-3S, 4R-epoxide) which displays high 
tumourigenicity in the mouse skin and newborn mouse models (Hecht et al.,
1987). The high genotoxicity of this diol-epoxide has been attributed to the
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presence of the methyl group in the same bay-region as the epoxide which 
alters the conformation of the diol-epoxide, resulting in higher biological 
activity than the parent compound (Sayer e ta l., 1981). The lack of 
mutagenic activity in the Ames test by the members of this family in the 
presence of control and autoinduced microsomes as activation systems, 
which otherwise would elicit a positive response in the presence of 
Aroclor 1254-induced activation system, is most likely ascribed to limiting 
levels of epoxide hydrolase, the enzyme responsible for the hydration of the 
cytochrome P450 generated epoxide to the trans dihydrodiol; epoxide 
hydrolase is readily inducible by Aroclor 1254 (Parkinson et al., 1983).
In the case of the other series of structurally related compounds studied, 
namely the azobenzenes, diaminonaphthalenes and related aromatic 
amines, and the diaminotoluenes, there appears to be good correlation 
between CYP1A induction and mutagenicity on the one hand, and 
carcinogenicity on the other. However, with certain classes of compounds 
such as polychlorinated biphenyls, where the compounds are marked 
CYP1A inducers but are not metabolised at an appreciable rate to form 
electrophiles, but which are still carcinogenic (Poland and Glover, 1979; 
Safe, 1989) it may be that these compounds elicit their toxic carcinogenic 
response through other Ah receptor-mediated activities such as by 
unregulated differentiation and cellular proliferation, which is an essential 
step in the carcinogenic process. TCDD a potent CYP1A inducer and 
carcinogen, which is resistant to activation may at least partly exhibit its 
carcinogenic properties through protein kinase 0  and tyrosine kinase 
activity. In vivo exposure to TCDD leads to protein kinase C induction and 
down regulation of the EG F receptor through phosphorylation of the serine 
and threonine residues on the receptor. Furthermore, an increase in tyrosine 
kinase activity is seen, which may be responsible for abnormal cell growth
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and differentiation (Newstead and Giesy, 1993). An additional alternative 
mechanism by which CYP1A inducers may lead to the onset of chemical 
carcinogenesis may be through the induction of c-fos and c-Jun proto­
oncogenes along with AP-1 transcription factor which are required for cell 
proliferation (Puga etal., 1992).
THE ROLE OF THE Ah RECEPTOR IN CYP1A2 INDUCTION
The role of the cytosolic Ah receptor in the induction of CYP1A1 is very well 
documented. However, the role of the Ah receptor in the induction of the 
other CYP1A isoform, CYP1A2 is less well understood. It is believed that 
CYP1A2 induction is also mediated by the Ah receptor (Poland et al., 1976) 
through the regulation of gene transcription as with the 1A1 isoform, but a 
post transcriptional element has also been implicated in the induction of 
CYP1A2 (Kimura et al., 1986; Pasco et al., 1988; Silver et al., 1988; 
Soderkvist et al., 1988). Our studies also indicate that the induction of 
CYP1A2 is modulated by the Ah receptor as evidenced by the work on the 
aromatic amines where a good correlation could be established between 
CYP1A2 inducibility and binding to the Ah receptor (Figures 7.5.1 and 7.5.2).
THE ROLE OF METABOLITES IN CYP1A INDUCTION
In addition to the binding of parent compounds to the Ah receptor it is 
possible that generated metabolites may themselves bind to the Ah receptor, 
and activate the transcription of the CYP1A gene. This is especially pertinent 
in the case of the aromatic amines, where generation of metabolites capable 
of binding to the Ah receptor may possibly be achieved by constitutive 
CYP1A2. The metabolites formed on metabolism by CYP1A2 may then 
further potentiate CYP1A transcription. From the work into the possible role 
of metabolites in binding to the Ah receptor, and subsequently CYP1A
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induction, the results obtained showed the N-hydroxy metabolite of 
2-naphthylamine to be the most potent displacer of pH]-TCDD from the Ah 
receptor whilst the ring-hydroxylated metabolites of 2-naphthylamine were 
weaker by comparison, especially the 6-hydroxy derivative. However, in the 
case of 4-aminobiphenyl, the N-hydroxy derivative which, by analogy with 
the N-hydroxy derivative of 2-naphthylamine would be expected to bind to 
the Ah receptor, displaced pH]-TCDD from the Ah receptor to a similar 
extent as the ring-hydroxylated derivatives. These findings imply that the role 
of metabolites in CYP1A induction, may be dependent on the structure of the 
metabolite and its stability. Another point which merits consideration is that 
the displacement of the TCDD ligand by N-hydroxy-2-naphthylamine may to 
some extent, represent electrophilic attack to form covalent bonding with the 
receptor rather than true binding to the receptor site. Finally, It is pertinent to 
point out that the dihydrodiol of benzo[a]pyrene binds avidly to the Ah 
receptor (Bigelow and Nebert, 1982).
CYP1A INDUCTION AND MUTAGENICITY AS A PREDICTOR OF 
CARCINOGENICITY
The use of CYP1A induction and mutagenicity studies for predicting 
carcinogenesis in animals is only applicable to genotoxic carcinogens which 
require metabolic activation catalysed by CYP1A; these parameters would 
be inappropriate in predicting the carcinogenic potential of epigenetic 
carcinogens except where the effects are mediated through the Ah receptor 
eg. TCDD.
Most carcinogenicity studies are usually carried out in rodents, usually rats 
and mice. However, there appears to be differences between these two 
species in their use as predictors of carcinogenicity based on their 
mutagenic response in the Ames test; a study on the association between
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mutagenicity and carcinogenic potency of chemicals evaluated in the U.S. 
National Toxicology Program has shown the mouse to be a poor choice for 
predicting carcinogenic potency (Rosenkranz and Ennever, 1990). The lack 
of association between mutagencity and carcinogenic potency for the mouse 
suggests that in the mouse, compounds may be activated to reactive 
intermediates by pathways not reflected in the Ames test such as the 
prostaglandin H-synthase system or other cytochrome P450 isoforms. Thus, 
CYP1A Induction and mutagenicity studies in the rat may be a more 
appropriate means of predicting carcinogencity than that pertaining to the 
mouse.
Carcinogenicity studies are usually carried out over a two year period by 
administration of the test compound in the diet, however, the induction data 
in the present study was obtained by treatment of rats with a single i.p. dose 
of the test compound and sacrifice 24 hours later. Thus, this may be a 
limitation in the present work where correlations were carried out between 
CYP1A levels obtained by single dose studies, and carcinogenic potency 
based on multi-dose studies.
'Ah RECEPTOR BINDING AS A PREDICTOR OF POTENTIAL 
CARCINOGENICITY
Binding to the cytosolic Ah receptor cannot be used as an universal 
predictor of CYP1A induction and carcinogenicity. This is true for 
compounds which are not activated to reactive intermediates by CYP1A but 
by other enzymes systems such as the prostaglandin H-synthase system 
and possibly other cytochrome P450 isoforms, such as CYP2E1. 
Furthermore, although previous good correlations have been established 
between binding to the Ah receptor and CYP1A induction as already 
discussed, there is also evidence which suggests that binding to the Ah
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receptor does not necessarily lead to CYP1A induction as in the case of the 
benzocoumarins (Liu etal., 1993).
CYP1A INDUCTION IN HUMANS
Studies into the role of CYP1A in chemical carcinogenesis have been 
essentially carried out in experimental animals. These studies are of 
relevance to man as the isolated human orthologue of CYP1A2 has been 
shown to metabolise the same substrates and play the same role in 
chemical carcinogenesis as in rodents (Butler et al., 1989; Shimada et al., 
1989; Yun et al., 1991) . Furthermore, CYP1A is also readily inducible in 
man, both in the liver and in extrahepatic tissues such as the lung and 
placenta (Song etal., 1985; Sesardic etal., 1988; Petruzzelli etal., 1988; 
Passanan etal., 1990; Vahakangas ef a/., 1989). CYP1A induction has been 
demonstrated in smokers, people exposed accidentally to polychlorinated 
biphenyls (Wong etal., 1986) and patients treated with therapeutic doses of 
the drug omeprazole (Diaz etal., 1990; Rost et al., 1992). CYP1A in humans 
is also inducible through diet eg. barbecued beef contaminated with 
polycyclic aromatic hydrocarbons and cruciferous vegetables which contain 
high levels of indoles (Pantuck et al., 1979 and Conney et al., 1976). The 
human CYP1A1 isoform has not as yet been purified, but it has been 
expressed in Cos-1 cells and been shown to catalyse the oxidation of 
polycyclic aromatic hydrocarbons and N-oxidation of aromatic amines as in 
experimental animals (McManus etal., 1990). In addition, human liver 
biopsy samples have been shown to display high levels of N-hydroxylase 
activity towards 2AAF (Dybing et al., 1979), which confirm that humans 
possess CYP1A2 activity.
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THE ROLE OF CYP1A IN HUMAN CHEMICAL CARCINOGENESIS
Epidemlolglcal studies have provided evidence for the role of CYP1A in 
human chemical carcinogenesis. Lung cancer patients who were recent 
smokers have been demonstrated to possess elevated levels of aryl 
hydrocarbon hydroxylase (AHH), shown to be due to CYP1A, in their lung 
parenchyma when compared to smoking non-cancer patients. Furthermore, 
lung AHH activity was positively correlated with the level of tobacco smoke- 
derived DNA adducts, as determined by 32p_post-labelling, in recent 
smokers (Bartsch et al., 1992). In breast cancer patients, significantly higher 
survival and disease-free intervals have been associated with low AHH 
activity in breast cancer tissue when compared to those with high AHH 
activity; this suggests that AHH activity may be a good indicator of the 
malignancy (Pykko etal., 1989).
THE RELEVANCE OF CYP1A INDUCTION TO CHEMICAL 
CARCINOGENESIS
In view of the findings of the work contained in this thesis and studies cited in 
the literature (Ayrton etal., 1990a and b), CYP1A induction should be 
viewed as a strong indicator of potential carcinogenicity, especially when it 
is clear that a reactive intermediate is generated by metabolism. Although a 
chemical may be a potent inducer of CYP1A, it may only be a weak 
carcinogen either as a result of other enzymes, as in the case of 
6-methylchrysene, being important in the activation, weak electrophilicity of 
the reactive intermediate or rapid detoxication by phase 2 enzymes. Many 
industries take the view that chemicals which are inducers of CYP1A should 
not be further developed as they are very likely to be positive in long-term 
carcinogenicity studies. Furthermore, chemicals that induce CYP1A do so by
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Interacting with the Ah receptor and consequently induce cell proliferation, 
an important aspect of the process of carcinogenesis.
Conclusion
The hypothesis that the carcinogenic potential of a chemical may be related 
to its ability to induce the enzyme system(s) responsible for its metabolic 
activation to reactive intermediates may have limitations which must be 
recognised and appreciated so that this indicator may be used effectively as 
a predictor of chemical toxicity and carcinogenicity. Other factors may be 
important in the initiation of carcinogensis, in addition to the induction of 
enzymes responsible for activation of the chemical carcinogen to reactive 
intermediates, such as the genotoxicity of the reactive intermediates, 
detoxication mechanisms and unregulated cell proliferation, as in the case 
of promotion. Promotion may be as an important event as the initial mutation 
caused by genotoxic species eg. TCDD, where the compound is resistant to 
metabolism but interacts very avidly with the Ah receptor and is perhaps the 
most important CYP1A inducer.
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